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Abstract
Obesity is a major predisposing factor for a variety of life threatening diseases
such as Type II diabetes, hypertension and coronary heart diseases, resulting in
enormous financial costs. Although recent research has demonstrated the importance of
the central regulation of body energy balance, information on the development and
maintenance of chronic diet-induced obesity is still sparse. The aim of this thesis is
investigate the progressive course of development of chronic high fat diet-induced
obesity. To achieve this goal, Experimental Section A was conducted to feed the mice
with a high or low fat diet for up to 19 weeks to examine the progressive development

high fat diet induced obesity. This was then followed by the examinations of peripheral
and central exogenous leptin sensitivity. In the Experimental Section B, the mRNA
expressions of leptin receptor (LR), pro-opiomelanocortin (POMC) and neuropeptide Y
(NPY) in the hypothalamus were examined using quantitative in situ hybridisation
method. Furthermore, hypothalamic c-Fos-like immunoreactivity (FLI), alphamelanocyte-stimulating hormone (cc-MSH), and NPY were also examined in this animal
model.
In the Experimental Section A, the results demonstrated that long-term high fat
feeding resulted in a progressive dysregulation of energy homeostasis. The process of
development of high fat diet-induced obesity (DIO) in C57 B1/6J mice can be divided

into three stages: 1) an early stage in response to high fat diet that mice were sensit
exogenous leptin; 2) a middle stage when mice had an increase in leptin production and
still remained central leptin sensitivity; and 3) an increased food intake stage,
accompanied by a reduction of central leptin sensitivity.

viii

The results from Experimental Section B showed a rise, then fall, of brain leptin

receptor mRNA expressions, which corresponded to the Stages 2, and 3, of high fat diet-

induced obesity defined in Experimental Section A. This rise, and associated decline in
NPY mRNA levels, was associated with at least partially successful regulation of food
intake, and if not adiposity, homeostasis. After a longer-term exposure to high fat
feeding, a more profound breakdown occurred with overt hyperphagia and major
obesity, associated with the reduced leptin receptor expression and failure of leptin

stimulation of the POMC system. Furthermore, an increase in FLI activity in the lateral
hypothalamus (LHA), dorsomedial hypothalamic nucleus (DMH), hypothalamic arcuate
hypothalamic nucleus (Arc), and perifornical nucleus (PeF) of obese mice suggested

that these areas might be involved in the central mechanisms of the high-fat diet induc
obesity.
In conclusion, this study has provided new information for a better understanding

of central factors controlling energy balance, and clarification of the central factors

responsible for dysregulation of this system by chronic consumption of a high fat diet.

The findings may also assist identification of therapeutic targets for treatment of ch
high fat diet-induced obesity.
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Chapter 1
The Problem of Obesity
1.1 Introduction
Obesity is defined as an increase in body fat, resulting from a systemic imbalance

between caloric intake and energy expenditure, and linked to a cluster of prevalent di
including hypertension, cardiovascular diseases, and non-insulin dependent diabetes
mellitus (Atkinson, 1997; Porte et al, 1998). Obesity is believed to be of both genetic
environmental origin, involving excess caloric intake, decreased physical activity,
metabolic and endocrine abnormalities (Scheen, 1996; Perusse etal., 1997).
Several studies in both obese humans (Andersson, 1996; Clement et al., 1997;

Montague et al., 1997) and animal models (Zhang et al., 1994; Lee et al., 1996) confir

that obesity has a genetic component. Ob and db genes, two interesting gene candidates,

the products that are probably a satiety hormone named leptin and its receptor, are we

conserved among mammals (Zhang et al., 1994; Lee et al., 1996; Tartaglia et al., 1995;

Chen et al., 1996; Friedman and Halaas, 1998). It has been reported that leptin synthese
adipose depots (Zhang et al., 1994; Vydelingum et al., 1995), and an increasing leptin

expression is accompanied by increasing plasma leptin in several genetically defective

obese animal models (Maffei et al., 1995b; Vydelingum et al., 1995). In ob/ob mice, whic
are markedly obese, the ob gene is mutated and also has a massively elevated ob gene

expression, but no biologically active leptin is secreted due to defective protein syn
(Zhang et al., 1994). Obese mice of another strain db/db, with a mutation in the mouse

gene, result in obesity and diabetes in a syndrome resembling morbid human obesity. The

db/db mice have normal ob genes that produce normal leptin, but they lack a functional

receptor for leptin and result in a hyperleptinaemia (Halaas et al., 1995; Lee et al., 1
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Several environmental factors have been suggested to induce progressive
development of obesity in humans and animal models (Frederich et al., 1995a; Devaskar et

al., 1997). Firstly, obesity has often been considered to be mainly due to overeating a h

fat diet. The influence of excess high fat intake is clearly of great importance. Similar
is known that an oversupply of fat is associated with the development of obesity in the
C57B1/6J mice (Surwit et al., 1988). An investigation by Rebuffe-Scrive et al (1993)
showed that C57B1/6J mice fed a diet containing 35.8% fat and 36.8% carbohydrate for 5
months had greater body weight and visceral fat mass compared with mice fed a diet

containing 9.8% fat and 56% carbohydrate controls. It implies that not only fat increases

the palatability of food but it is also converted into body fat far more efficiently than
carbohydrates. However, the mechanism of high-fat diet induced obesity is still unclear.

After acute exposure (1 week) to the high-fat diet (35.8%), mice do not significantly alt
body weight, blood glucose and insulin levels (Surwit et al., 1988). However, long-term
exposure to a high-fat diet can induce obesity with hyperphagia, hyper glue onemia,
hyperleptinemia and insulin resistance (Surwit et al., 1988; Widdowson et al., 1997). It
been suggested that the high-fat diet induced obesity might be attributed to an increase
white and brown fat growth (Storlien et al., 1986). It has also been found that high-fat

induced obese rodents have a low sympathetic activity, which in turn results in decreased
energy expenditure (Levin et al., 1983a; Levin, 1996). But, it is not known whether the
reduced sympathetic activity is due to a primary defect in the central nervous system
during the development of diet-induced obesity.
Another environmental factor promoting obesity is a sedentary lifestyle with
lessened physical activity (Perusse et al., 1997). A low level of physical activity is
associated with a low daily energy requirement and causes obesity unless food intake is
limited accordingly (Stunkard, 1996).
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Accumulative evidence shows that increase in fat mass is associated with an
increased leptin synthesis in either obese humans or animal models (Frederich et al.,

1995b; Maffei et al., 1995b). The relation between body fat distribution and plasma levels
in the human has been examined in 51 obese and 41 non-obese subjects (Takahashi et al.,

1996). The results show that plasma leptin has a positive correlation with body mass index
and subcutaneous fat mass in obese subjects, but not with visceral fat mass (Takahashi et

al., 1996). In humans, diet-induced weight loss also results in a decrease in plasma lepti
concentration (Considine et al., 1996b), while there is an increase in plasma leptin

concentration along with weight gain (Kolaczynski et al., 1996) as well as in diet-induced

obese mice OFrederich et al., 1995a). It is suggested that the increasing plasma leptin in
obese humans and diet-induced obese animals might be due to peripheral or/and central
resistance to leptin (Widdowson et al., 1997; Friedman and Halaas, 1998).
In humans, the observation of strong positive correlation, between the percentage
of body fat and plasma leptin, argues against the hypothesis that an absolute leptin
deficiency can induce a high prevalence of human obesity. Conversely, plasma leptin

concentration positively correlates with body fat mass and is usually elevated in the grea
majority of obese humans (Chessler et al., 1998). This suggests that human obesity is

generally associated with insensitivity to leptin, or in other words, it is related to lep
resistance. The basis of leptin resistance in obese human subjects is unknown. Two

potential mechanisms for this resistance have been explored (Caro et al., 1996b). The firs
is that a defect of the blood-brain barrier transport system results in less leptin being

brought into the brain. That such a defect exists is supported by the fact that high level
plasm leptin in obese subjects are not paralleled by proportional rises of leptin in

cerebrospinal fluid (Caro et al., 1996b; Schwartz et al., 1996b). A second possibility for

leptin resistance involves defects in the sites of leptin action within the central neuro
system, specific to the hypothalamus (Chang et al., 1999). Therefore, great attention is
3

focused on the molecular target of leptin action in the region of the brain. In the obese
animal, the diet-induced C57 obese mouse is a well-defined animal model resembling

human obesity, particularly susceptible to a high-fat diet-induced obesity with high ser
leptin (Chessler et al., 1998). While much is now known about the characteristics of
developed obesity in the C57 mice, the mechanisms underlying the dysfunction of the

central neuronal regulative system that leads to develop leptin resistance are still lar
unclear.
Previous evidence shows that leptin, secreted by adipocytes, is transported through
the blood stream, and acts on the hypothalamus to regulate energy intake and expenditure

(Schwartz et al., 1996b; Schwartz et al., 1996c). Choroid plexus contains leptin receptor

and plays an important role in transporting plasma leptin into the brain (Lee et al., 199

Malik and Young, 1996; Schwartz et al., 1996c). The leptin receptor is highly expressed i
the hypothalamic Arc, where the leptin receptor co-localizes with POMC (Cheung et al.,

1997; Thornton et al., 1997) and NPY neurons (Baskin et al., 1999c; Mercer et al., 1996a)

There is speculation that the reduction in leptin activity on dietary induced obese rode
might be caused by down-regulation of the transporter or leptin receptor mRNA expression
in the Arc (Widdowson et al., 1997), in turn to cause its downstream pathways
dysfunction. Both the leptin-Arc leptin receptor-POMC and leptin-Arc leptin receptorNPY pathways have been suggested as playing an important role in regulating feeding
behavior and energy balance in the development of diet induced obesity (Friedman,
1997a). However, there is no direct evidence to support the hypothesis.
The POMC gene, encoding the precursor for a-MSH (Cone et al., 1993; Tonon et

al., 1993) is expressed in the hypothalamic Arc of mice (Cheung et al., 1997; Thornton et
al., 1997). Intraventricular injection of a-MSH or the stable a-MSH analogue (MT-II)

inhibits feeding in both a time and dosage dependant manner OFan et al., 1997). Reduction
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of P O M C m R N A is seen in ob/ob and db/db mice (Mizuno et al, 1998). Furthermore,
injections of leptin significantly increase POMC mRNA expression in Arc of ob/ob mice

(Thornton et al., 1997; Mizuno et al., 1998). Therefore, the pathway leptin-leptin receptor
POMC neurons are clearly involved in the regulation of the negative balance of energy
intake and expenditure.
NPY consisted of 36 amino acids and is one of the most potent stimulants of food
intake O-arhammar et al., 1987). Hypothalamic NPY neurons lie primarily in the Arc
(Chronwall et al., 1985). An over-expression of Arc NPY mRNA is reported in the ob/ob
and db/db mice (Mercer et al., 1996a; Schwartz et al., 1996c). Intraventricular injection

leptin significantly reduces the level of NPY mRNA expression in the rat Arc (Wang et al.,
1997a). Therefore, the pathway of leptin-leptin receptor-NPY neurons is clearly involved
in the regulation of the positive balance of energy intake and expenditure.
In summary, obesity, characterized by increased mass of adipose tissue, arises from
complex interactions between environmental and genetic factors. It is suggested that
dysfunction of leptin or its two hypothalamic downstream pathways might be critically
involved in the development of high fat diet-induced obesity. However, the mechanisms
underlying the energy balance derangement that lead to obesity are still largely unclear.

1.2 Aims of the Study
The main aims of the present thesis are:
I. To investigate the development of high fat diet-induced obesity and leptin resistance
in mice.
II. To determine the alterations of leptin related neural pathways during the progressive
course of the development of high fat diet-induced obesity.
In order to achieve these aims it is necessary to study the progressive course of
development of obesity, which relates to leptin sensitivity. Two studies (Chapters 3 and
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are designed for the purpose and presented in Experimental Section A of this thesis.
Choroid plexus and Arc leptin receptor mRNA, Arc POMC mRNA and Arc NPY mRNA
are examined using radioquantitative in situ hybridization detection method established
Experimental Section B (Chapters 6, 7 and 8). Using immunohistochemical technique,
hypothalamic c-Fos, a-MSH and NPY proteins are examined in the obese mice also
established in Experimental Section B (Chapters 5, 7 and 8).

1.3 Significance of the Study
The outcome of this study will contribute to our understanding of central molecular

and chemical expression changes that occur during different stages of diet-induced obesi

These findings will further elucidate some uncovered central regulating mechanism that i
related to the cause of leptin resistance. The new discoveries about the functional

significance of the central neuroanatomical structure, changes of central leptin recepto
mRNA or its physiological function, as well as downstream pathways in the diet-induced
obese animal model, may provide important information for designing new
pharmacological treatment for human obesity and diabetes.

1.4 Hypotheses
I. A high fat diet may progressively induce development of obesity with insensitivity to
leptin in the C57B1/6J mice.

II. Leptin resistance in DIO mice may be caused by high plasma leptin to alter the centra
leptin receptor mRNA expression, thus, causing a reduction in the leptin sensitivity in
the brain.
III. The down-regulation of Arc leptin receptor mRNA in DIO mice may result in its
downstream POMC or NPY pathways dysfunction.
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Chapter 2
Review of the Literature
2.1 General Introduction
Dietary induced obesity has been reported in both humans and experimental
animals (Frederich et al., 1995a; Devaskar et al., 1997). C57 B1/6J mouse is one type of
most commonly used animal model in studying diet-induced obesity (Surwit et al., 1988).
Since the discovery of leptin in 1994, the elucidation of leptin-leptin receptorhypothalamus pathway has generated tremendous excitement in the obesity research

(Zhang et al., 1994; Tartaglia et al., 1995; Chen et al., 1996; Lee et al., 1996; Friedma
Halaas, 1998). Some novel data have been accumulated, bearing on the regulation of leptin

secretion as well as its down-stream of hypothalamic neurotrasmittes involved in reducing
food intake and energy expenditure (Friedman and Halaas, 1998). Before describing

detailed experimental studies of this thesis, it is necessary to review the literature in

relation to diet and obesity, hypothalamic structure and leptin and leptin receptor, proopiomelanocortin and neuropeptide Y systems, which relate to high-fat diet induced obese

in C57 B1/6J mice. Therefore, the literature related to the following sections is reviewe
and presented in this chapter.
(1) Obese gene and leptin
(2) Leptin receptor
(3) High fat-diet induced obesity
(4) Body weight and fat storage
(5) Hypothalamus, choroid plexus and obesity
(6) Neuropeptide Y mRNA and protein
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(7)

Pro-opiomelanocortin m R N A and a-melanocyte-stimulating hormone

2.2 Obese Gene and Leptin
2.2.1 Obese Gene
Using a positional cloning approach, Friedman and his colleagues (Zhang et al.,
1994) identified and characterized the obese gene, mutated in the obese mouse strain
ob/ob. The ob gene encodes a 4.5 kb mRNA with a 167-animo-acid open reading frame
that shares no significant homology with any known gene in Genebank (Zhang et al.,
1994). It is demonstrated that the amino acid sequence is 84% identical to that in
humans and mice and has features of a secreted protein, which is named as leptin.
Obesity in the mutant ob/ob mice can be attributed to a deficiency in active leptin,
which increases calorie intake and decreases energy expenditure (Zhang et al., 1994).
While db/db mice, with a defective receptor response to the leptin, ob gene expression
is increased (Tartaglia et al., 1995; Lee et al., 1996). The ob gene is expressed
exclusively in white and brown adipose tissue (Zhang et al., 1994; Vydelingum et al.,
1995; Tsuruo et al., 1996). In the rat, the mRNA expression of ob gene in the adipose
tissue is the lowest during the light cycle, increasing after the rat starts eating at
p.m. and reaches a maximum around 4.00 a.m. The rhythm of adipose tissues ob
mRNA expression is entirely linked to changes in food intake. Under normal

conditions, the level of ob gene expression is correlated with the amount of body fat i
humans and mice (Lonnqvist et al., 1995; Trayhurn and Rayner, 1996). Increased ob
mRNA level in white adipose tissue has been reported for several types of obese
animals, including the db/db mouse, Zucker (fa/fa) rat and the mice made obese by the
administration of goldthioglucose or monosodium glutamate (Maffei et al., 1995a;
Murakami and Shima, 1995; Vydelingum et al., 1995). Conversely, weight reduction
leads to decreased ob gene expression in both humans and rodents (Considine et al.,
8

1996b). After 12 weeks feeding, high fat-diet induced obese mice can also increase ob

gene expression in the white adipose tissue (Frederich et al., 1995a). Altogether, thes
observations suggest that the level of ob gene mRNA is tightly linked to total body
adipose mass and reflect cyclic variation of ob mRNA level changes in response to
feeding behavior.

2.2.2 Plasma Leptin
Leptin, secreted from adipose tissue in proportion to body adiposity (Maffei et
al., 1995b; Considine et al., 1996b), circulates in blood and acts on central neural
networks that regulate feeding behavior and energy balance (Lynn et al., 1996; Baskin
et al., 1999a; Eichler et al., 1999). The main determinant of circulating leptin
concentration in both rodents and humans is fat mass (Maffei et al., 1995b; Considine
et al., 1996b). Accumulating evidence suggests that leptin appears to play a key role
the control of body fat mass through coordinated regulation of body energy balance in
rodents and humans (Cusin et al., 1996; Hwa et al., 1996; Prolo et al., 1998). Leptin
levels increase exponentially with body mass index (BMI) or percentage body fat

(Chessler et al., 1998). Therefore, a relatively small variation in body fat mass resul

in a large variation of circulating leptin levels (Niskanen et al., 1997b; Chessler et
1998). In addition, consistent with the rhythm of adipose tissues ob mRNA expression

as mentioned previously, plasma leptin also shows a significant diurnal variation in r
with a peak at early morning (Sinha et al., 1996a).
Much information on the role of leptin in regulation of energy balance has
come from the study of ob/ob and db/db mice. Ob/ob mice have a deficiency of

functional leptin (Zhang et al., 1994). Leptin acts as a potent inhibitor of feeding i
both lean and ob/ob mice (Campfield et al., 1996). After four days with daily
intraperitoneal injection of leptin, the ob/ob mice showed 60% reduction in food
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consumption compared with untreated ob/ob mice. Four weeks later, the ob/ob mice
reduced their body weight by 40% (Halaas et al., 1995). All body weight loss was due
to a reduction of the fat mass, which showed a decrease by 75% (Halaas et al., 1995).

The physical activity of ob/ob mice also increased considerably with decreases in bloo
glucose, insulin and normalisation of metabolic status relative to controls
(Pelleymounter et al., 1995). However, db/db mice did not respond to leptin treatment

in the reduction of either food intake or loss of body weight (Schwartz et al., 1996c)

Interestingly, when normal lean controls are injected with leptin (12.5 ug/twice daily
body weight reduces by 12% and total fat mass drops by 95% (Halaas et al., 1995).

Single intracerebroventricular injection of leptin into lateral ventricle of ob/ob mic
induces a dose-dependent reduction of food intake and body weight compared with
controls (Campfield et al., 1995). These experimental results suggest that circulating
leptin, generated in adipose tissue, acts on central neuronal networks. These results

suggest that ob/ob mice fail to produce leptin from their fat cells but their brains r
sensitive to exogenous leptin, while db/db mice produce leptin but their brain leptin
receptors cannot respond to it (Campfield et al., 1995).

2.2.3 Leptin Production Correlates With Fat Stores
In humans, several studies have shown that a strong correlation between
percentage of body fat and plasma leptin concentration (Considine et al., 1996a;
Kolaczynski et al., 1996). When normal weight subjects (136 cases) were compared
with 139 obese patients (139 cases), it was revealed that a mean plasma leptin
concentration of 7.5 ± 9.3 ng/ml in normal weight subjects was much lower, compared
to 31.3 ± 24.1 ng/ml in obese patients (Considine and Caro, 1996; Considine et al.,
1996b). The results suggest that obesity in humans appears to be associated with

reduction of leptin sensitivity, rather than a leptin deficiency. In humans, diet-indu
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body weights loss results in a decrease in plasma leptin concentration (Considine et al.,

1996b). This result implies that plasma leptin not only reflects body fat during the fa
gain, but also during the weight loss, as low plasma leptin is likely to be a potent
stimulus to weight gain. In addition, leptin treatment in humans is being studied in

clinical trials. Preliminary data shows that daily leptin injection for four weeks are
and cause small but significant weight loss in both lean and obese patients compared
with the controls (Friedman and Halaas, 1998).

2.2.4. High Fat Diet and Leptin Sensitivity
A DIO animal model is more applicable to mimic human obesity than those
with a genetic deficiency (Caro et al., 1996b). DIO mice can be induced by feeding a
diet composed of high fat content (Surwit et al., 1988). It has been demonstrated that

the DIO mice are still sensitive to i.p.injection of leptin after a short term of high
diet feeding (Campfield et al., 1996; Van et al., 1997). For example, the mice fed a
high fat diet for 4 days showed a similar reduction in cumulative food intake (-14%)

following leptin injection {i.p. lOmg/kg) compared to those fed a low fat diet (-20%

(Van et al., 1997). Halaas et al (1997) reported that after 6 weeks of a high fat diet,
DIO mice had a reduced sensitivity to intraperitoneal injection of leptin (12.5mg/kg,
twice daily). It showed that the body fat of DIO mice was reduced by 30.5%, while the
lean group on a lab chow diet lost 82.7%. Similar results were reported by others (Van
et al., 1997). This clearly indicates the existence of peripheral leptin resistance in
mice fed a high fat diet for a relatively long term. A high fat diet was given for a
further longer period, the obese rats could develop insensitivity to exogenous leptin

centrally. Widdowson et al (1997) showed that after a high fat diet for 8 weeks, Wistar
rats became obese with hyperleptinemia and hyperglycemia. These obese rats had a

reduced central leptin sensitivity measured by food intake after i.c.v injection of le
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(Widdowson et al., 1997). It is n o w k n o w n that leptin sensitivity varies according to
the sites of deficiency (Fig 2.1). The ob/ob mice are the most sensitive to leptin,
a deficiency of endogenous leptin (Zhang et al., 1994). The db/db mice are totally

insensitive to exogenous leptin, due to a lack of a functional leptin receptor (Tart
et al., 1995; Lee et al., 1996). The sensitivity of DIO mice to exogenous leptin is
between normal and db/db mice. It has been suggested that the majority of obese
humans might respond to leptin administration in a similar manner to DIO mice (Caro
et al., 1996b).

Leptin
Effect in
Humans
ob/ob
Mice

Normal
Mice

DIO
Mice

db/db
Mice

< •
Most Sensitive

Most Resistance

Fig. 2.1 The wide range of leptin response in mice and the prediction
that most obese humans will respond like the DIO mice (Reprinted
from Caro et al., 1996b).

2.2.5 The Physiological Functions of Leptin
Over the last 8 years, more than 2500 papers on leptin have been published,
creating a substantial and rapidly changing body of knowledge. The physiological
functions of leptin can be summarized as:
1. Leptin can regulate energy intake and expenditure by acting peripherally and
centrally.
2. Leptin can regulate reproduction functions.
3. Leptin can interact with other hormones such as insulin.

12

4.

Leptin can regulate some neurotransmitter functions such as neuropeptide Y and

POMC.
5. Leptin can stimulate sympathetic neural activity in adipose tissues, kidney, and
adrenal gland.

2.3 Leptin Receptor
A big step to understanding leptin action was taken when Tartaglia et al (1995) first
isolated the leptin receptor (LR) from a mouse choroid plexus by expression cloning. The
leptin receptor consisted of 894 amino acids possessing a 23-amino acid trans-membrane
domain, and a short cytoplasmic domain of 34 amino acids.
Chen et al (1996) identified a leptin receptor cDNA in db/db mouse hypothalamus.

They show that the leptin receptor is identical to that of the choroid plexus except that a

intracellular region contains an additional 268 amino acid. The extracellular domain of th
leptin receptor shows many features of the class-I cytokine receptor family and contains a

januks kinase interaction motif and a signal transducer and activator of transcription mot
(Chen et al., 1996). The human leptin receptor was cloned from a human infant cDNA
library. The amino acid sequence of the human leptin receptor extracellular domain is 78%
identical to that of the mouse leptin receptor (Tartaglia et al., 1995).
It has been reported that there are at least 5 splice variants of leptin receptor
isoforms, which play different physiological functions.

2.3.1 Five Isoforms of Leptin Receptor and Functions
At least five isoforms of leptin receptors have been identified in experimental
animals (Lee et al, 1996), referred to LRa, LRb, LRc, LRd and LRe. (Fig. 2.2).
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Alternative Splicing of the Leptin Receptor
His796

Lys»w

TM

Extracellular

1 I

Boxl

L R a (Choroid Pleux)

NFQK889

RTDTL*

L R b (Hypothalamus)

NFQK889

270aa TaH

LRc

NFQK889

VTV*

LRd

NFQK889

DISFHEVFIFR*

L R e (Soluble)

FYIH796

Box2

GMCTVLFMD*

Fig. 2.2 Alternatively spliced form of the leptin receptor. The extracellular domain, transmembrance domain ( T M ) and J A K binding domains (Box 1 and B o x 2) of the full-length receptor
are illustrated. The truncations and terminal amino acid sequences for receptor variants Ra, Re, R d
and R e are shown using the single letter amino acid code. Adapted from Ref: Lee et al (1996).

The mouse L R b has a long cytoplasmaic region containing several motifs

required for signal transduction. This isoform is highly expressed in the hypothalamu
a brain region known to be important in regulation of body energy balance.
The mouse LRa is highly expressed in the choroid plexus. The function of LRa
is thought to be primarily responsible for transporting leptin from the blood stream
the brain (Lee et al, 1996; Caro et al., 1996b). The LRa has a 34 amino acid
intracellular domain and 100% homologous to the long isoform of leptin receptor from

the N-terminus to an alternate splice site at Lys889 (Tartaglia et al., 1995; Lee et a
1996).
The functions of another two leptin receptors, LRc and LRd, are unclear (Lee et
al., 1996).
The LRe is the shortest and lacks a transmembrance domain (Lee et al., 1996).

Therefore, it has been suggested that the LRe is a soluble receptor as a carrier to b
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leptin. This isoform of leptin receptor assists transporting and clearance of blood leptin
(Sinha et al., 1996b; Diamond et al., 1997).

2.3.2 Leptin Receptor Mutation in db/db mice
A point mutation in hypothalamic leptin receptor in db/db mice has been

identified (Chen et al., 1996; Lee et al., 1996). There is a 106 base insertion at th
junction where the long and short form transcript diverge (Fig. 2.3). The insertion

caused by a G to T substitution and generates a new splice donor within the exon of t

short receptor. Since the inserted 106 sequence is the same as the initial 106 basep

of the short form specific C-terminal sequence and includes a stop codon, it results
synthesis of a truncated long receptor which is lacking in the most of intracellular

domain. The mutation causes alternative splicing of the leptin receptor gene to prod
a nonfunctional long form leptin receptor and leads to the severely obese phenotype
found in db/db mice.

2.3.3 Distribution of Leptin Receptor mRNA Expression
2.3.3.1 Leptin Receptor mRNA Expression in Brain
Using in situ hybridisation, the leptin receptor mRMA has been found in
choroid plexus and several hypothalamic nuclei, including the Arc, VMH, DMH,
LH and PVN (Schwartz et al, 1996c; Malik and Young, 1996; Baskin et al 1998).
Binding study shows that choroid plexus has very high binding affinity to leptin in
both humans and animals (Tartaglia et al., 1995; Boado et al., 1998). The Arc is the
nucleus where the leptin receptor co-localized with NPY and POMC neurons
(Mercer et al., 1996a; Cheung et al., 1997; Thornton et al., 1997; Baskin et al.,
1999b). The LR-b isoform is highly expressed in the Arc, which plays an important
role in modulating its downstream nerurotrasmittes (Baskin et al., 1998). The VMH
and LH have projections both within and outside the hypothalamus (Flier and
15

Maratos Flier, 1998; Elias et al., 1999). T h e D M H projects to the P V N and then
controls secretion of the peptides from both the posterior and anterior pituitary to
regulate food intake and body weight (Bernardis and Bellinger, 1987).

Fig. 2.3 T h e db/db mutation apparently produces a shortened, and probably
nonfunctional, leptin receptor.
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Leptin receptor mRMA expression has also been found in peripheral
tissues, including T-cells, hepatic cells and vascular endothelial cells (Lee et al.,
1996; Lollmann et al., 1997; Wang et al., 1997b), and organs such as heart, lung,
testes, kidney, placenta and spleen (Hoggard et al., 1997). Growing evidence
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suggests that leptin is not only a central regulator related to energy balance, but also
a modulator involved in circulative, reproductive and immunological functions.

2.3.4 Adipose Tissue-hypothalamic Leptin-Axis
Kennedy suggested a link between adipose tissue and central neural network
pathway over 40 years ago (Kennedy, 1952). The lipostasis theory postulated that a
regulating system would require afferent signals (negative feedback) indicating the
status of energy stores, efferent processes regulating energy intake, storage and
expenditure and finally integration of components in the central nervous system. The

evidence that negative feedback signals for such lipostatic regulation was a circulatin
factor coming from parabiosis studies (Coleman, 1973). When the parabiosis
experiments were performed between the ob/ob and db/db mice, the ob/ob partner
reduced its food intake and loss of body weight, while the db/db mice partners
maintained both their food intake and body weight. These results suggest that ob/ob
mice can not make an adiposity negative feedback signal factor due to suffering from
autosomal recessive mutation at the ob locus, whereas db/db mice can not respond to
this signal factor with mutations at the db site (Coleman, 1973).
Since identification of the ob gene in 1994, rapidly accumulating evidence
suggests that leptin is the primary afferent signal by which adipose tissue
communicates with the hypothalamic leptin receptor for the purpose of regulating
energy balance. The discovery of the ob gene and its encoded hormone production,
leptin, confirms the hypotheses by Coleman (1973) that ob/ob mice have a genetic
leptin deficiency, whereas db/db mice have genetic leptin resistance as a result of a
leptin receptor defect. This hypothesis has been supported by evidence from several
sources: (1) Plasma leptin levels vary with metabolic status and the level of stored
adipose tissue, which show that both the ob gene and circulating levels of leptin are
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reduced by food deprivation and increased in satiety (Saladin et al., 1995; Takahashi et

al., 1996; Wing et al., 1996); (2) I.c.v injections of leptin into the third ventricle
ob/ob mice, lowered food intake and body weight within 24 h, and increased 53%
thermogenesis and mobilized fat metabolism (Hwa et al., 1996), but this was not the
case in db/db mice; (3) Leptin binding sites have been identified in the hypothalamus
and the leptin receptor mRNA has been localized at the hypothalamic arcuate nucleus

(Baskin et al., 1999b; Mercer et al., 1996a; Cheung et al., 1997; Thornton et al., 199
(4) In ob/ob mice the hypothalamic leptin receptor is over-expressed, and this can be

reversed by leptin treatment (Mercer et al., 1996a; Baskin et al., 1998); (5) Leptin c
increase hypothalamic POMC mRNA levels, while inhibiting hypothalamic NPY
mRNA expression in ob/ob mice. Both neurotransmitters are known to be critically
involved in energy balance (Stephens et al., 1995; Schwartz et al., 1996a; Mizuno et

al., 1998). Taken together, these findings lead to the concept that there is an adipos
tissue-hypothalamic leptin regulatory axis for energy balance. Leptin may function as
a lipostast. When fat stores rise, adipocytes produce leptin, which signals the
hypothalamic energy balance center, indicating that it is time to stop eating and
increase activity. Conversely, when fat stores decline, leptin production reduces and
signals hypothalamic energy balance center to try to counteract the weight loss and
increase feeding and reduce activity.

2.3.5 Leptin Resistance
2.3.5.1 High Plasma Leptin and Leptin Resistance
Leptin has been postulated to be a blood borne signal from the adipocytes
that informs the brain, through the leptin receptors in the hypothalamus, about the
size of fat mass. However, in the majority of obese humans and most experimental
animal models, there is an increased plasma leptin, indicating that most obese
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individuals m a y be leptin resistance (Caro et al., 1996a; Takahashi et al., 1996),
The cause of leptin resistance is unknown at this point.

2.3.5.2 Potential Mechanisms for Leptin Resistance
At least, Five potential mechanisms for causing leptin resistance have been

explored (Fig. 2.4). The first is that there might be a defect in the blood-brain b
transport system for bringing leptin into the brain. That such a defect exists has
supported by the fact that a high serum leptin observed in obese human subjects is
not paralleled by proportional rises in cerebrospinal fluid (CSF) leptin, which

suggests that this leptin resistance results from reduced levels of leptin transpor
into CSF (Schwartz et al., 1996b). It has been suggested that the second potential

mechanism of leptin resistance may lie in the hypothalamic leptin receptor. Due to a
high level of leptin stimulation, it might be down-regulated hypothalamic leptin
receptor production in a high fat diet-induced obese rat (Widdowson et al., 1997).
Similar findings were reported in the conference proceedings that a high fat diet
could induce low mRNA expression of leptin receptor in PVN and Arc (Chang et

al., 1999). The third site for leptin resistance might involve defects in the centra
leptin receptor's downstream neurotransmitters such as POMC and NPY pathways.

It has been reported that genetic leptin resistance db/db mice have an increased NPY
production, and reduced POMC production (Schwartz et al., 1996c; Mizuno et al.,

1998). However, no systematic investigation has yet been carried out in the study of
leptin sensitivity, and the gene expressions of leptin receptor, NPY, and POMC in
diet-induced obese animal model. Another possible mechanism of leptin resistance
might be due to an improper amount of soluble leptin receptors in the blood stream

to limit the concentration of free leptin that reaches the brain (Caro et al., 1996b

This hypothesis has not yet been confirmed. Finally, it is also possible that the l
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resistance is caused by a hyperactivity of Suppressors-of-Cytokine-Signaling 3
(SOCS-3), which can inhibit intracellular leptin signal transduction pathway
(Bjorbaek et al, 1998).
In summary, although these experimental results might partially explain

some aspects of leptin resistance, the molecular basis in the central neural syst
causing leptin resistance is still poorly understood.

Possible Defect Sites of Leptin Resistance

Fat Store & Obesity

Food Intake t
Energy Expenditure |
Activity ?
Temperature |

High Fat Diet
Fig. 2.4 Possible defect sites of leptin resistance (1) Blood-brain barrier LR-a defect;
(2) Hypothalamic arcuate neucleus LR-b mutation or dysfunction; (3) Defects in the
leptin receptor's downstream transducers ( N P Y or/and P O M C ) pathways; (4) Blood
stream leptin carrier (LR-e) defect; (5) Hyperactivity of Suppressors-of-CytokineSignaling 3 (SOCS-3).
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2.4

High Fat Diet-Induced Obesity

2.4.1 C57 B1/6J Mice
A high fat diet can induce obesity in several animal models (Surwit et al., 1988;
Frederich et al., 1995a; Masuzaki et al., 1995). The C57 B1/6J mouse was an animal
model that was particularly susceptible to the development of high-fat diet induced
obesity (Surwit et al., 1988). The mice carried a genetic predisposition, which could be
created through dietary manipulation and develop severe obesity, hyperglycemia,
hyperinsulinemia and hyperleptinemia (Ikemoto et al., 1996; Van et al., 1997). After
development of obesity, as an animal model, C57 B1/6J mice were reported to closely
resemble common forms of human obesity and type II diabetes as well as leptin

resistance (Surwit et al., 1988; Surwit et al., 1997). Therefore, it is very valuable to u
the diet-induced obese animal models to produce the data for potential understanding
of the development of human obesity and its related metabolic disorders.

2.4.2 Development of Diet-induced Obesity is Determined by Interindividual Genetic Background or Susceptibility
Compared with diet-resistant mice (A/I mice), C57B1/6J mice have several
differences in metabolic response to high fat diet feeding.
(1) C57 B1/6J mice, but not A/J mice, show a decreased adenylyl cyclase activity
in both white and brown adipose tissues in response to beta-adrenergic stimulation

(Collins et al., 1997). This results in reducing lipolysis in white fat and thermogenesis
in brown fat (Collins et al., 1997).
(2) After 4 weeks of a high fat diet, the plasma leptin level in C57 B1/6I mice is 2
fold lower than that of A/J mice (Surwit et al., 1997). It is known that leptin can
increase sympathetic outflow (Collins et al., 1996). Therefore, low production of leptin
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in response to a high fat diet in C 5 7 B1/6J mice m a y cause less ability to dissipate

calories as heat via thermogenesis in the early development of obesity (Surwit et al.
1997).
(3) After 8 months of a high fat diet, C57 B1/6J mice present adipocyte hyperplasia
accompanied by a significant increase in plasma glucose, insulin and leptin compared
with A/J mice (Surwit et al., 1997).
(4) C57 B1/6J mice have a significantly higher feed efficiency (FE = weight
gained/calories consumed) on a high fat diet, compared with A/J mice (Parekh et al.,

1998). This suggests that C57 B1/6J mice actually consume fewer calories calculated i
per gram of body weight gain than those of A/J mice during development of obesity.

2.4.3 Composition of Diet
2.4.3.1 Composition of Dietary Fat and Carbohydrate
The effects of diet composition on the development of obesity can be
clearly seen in animal experiments. Obesity is rare in experimental animals
maintained on a low-fat diet compared with a high fat diet, even when they are
housed in small cages that limit physical activity. A model with potentially more
applicability to human obesity is a high fat diet induced obesity in mice and rats
(Surwit et al., 1988; Masuzaki et al., 1995). After a high fat diet feeding for 4 to
weeks, West and his colleagues found that approximately 70% of some, but not all,
strains of mice and rats rapidly gained body weight and become very obese,
compared with low fat diet fed controls (West et al., 1994). C57 B1/6J mice fed a
high fat diet containing 65% fat and 17% carbohydrate for 19 weeks increased 32%
body weight with hyperglycemia and hyperinsulinaemia, compared with the mice
fed a high carbohydrate diet (containing 60% carbohydrate and 4 % fat) controls
(Ikemoto et al., 1996).
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Studies in humans also show a role for dietary fat in the development of
obesity. In numerous studies, total energy intake is higher when subjects consumed

diets relatively high in fat than when they eat a lower fat diet (Lissner et al., 198
Rolls and Shide, 1992; Rolls, 1995). It is found that fat is overeaten because it is
highly palatable and provides more energy in a given volume of food. These

results lead to the conclusion that a high fat diet can induce obesity in both humans
and animals.

2.4.3.2 Different Dietary Fat in Development of Obesity
A high fat diet can induce obesity. Different dietary fat contents play a
different role in dietary development of obesity. However, not all types of dietary

fat induce obesity. In general, dietary fats include saturated, monounsaturated, and
polyunsaturated fatty acids.
In experimental animal models, a high-saturated fat diet is more likely to
cause excess fat gain than diets high in polyunsaturated fats (Pan et al., 1994). In
epidemiological studies there is a significantly positive correlation between body
mass index and saturated fatty acid intake (Berry et al., 1986). Romueu et al (1988)
report that the body mass index in obese women is positively correlated with

intakes of saturated fatty acids. Beef tallow contains high saturated fat. It has be
suggested that beef tallow diet promotes body fat accumulation and reduces

sympathetic activity (Matsuo et al., 1995). This might result from altering the fatty
acid composition of the plasma membrane and changing in the affinity of betaadrenoceptors in the hypothalamus and cortex of the rat (Matsuo and Suzuki,
1997). Fish oil and some monosaturated oil have been proposed as favourable diets
for NIDDM patients (Storlien et al., 1987; Campbell et al., 1994). Diets high in

saturated or n-6 polyunsaturated fatty acids lead to severe insulin resistance in the
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rat (Storlien et al., 1991). The insulin resistance can be prevented by the addition of
fish oil (high in n-3), with improvement of insulin resistance and incorporation of
highly unsaturated long-chain n-3 fatty acids into the phospholipid component of
skeletal muscle tissues (Storlien et al., 1991). Furthermore, Bell et al (1997) find
that the amount of fat deposition in mice fed monounsaturated canola oil is
significantly less than that of mice fed the saturated fat diet. This suggests that the
type of fat influences the amount of fat storage.

2.5 Body Weight and Fat Storage
2.5.1 High Fat Diet and Body Fat Storage
It is suggested that C57 B1/6J mice are more prone to high fat diet-induced

obesity than that of A/J strain (Surwit et al., 1988). After a high fat diet feeding for f
months, C57 B1/6J mice not only gained more weight but also showed a 93% increase
in body fat storage compared with controls fed a low fat diet (Black et al., 1998).
Further, a high fat diet has also been shown to increase the size of adipocytes in
mesenteric and inguinal fat in both A/J and C57 B1/6J mice, but it is shown to increase
adipocyte number in the C57 B1/6J mice only (Surwit et al., 1995). These results
support the suggestion that the background genes of C57 B1/6J mice may be more

sensitive to the high fat diet to induce obesity (Surwit et al., 1988; Black et al., 1998)

2.5.2 High Fat Diet and Food Consumption
Food consumption can be presented as the amount of food intake (grams in
mice) or energy intake (calorie). Food intake is a form of behaviour and believed to be
largely voluntary control. A high fat diet induced more energy intake due to its higher
energy density as well as palatability. The current environment provides more frequent
opportunities for the consumption of large quantities of food. For example, a variety of

highly palatable high fat food is available everywhere. It is believed that a high fat die
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contributes to the current increasing obesity. There is also good evidence to suggest

that obese humans are likely to prefer and ingest more dietary fat and less carbohydr
than lean individuals (Hill and Peters, 1998).
Animal experiments provide strong evidence to suggest that an excessively
high fat diet intake induces obesity (Surwit et al., 1988; Van et al., 1997; Widdowson
et al., 1997). In the study of diet induces obese animal models, several reports show
that a high fat diet can induce hyperphagia, obesity, as well as hyperinsulinaemia,
hyperglyceamia and hyperleptinaemia (Surwit et al., 1997; Van et al., 1997;
Widdowson et al., 1997). However, West et al (1992) compared the effects of a high
energy density food diet (33% fat, 15% protein and 52% carbohydrate) with a low
energy density food diet (12% fat, 26% protein and 62% carbohydrate). They found

that there was a transient hyperpheragia during the first week of exposure to a high fa

diet in most strains of mice. However, after 1 week until 7 weeks, the mice fed a highdensity diet, consumed fewer kilocalories per gram of body weight, compared with low

energy density diet fed mice. These findings indicated that as body adiposity increase
regulatory factors might cause a decreased energy intake to limit further increases in

adipose lipid stores (West et al., 1992). It also suggests that during the course of th
development of diet-induced obesity, energy intake may be controlled by a regulatory
factor in these animal models.
Food deprivation can reduce ob gene expression in adipocytes and lowered
plasma leptin in both human and experimental animals (Frederich et al, 1995b). The
patients with anorexia nervosa had an extremely low level of plasma leptin. After food

intake, these patients showed a rapid increase in plasma leptin level (Casanueva et al
1997). Clearly, exogeneous leptin treatment reduces body weight in mice (Campfield et

al., 1995; Halaas et al., 1995; Pelleymounter et al., 1995). For example, after four da
of z'.p.daily leptin injection, ob/ob mice consumed 60% less food compared with
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vehicle controls. Four weeks later, the body weight of ob/ob mice reduced by 4 0 %
(Halaas et al., 1995). The weight loss was due to a reduction of fat mass by 75%. These

results indicate that leptin is involved in central regulation of energy balance, and D
mice have reduced leptin sensitivity centrally.
Rapidly, cumulative evidence has demonstrated that leptin plays an important

role in the regulation of energy intake and expenditure (Frederich et al., 1995a; Qures
et al., 1997; Friedman and Halaas, 1998). However, the reason for increased plasma
leptin leading to a reduction of food intake in DIO mice is unclear.

2.5.3 High Fat Diet and Energy Expenditure
It is known that animals possessing low sympathetic activity have low energy
expenditure (Levin et al., 1984). Studies have shown that a high fat diet- induced
obesity in experimental animals has low sympathetic activity (Levin et al., 1983a;
Levin et al., 1984; Yoshioka et al., 1992). Levin et al (1983a) reported that the rats

prone to diet-induced obesity had lower sympathetic activity than the rats resistant to

diet-induced obesity. Consistent with these results, Yoshioka et al (1992) demonstrated

that a high fat diet-induced obese sprague-dawley rat had a significantly lower (-21%
mitochondrial oxygen consumption in brown adipose tissue than the rats fed a low fat

diet. Therefore, these results indicate that obese rats induced by feeding high fat die
have lower energy expenditure than the rats fed a low fat diet (Yoshioka et al., 1992).
Low sympathetic activity and energy expenditure has also been found in several
genetic obese animal models such as in ob/ob mice and Zuker fa/fa rats (Levin et al.,

1983b; Collins et al., 1997). Leptin administration to ob/ob mice results in an increase
in sympathetic activity in brown adipose tissue during a 2-hour treatment period
(Collins et al., 1997). Direct measurements of nerve activities has shown that
intravenous injection of leptin significantly increase sympathetic activity in brown
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adipose tissue, kidney and adrenal grand (Haynes et al., 1997). These results clearly
indicate that leptin can increase thermogenesis and play an important role in the
regulation of energy expenditure.

2.5.4 High Fat Diet, ob Gene, and Plasma Leptin
Three aspects of correlation between high fat diet and plasma leptin level are

considered here. Firstly, a high fat diet can promote fat storage in the body and a lar

amount of body fat mass secretes more leptin into the bloodstream. Secondly, a high fat
diet can induce an increased level of ob mRNA. For example, after 2 weeks of a high
fat diet, obese rats have an augmented expression of ob gene in adipose tissue

(Masuzaki et al., 1995). Similarly, increased ob gene and plasma leptin levels have als

been reported by others (Frederich et al., 1995a; Surwit et al., 1997; Van et al., 1997
Widdowson et al., 1997). Thirdly, Surwit et al (1997) report that during development
of high fat induced obesity in C57 B1/6J mice, the levels of plasma leptin rise very
gradually along with a significant increase in adiposity, hyperinsulinemia and
hyperglycemia compared with A/J mice.
The effects of a high fat diet on leptin concentration have also been investigated
in humans. Schrauwen et al (1997) report no changes in plasma leptin level in twelve
non-obese subjects who consumed a high fat (29%) diet for 7 days. They suggest that a
short-term high fat diet has no effect on leptin concentration in lean subjects
(Schrauwen et al., 1997). The longer-term effects of a high fat diet have not been
investigated. However, it is known that obese humans have higher plasma leptin
concentration than lean individuals (Maffei et al., 1995b; Considine et al., 1996b).
When obese subjects lose weight by restriction of energy intake, leptin concentration
declines (Considine et al., 1996b).
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2.6

Hypothalamus, Choroid Plexus, and Obesity

The hypothalamus is well known for its important role in the regulation of food
intake, energy homeostasis and nutrient metabolism in animals and humans. It is believed

that the regulation is through the modulation of the hypothalamic neural network related
autonomic and neuroendocrine control. Thus, it is important to study the relationship
between the hypothalamic neuronal network and neurotransmitters involved in this study.
Current studies suggest that leptin regulates the hypothalamic regulatory pathway

controlling energy intake and expenditure. The regions of hypothalamus critically involv
in the regulation of energy balance are Arc, VMH, DMH and LHA.

2.6.1 Arcuate Hypothalamic Nucleus
Arc anatomy: The Arc lies on the floor of the third ventricle and plays a key

role in the regulation of energy homeostasis (Woods et al., 1998; Elmquist et al., 1999).
It contains neurotransmitters and receptors and can receive and initiate hypothalamic
neuropath ways controlling autonomic and neuroendocrine functions. It has been
demonstrated that the medial part of the Arc contains NPY and agouti-related protein
(AgRP) neurons while the lateral part contains POMC neurons. The projections of
NPY neurons are to the PVN and LHA while POMC neurons project to LHA. It is
known that the Arc leptin receptor provides a communication link in the hypothalamus
between the circulating leptin and its two downstream pathways, NPY and
melanocortinergic pathways, which are involved in body weight control and energy
balance (Friedman, 1997a; Gura, 2000).

2.6.1.1 Arc Leptin Receptor
Studies have shown that the Arc neurons express leptin receptor mRNA
(Huang et al., 1996; Mercer et al., 1996b). The leptin receptor plays a critical role
in modulating its downstream nerurotransmitters, particularly NPY and POMC
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neurons. Fasting increased Arc leptin receptor m R N A expression in lean mice (Lin
and Huang, 1997; Baskin et al., 1998), but not in obese mice {ob/ob) (Lin and
Huang, 1997). Genetic obese and diabetic mice including ob/ob and db/db show an
upregulation of leptin receptor mRNA expression in the Arc (Huang et al., 1997;

Baskin et al., 1998). In the ob/ob mice, systemic administration of leptin reduces
Arc leptin receptor mRNA by 30% compared with controls (Baskin et al., 1998).
These results suggest that the leptin receptor may be an autoreceptor involved in
self-regulation by leptin, and the expression of the Arc leptin receptor mRNA is

sensitive to genetic and physiological changes that alter circulating leptin (Hua

al., 1997; Baskin et at., 1998). It can be speculated that upregulated expression o
leptin receptor is due to a suppressed inhibition by lack of leptin binding on to
leptin receptor in the Arc of ob/ob mice.
At present, there is little information available in respect of the Arc leptin
receptor mRNA expression in high fat diet induced obese animal models. Chang et

al (1999) has reported some preliminary results indicating a significant reductio
Arc leptin receptor mRNA expression in high fat fed rats. Accumulated evidence
suggests that downregulated Arc leptin receptors might contribute to hyperphagia,
increased adiposity, and hyperleptinemia in obese animal models induced by a high
fat diet.

2.6.1.2 Arc NPY
The Arc NPY neurons are the main source of NPY production in the
hypothalamus (Chronwall et al., 1985; Dumont et al., 1992), which project to the
PVN, anterior hypothalamus (AH), as well as the VMH and DMH (Dumont et al.,
1992). Coexpression of leptin receptor with NPY mRNA in the Arc is reported in
several studies (Baskin et al., 1999b; Mercer et al., 1996a). It has been
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hypothesized that the leptin-leptin receptor-NPY neural pathway is critically
involved in promoting a positive energy balance (Friedman and Halaas, 1998).
The Arc expresses a high level of NPY mRNA (Morris, 1989). Schwartz et
al (1993) compared the levels of Arc NPY mRNA expression between the rats fed
at ad libitum and food deprivation. With food deprivation Arc NPY mRNA
increased by over 40% and 127% in 24 and 48 hours, respectively. Over-expression
of Arc NPY mRNA was reported in the ob/ob and db/db mice (Stephens et al.,
1995). Systemic administration of leptin reduces the level of Arc NPY mRNA
expression in the ob/ob mice, which provides direct evidence that NPY is
suppressed by circulating leptin (Schwartz et al., 1996a).
Inconsistency in the level of Arc NPY mRNA expression in high fat diet
induced obese animal models is found in the literature. A reduction of Arc NPY

mRNA is reported in a high fat diet induced obese animals (Beck et al., 1994; Gua

et al., 1998). The explanation is that it may be a counter regulatory effect to li
the over consumption of food, while increased obesity is due to high efficacy of
energy intake in a high fat diet. On the other hand, increased Arc NPY mRNA
expression (39%) is reported in rats after 2 weeks of a high fat diet (Levin and
Dunn Meynell, 1997). One possible reason for such discrepancy might be due to
different time points examined during the development of high fat diet induced
obesity. This hypothesis will be examined in my study.

2.6.1.3 Arc POMC
Hypothalamic POMC neurones are also co-localised with leptin receptor
mRNA in Arc (Cheung et al., 1997; Thornton et al., 1997). This finding supports
the hypothesis that the existence of the leptin-Arc leptin receptor-POMC pathway
in the hypothalamus for regulating energy balance (Friedman and Halaas, 1998).
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A reduction of Arc P O M C m R N A expression was found in ob/ob and db/db
mice (Schwartz et al., 1997). Leptin administration significantly increases Arc
POMC rnRNA expression in ob/ob mice by 73%, but no effect in db/db mice
(Schwartz et al., 1997). It is also reported that food deprivation for 48 hours
significantly reduces Arc POMC mRNA expression (53%). Conversely,
i.c.v.injections of leptin can significantly increase Arc POMC mRNA expression by
39% (Schwartz et al., 1997). Furthermore, Bergen et al (1998) demonstrate that
VMH-lesioned C57B1/6J mice increase in body weight and plasma leptin with a
decreased activity of Arc POMC neurons. These results suggest that the leptinleptin receptor-POMC pathway may be critically involved in the regulation of
negative energy balance (Friedman, 1997a).

2.6.1.4 Alpha-MSH-Immunoreactive Neurons in Arc
The a-MSH-immunoreactive neurons are derived from POMC mRNA and
colocalised with the leptin receptor in the Arc (Thornton et al., 1997). These
neurons are small in size and project to the PVN and DMH, and are involved in the
regulation of energy balance (Yoshida and Taniguchi, 1988).

2.6.2 Lateral Hypothalamic Area and Zona Incerta
The LHA can be divided into three subdivisions named as the anterior, tuberal
and mammilary subdivisions of the hypothalamus (Saper et al., 1979). The lateral
hypothalamic area and zona incerta are mainly located in the tuberal subdivision of
hypothalamus. Many neurons in these regions are stained for alpha-MSH and melanin
concentrating hormone immunoreactivity positive. The neurons in these regions

project to the autonomic regulatory centers in the brainstem, spinal cord and cerebr
cortex (Saper et al., 1986; Sanchez et al., 1997).
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Destruction of the L H A produces graded hypophagia and weight loss with an
increased peripheral nonepinephrine turnover and metabolic rates (Yoshida et al.,
1983). Electrical stimulation of LHA of rats can cause increased food intake, body
weight gain and fat storage (Teitelbaum et al., 1969). However, when electrical
stimulation is stopped, food intake drops and body weight returns to normal
(Teitelbaum et al., 1969). Hence, LHA is considered to be a 'hunger center', which
stimulates food intake, and decreases parasympathetic, and increases sympathetic
activities (Yoshida et al., 1983; Bray, 1985).
Elias et al (1999) report that leptin can activate Arc POMC neurons in rats, of

those neurons project to the lateral hypothalamic area. Central microinjection of lepti
into the LHA can reduce food intake and body weight in rats. However, the effect of

leptin is much lower than that of direct injection of leptin into the Arc (Satoh et al.
1997a). This result suggests that LH is not a primary hypothalamic action site of the
satiety effect of leptin.
High fat diet-induced obese mice have an increased body weight and plasma
leptin, accompanied by an elevated neuronal FLI in the LHA (Xin et al., 1999). The
increased FLI can be reversed by substituting the high saturated fat diet with low fat

with n-3 polyunsaturated fat diet (Xin et al., 1999). Therefore, these results suggest t
the constantly activated status of LHA neurons might be responsible for differences in
body weight and plasma leptin between the DIO and lean mice. However, little study

has been carried out investigating the specific neurotransmitters in the LHA related to
diet-induced obesity.

2.6.3 Ventromedial Hypothalamic Nucleus
The VMH lies in the tuberal region of hypothalamus and is one of the largest
cell groups in the tuberal region (Gurdjian, 1927). The VMH connects with regions
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involved with feeding behaviors, such as the P V N and D M H . (Rohner-Jeanrenaud,
1995;Elmquistetal., 1998).
It is known that the sympathetic nervous system is modulated by VMH (Bray et
al., 1981). In hypothalamic obesity, destruction of VMH produces hyperphagia,
hyperinsulinemia and hypertriglycemia (Bray et al., 1981; Bray, 1985). The
parasympathetic nervous system appears to become hyperactive after damage to the
VMH, while the sympathetic nervous system shows a reduced firing rate of
sympathetic nerves that innervate the brown adipose tissue (Niijima et al., 1984;
Sakaguchi et al., 1988). In addition, Satoh et al (1997b) reported that VMH-lesioned
rats had an elevated plasma leptin during the development of obesity. However, they
found that intracerebroventricular injection of leptin had no significant effects on

intake or body weight gain in the VMH-lesioned obese rats (Satoh et al., 1997b). These
results provide the evidence that the VMH-lesioned obese rats can overproduce leptin

but can not respond to it, and they suggest that loss of its satiety effects might be
damage of the leptin pathway and contribute to the development of obesity (Satoh et
al., 1997b). Taken together with these results, the VMH as a satiety centre plays an
important role in controlling energy intake and expenditure (Bray, 1993).
Several studies have reported that the leptin receptor lies in VMH (Hakansson
et al., 1996; Huang et al., 1996). Upregulation of the leptin receptor mRNA has been
found in the VMH of ob/ob mice (Huang et al., 1997). Fasting can increase leptin
receptor mRNA expression in the VMH of lean mice, but not ob/ob mice (Lin and
Huang, 1997). It has been reported that genetically ob/ob mice have an absence of
functional leptin. Food deprivation induces a low ob gene expression as well as a low

level of plasma leptin in lean mice. These results imply that nutritional status and t

level of circulating leptin concentration might be able to influence the leptin recep
gene expression in the VMH.
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The effects of exogenous leptin in the V M H have also been investigated in

several studies (Elmquist et al., 1997; Jacob et al., 1997; Satoh et al., 1997b). Elmq
et al (1997) demonstrate a population of leptin-activated neurons in the VMH that

innervates the subparaventricular zone and might be ultimately mediated by projection
of the DMH to the PVN. Similarly, the specificity of action site by leptin was
examined by the injection of leptin into the dorsal raphe nucleus or VMH. The VMH

injection with leptin showed a significant reduction in food intake and body weight, b
not in the dorsal raphe nucleus (Jacob et al., 1997). These suggest that VMH is also a
sensitive hypothalamic site of satiety for the biological action of leptin (Satoh et
1997b; Jacob et al., 1997).
C57 B1/6J mice fed a high fat diet for 6 months became obese accompanied by
a 40-fold elevated NPY mRNA expression in VMH and DMH (Guan et al., 1998). In
an early study, Beck et al measured the hypothalamic NPY levels in diet induced-obese
rats and did not show the alteration of NPY in the VMH and DMH (Beck et al., 1992).

Wilding et al (1992) also reported that there was no significant change in the level of
NPY mRNA in the VMH of diet induced obese rats. The reason for such a discrepancy
is not known.

2.6.4 Paraventricular Hypothalamic Nucleus
The PVN lies in the rostral part of the tuberal region of hypothalamus and can
be divided according to the size of neurons into magnocellular and parvocellular

divisions. The parvocellular division is the area critically involved in central auton
control (Swanson and Kuypers, 1980). The PVN is a key-integrating centre for a
variety of metabolic and neural signals related to nutritional status. Several
neurotransmitters project to PVN neurons that innervate sympathetic and
parasympathetic preganglionic neurons in the medulla and spinal cord (Jhanwar Uniyal
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et al., 1993; Dryden et al., 1994; Frankish et al., 1995). N P Y is one important
neurotransmitter, synthesised in the Arc and released into the PVN where it potently
stimulates food intake and reduces energy expenditure (Bai et al., 1985; Jhanwar
Uniyal et al., 1993; Dryden et al., 1994).
Sakaguchi et al (1988) report that lesions of the PVN can induce hyperphagia
and obesity, but do not significantly reduce sympathetic activity. It implies that
hyperphagia appears to be essential, but disturbs either sympathetic or vagal systems
might not play a main role in the development of obesity after PVN lesions (Fukushima
et al., 1987; Sakaguchi et al., 1988).
The leptin-Arc NPY-PVN pathway has been suggested as being a critical
pathway related to the promotion of positive energy balance. Increased activity of the
Arc NPY-PVN pathway has been observed in fa/fa Zucker rats and db/db mice and
those of genetically obese animal models have leptin resistance (Dryden et al., 1995;
Stephens et al., 1995). The PVN regulated the feeding behaviour and pituitary gland
function. Woods and Stock firstly reported that after i.e.v.injection of leptin for 3
ob/ob mice showed a dense Fos protein staining in the PVN (Woods et al., 1998).

Consistent with this result, Elmquist et al (1997) reported that intravenous injection
leptin in rats induced a dose-dependent pattern of Fos expression in the ventral and
dorsal parvocellular subdivisions of the PVN. These regions are a source of descending
axons to autonomic preganglionic neurons within the medulla and spinal cord
(Swanson and Sawchenko, 1983; Elmquist et al., 1997). Administration of leptin into

the lateral ventricle of fasted Wistar rats can inhibit food intake, significantly red
NPY concentration (-50%) in PVN, and stimulate brown adipose tissue UCP mRNA

expression (Wang et al., 1997a). This result indicates that leptin can act centrally to
decrease NPY levels in the Arc-PVN pathway, resulting in a modulation of feeding
behaviour and the homeostatic circuit that regulates body fat storage.
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Using a diet-induced obese animal model, Beck et al (1994) reported that after
14 weeks of a high fat diet, Long-Evans rats increased 30% of body weight with 28%
and 48% reduction of NPY concentration in Arc and PVN. The results suggest that the
decreased NPY content in the Arc-PVN pathway might contribute to an attempt to
increase thermogenesis and then to a decreased fat storage. However, the reaction was

not sufficient to control the increasing accumulated adipose tissues in the obese rats
(Beck et al., 1994). After a high fat diet for 15 weeks, it was shown that the diet
induced obese mice had no significant changes in the number of FLI neurons in the
PVN compared with the lean controls. However, after food deprivation for 24 hours,
the DIO mice increased 100% FLI neurons in the PVN (Lin and Huang, 1999). These

results indicate that dietary composition might not directly affect PVN neural activit

while a nutritional state change might be responsible for the increase in neural activ
in the PVN.
In addition, Jhanwar-Uniyal et al report that there is a positive correlation
between carbohydrate intake and NPY levels in the PVN of the rats (Jhanwar Uniyal et

al., 1993). This results suggest that a role of endogenous NPY and its projection from
the Arc to the parvocellular division of PVN might control a natural appetite for
carbohydrate.

2.6.5 Dorsomedial Hypothalamic Nucleus
The DMH lies in the dorsal half of the tuberal region. The DMH receives
substantial afferents from the solitary nucleus and the parabrachial nucleus, and the
descending fibres project to the parabrachial nucleus, vagal complex and spinal cord
(Bleier and Byne, 1985). It has been suggested that the DMH is important in
integrating information from other hypothalamic regions including the VMH and LHA
(Frankish et al., 1995).
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It has been suggested that the D M H is a regulator of a large range of

physiological functions related to modulate the hypothalamic outflow to the autonomic
nervous systems. Destruction of the DMH can produce alterations in feeding behavior

that results in a reduced body weight, linear growth, and food intake (Bernardis, 1985;
Bernardis and Bellinger, 1987). Dimicco et al report that the DMH plays a role in
regulating cardiovascular parameters, including blood pressure, heart rate and
respiratory rate (Dimicco et al., 1996). These results support the hypothesis that the
DMH is involved in the autonomic nervous system, presumably through interactions
with visceral sympathetic and parasympathetic preganglionic neurons (Dimicco et al.,
1996). The neuronal anatomic structure also supports the hypothesis, because the DMH
projects to PVN subdivisions that directly innervate sympathetic and parasympathetic
preganglionic neurones in the medulla and spinal cord (Swanson and Sawchenko,
1983).
Elmquist et al demonstrate that a population of leptin-sensitive cells that are
localized in the DMH, directly projects to the PVN, and they also suggest that
circulating leptin might induce its autonomic regulation through this projection
(Elmquist et al., 1998). Increased NPY mRNA expression in the DMH has been

reported in fa/fa Zucker rats (McCarthy et al., 1991). Direct injection of leptin into
third ventricle of rats reduces NPY concentration in the DMH with reduced food intake
and increased energy expenditure (Wang et al., 1997a). Accumulating evidence
suggests that the leptin-DMH-PVN pathway plays a role in the regulation of energy
intake and balance. In particular, increased NPY mRNA expression found in the DMH
of DIO mice suggests that a high fat diet composition might influence the NPY gene
expression in the DMH (Guan et al., 1998).
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2.6.6

Hypothalamic Neuronal Pathways Related to Energy Intake

and Balance
2.6.6.1 Dual Centre Hypothesis in Regulation of Energy
Balance
The dual centre hypothesis suggests that an inhibitory centre in the
ventromedial hypothalamic nucleus that can terminate eating is named as the
'satiety centre', while the lateral hypothalamic area is a 'feeding centre' that can
stimulate food intake. Reciprocal interactions between the two centres are
important in the regulation of energy balance. In normal physiological conditions,
when an animal is satiated, the 'feeding centre' neuronal activity is decreased,
while 'satiety centre' neuronal activity increases to inhibit eating. Conversely,
when an animal is fasted, the 'feeding centre' neuronal activity is increased while
the 'satiety centre' neuronal activity decreases to stimulate eating. It is known that
body weight regulation is based on a negative feedback control system, in which
the two hypothalamic centres play a key role in determining food intake and energy
expenditure in response to afferent signals, which are produced in adipose tissue.
Therefore, when there is peripheral adipose tissue gain, increased circulating
signals act as an afferent satiety signal informing the satiety centre to switch off
feeding and increase energy expenditure. When there is peripheral adipose tissue
loss, reduced circulating signals inhibit the satiety centre and stimulate the feeding
centre to switch on feeding and decrease energy expenditure (Fig. 2.5). When
problems occur with any one of the two central regulative centres, it can result in
obesity due to disquilibrium between energy intake and energy expenditure.
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Figure 2.5 Schematic diagram of negative feedback loop between the hypothalamus and periphery
involved in energy balance. Changes in adipose tissue lead to alter circulating signal (leptin), which
influence ventromedial hypothalamic nucleus ( V M H ) and lateral hypothalamic area ( L H A ) to oppose
the change.

2.6.6.2 Leptin-Sensitive Hypothalamic Pathway

Leptin receptors have been found in several hypothalamic nuclei, including
Arc, VMH and DMH (Mercer et al., 1996b; Schwartz et al., 1996c). After

i.v.injection of leptin, these hypothalamic nuclei show Fos expression (E

al., 1997). Circulating leptin acts on the leptin receptor in the hypothal
projects to PVN (Fig. 2.6). Simultaneously, circulating leptin activates

the DMH whose efferent projections converge on the PVN (Elmquist et al., 19

In addition, circulating leptin also activates the neurons in the VMH whos

projections converge on the anterior hypothalamic area and then to the DM

(Elmquist et al., 1998). Finally, the hypothalamic PVN output control is be
be achieved through: (1) innervated to autonomic nervous system including
sympathetic and parasympathetic preganglionic neurons in the medulla and
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cord, and (2) projected through the neural endocrine output to the pituitary gland to
regulate the secretion of hormones. It has been suggested that engagement of these
parallel pathways is responsible for the modulation of the physiological effects of
circulating leptin and plays an important role in regulation of energy intake and
expenditure (Elmquist et al., 1998).

Neuroendocrine
Regulation

Pituitary
Gland

Autonomic
Regulation

Circulating
Leptin

Sympathetic
Parasympathetic
Pregangliogic
Neurons

Fig 2.6. Schematic demonstration of a neuroanatomical model of leptin action. Circulating leptin acts
on leptin receptors within the Arc, V M H and D M H . Finally, activation of the autonomic and
neuroendocrine components of P V N is responsible for the physiological effects of leptin (Adopted
from Elmquist et al 1998).

2.6.7 Two Central Pathways Regulating Body Weight
It has been proposed that two central pathways are involved in the regulation of
body fat mass that provides a framework for the system that controls body weight. One
of the pathways is NPY neuronal pathway in response to weight loss and low
circulating leptin, which results in increased hypothalamic NPY concentration and
stimulation of feeding, and decreases energy expenditure. The other pathway is the
alpha-MSH neuronal pathway, which responds weight gain, and high circulating leptin,
which leads to decreased alpha-MSH neurotransmitter and a reduction of feeding and a
corresponding increased energy expenditure (Friedman, 1997b) (Fig 2.7).
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Figure 2.7 Proposed framework by which body weight regulation m a y be involved in two
functionally distinctive pathways. N P Y and its receptor are important components in
response to low leptin levels, while alpha-MSH and M C 4 receptors are necessary for the
biological response to increased leptin levels (Adopted from Friedman 1997).

2.6.8 Choroid Plexus and Leptin
The choroid plexus (ChP) lies in the brain ventricles and is attached to the
ventricular walls. The choroid plexus is made of a highly vascularised connective
tissue enveloped by an extensively folded epithelial cover. The epithelium consists of
cuboidal cells that are sited on the basement membrane and exhibit microvilli on the

luminal surface. The specific anatomical structure of choroid plexus provides the basi
for a blood-cerebrospinal fluid barrier (Mckinley and Oldfield, 1990).
It is reported that leptin concentration in cerebrospinal fluid is strongly

correlated to the plasma leptin, suggesting the presence of a saturable transport syst
for leptin at the choroid plexues (Schwartz et al., 1996b). The CSF-to-plasma leptin

ratio declines with increasing plasma leptin levels in obese subjects, which implies t
the reduced efficiency of brain leptin delivery in obese subjects may result in leptin
resistance (Caro et al., 1996a; Schwartz et al., 1996b).
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Several studies have demonstrated high-affinity binding sites of leptin in the
choroid plexus of mice (Tartaglia et al., 1995; Chen et al, 1996; Lee et al., 1996).
Consistent with this, an extremely high expression of a short form of the leptin receptor
mRNA has also been reported in the choroid plexus (Bjorbaek et al., 1998). Because
the core of the choroid plexus contains numbers of capillaries with fenestrated
endothelial cells, there are speculations that leptin uptaked into the brain is more likely
to occur across the blood-brain barrier endothelium via a receptor-mediated mechanism
(Schwartz et al., 1996b), and is saturable (Golden et al., 1997). Further, saturable leptin
transported cross the blood-barrier is also reported in the rat brain (Banks et al., 1996).
High fat diet-induced obese mice are high in the level of plasma leptin (Surwit
et al., 1997; Van et al., 1997). However, it is not known if the DIO mice also have a
reduced ratio of CSF / plasma leptin. Boado et al (1998) report that high fat diet-fed
rats have an up-regulation of leptin receptor expression in the blood-brain barrier.
Because plasma leptin levels are not significantly increased in the high fat diet-fed rats,
it suggests that the increased blood-brain barrier leptin receptor appears to be mediated
directly by the fat content of the diet (Boado et al., 1998). However, their results
showed no significant change in plasma leptin in the obese rats, which is inconsistent
with other studies (Surwit et al., 1997; Van et al., 1997; Widdowson et al., 1997).
Therefore, it is important to determine the level of the choroid plexus leptin receptor in
obesity models, since the leptin receptor at the choroid plexus might play an important
role in transporting leptin into the brain.

2.7 Neuropeptide Y mRNA and Protein
2.7.1 Overview
NPY, originally isolated from a porcine brain, is first sequenced by Tatemoto et
al (1982). It shares sequence homology with a group of peptides known as the
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pancreatic polypeptide family and appears to be structurally similar in humans and
rodents (Tatemoto et al., 1982; Adrian et al, 1983; Morris, 1989). NPY is present in
large quantities in the hypothalamus, mesencephalon, medulla oblongata, amygdala,

ventral and dorsal striatum and throughout the cortex and hippocampus, (Adrian et al.
1983; Chronwall et al., 1985; Morris, 1989). NPY is also widely expressed in the
peripheral sympathetic nervous system, involved in modulating the central control of

various cardiovascular parameters and altering the release of some pituitary hormone
(Skoglund et al., 1991; Matsuda et al, 1993; Zarjevski et al., 1994). Hypothalamic

NPY plays a key role in responding to reductions in body energy stores by an increase
in food intake with a reduction in heat production from brown adipose tissue
(Billington et al., 1991; Egawa et al., 1991; Tomaszuk et al., 1996). The different
biological effects induced by NPY occur via its interaction with NPY receptors
localised in the hypothalamic nuclei (Martel et al., 1990; Dumont et al., 1992).

2.7.2 NPY Distribution in Hypothalamus
The distributions of NPY in the hypothalamus of humans and rodents have been

investigated using immunohischemical techniques (Allen et al., 1983; Chronwall et al
1985). The highest concentrations of NPY are found in Arc and PVN, which also
contain the highest density of NPY immunoreactive fibers. While other areas of
hypothalamus such as DMH, median eminence (ME), supraoptic nucleus (SO) and
medial preoptic area (MPO) have high concentrations of NPY and high densities of
NPY fibers (Allen et al., 1983; Chronwall et al., 1985). It is known that a major
hypothalamic NPY pathway arises from Arc neurons, which project to the anterior
hypothalamus, the preoptic area, PVN and DMH (Bai et al., 1985; Morris, 1989). The
biological effects induced by hypothalamic NPY are likely to be modulated by the

activation of specific NPY receptors (Gerald et al., 1996; Kalra et al., 1997). YI, Y
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and Y 5 are important N P Y receptor subtypes related to feeding and energy balance

(Martel et al., 1990; Kalra et al., 1997). The YI receptor mRNA expression lies in Arc,
ME, PVN and dentate gyrus (Mikkelsen and Larsen, 1992), while the Y5 receptor
mRNA expression is found mainly in VMH, MPO and Arc with moderate expression
in the DMH and PVN (Gerald et al., 1996).

2.7.3 The Role of NPY in Energy Homeostasis
NPY appears to act in the hypothalamus to stimulate feeding, to reduce energy
expenditure and to increase weight gain (Clark et al., 1984; Billington et al., 1991).
NPY suppresses the sympathetic activity to affect the metabolism of brown and white
adipose tissues (Egawa et al., 1991). Endocrine effects of NPY administration are also
seen in several studies (Skoglund et al., 1991; Ergene et al., 1993).
NPY has powerful, robust and coordinated effects on energy balance when

administered into the third ventricle (Clark et al., 1984; Billington et al., 1991; Ma
et al., 1993; Zarjevski et al., 1994). Clark and colleagues were the first ones who

reported the central effects of NPY in the induction of food intake (Clark et al., 1984
The effects of i.e.v.injection of NPY on energy metabolism were also reported in

several studies (Billington et al., 1991; Egawa et al., 1991). Billington et al reporte
that z.c.v.injection of NPY could decrease brown adipose tissue thermogenesis and

increased fat storage in white adipose tissue in the rat (Billington et al., 1991). The
results suggest that the exogenous NPY might produce coordinated effects on positive
energy balance.
An injection of NPY into PVN can cause a significant decrease of sympathetic
activity to brown adipose tissue (BAT) (Egawa et al., 1991). Reduction in sympathetic
activity also shows an increase in energy intake with whole-body energy expenditure

falling and leading to a positive energy balance (Billington et al., 1991; Egawa et al
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1991). Another study shows that the administration of N P Y into P V N significantly
reduces an uncoupling protein (UCP) mRNA expression in BAT, while increasing
white fat lipoprotein lipase mRNA expression (Billington et al., 1994). These findings
suggest that an injection of NPY into PVN might influence peripheral key enzymes,
which regulate energy balance. In addition, a microinjection of NPY into the MPO
significantly increases the sympathetic nerve activity to BAT (Egawa et al., 1991).
Administration of NPY into the PVN also influences the endocrine effects in
rodents. Direct injection of NPY into the PVN of the rat results in attenuated
noradrenaline (NA) release (Shibasaki et al., 1995). In the resting rats, administration
of NPY into the PVN attenuates the feeding-induced NA response without affecting
circulating levels of insulin or epinephrine. While during feeding, NPY administration
leads to reduce feeding-induced NA release and enhanced feeding-induced insulin
release in the rats (Shibasaki et al., 1995). NPY injected into PVN also causes

hyperphagia, obesity, and increased secretion of insulin, glucagon and corticosterone in
the rats. These results suggest that increased NPY-ergic activity in the hypothalamus
might be responsible for change of neuroendocrine abnormalities in obese animals

(Billington et al., 1994; Frankish et al., 1995; Shibasaki et al., 1995). Furthermore, th
central effects of NPY also show in elicited visceroendocrme responses. Microinjection

of NPY into the nucleus tractus solitarius (NTS) produces significant reduction of hear
rate, mean arterial blood pressure and respiratory rate (Ergene et al., 1993). Taken
together, these results suggest that NPY plays a crucial modulator role involved in
nutrient homeostasis and cardiorespiratory controls.

2.7.4 Leptin-Hypothalamic NPY Pathway
It has been suggested that the Arc NPY is a downstream regulator of leptin
action on feeding and energy balance (Friedman and Halaas, 1998). Leptin is thought
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to influence energy balance via binding to the leptin receptor in the hypothalamus

(Mercer et al., 1996b). The leptin receptor is found in the Arc NPY neurons of rodent

(Baskin et al., 1999b; Hakansson et al., 1996; Mercer et al., 1996a). The ob/ob mice, i
the absence of circulating leptin, have an increased NPY mRNA expression in the Arc,

indicating that leptin might interact with the NPY neural system in the hypothalamus.
Central administration of leptin has been shown to reduce the elevated NPY mRNA
expression in the Arc of ob/ob mice but not in those of db/db mice (Schwartz et al.,

1996c). Wang et al (1997a) also report that central leptin injection in rats reduces f
intake and NPY mRNA and NPY peptide levels in the Arc, PVN and DMH. These
findings provide direct evidence that the Arc-PVN pathway NPY system is suppressed
by circulating leptin. Taken together, leptin and the Arc NPY-PVN pathway might be
involved in a homeostatic loop to regulate body fat mass and energy balance. When
body fat mass is lost, in response to low circulating leptin, hypothalamic NPY is

increased to act the NPY receptor, resulting in stimulating food intake and decreasin
energy expenditure (Stephens et al., 1995). On the other hand, when body fat mass is

gained, in response to increased circulating leptin, hypothalamic NPY is decreased to

stimulate the NPY receptor, resulting in inhibiting food intake and increasing energy

expenditure (Friedman and Halaas, 1998). It has been suggested that the leptin and the
Arc NPY-PVN pathway is viewed as part of a normal physiological response to energy
balance. Dysregulation of this pathway might induce obesity. Figure 2.8 outlines the
role of the leptin-Arc NPY/NPY receptor pathway in food intake and energy
expenditure.

2.7.5 Hypothalamic NPY Levels and obesity
Hypothalamic NPY mRNA and protein levels have been measured in a number
of animal models of obesity. The effects of different nutritional status on NPY mRNA
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and protein levels have also been examined (Ahima et al., 1996; Q u et al., 1996;
Baskin etal, 1999a)
Most genetic obese rodents, such as ob/ob, db/db and fatty (fa/fa) Zucker rats,
show significant increases in NPY concentration in the hypothalamus (Frankish et al.,
1995; Schwartz et al., 1996a). The fatty Zucker rat features hyperphagia,
hyperinsulinemia and low brown adipose tissue thermogenesis (Frankish et al., 1995).
Increased NPY concentrations in the PVN of hypothalamus have also been found in the

streptozocin-induced diabetic rats (Sahu et al., 1992), indicating that the increased NP
secretion in the PVN might be responsible for hyperphagia in the diabetic rats.
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Figure 2.8 Schematic diagram of suggested response of hypothalamic
neuropeptide Y (NPY), to regulate body fat mass by circulating leptin.

Food deprivation induced fluctuation of N P Y levels has been reported in both
lean and obese animal models (Ahima et al., 1996; Qu et al., 1996). In response to low
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circulating leptin (Frederich et al., 1995b), the fasted animals have a high level of
hypothalamic NPY mRAN expression (Ahima et al., 1996; Baskin et al., 1999a).
Hypothalamic NPY levels in ob/ob mice are doubled over control animals in both the
fed and fasted state (Qu et al., 1996). Consistent with the fluctuation of circulating
leptin and NPY levels, hypothalamic leptin receptor mRNA expression also increases
after food deprivation in rats and murine (Baskin et al., 1999b; Lin and Huang, 1997).

These results indicate that the levels of circulating leptin play a role in the regula
leptin-hypothalamic NPY system activity and that decreased physiological response to
the altered leptin concentration might be one of the causes of obesity.
Erickson et al (1996) made mice with a signal NPY gene knockout exhibited
normal body weight and food intake and responded normally to fasting. Erickson et al
(1996) also produced double mutant mice with NPY knockout in ob/ob mice. It was
found that these double mutant mice were clearly obese compared to lean mice but not
as obese as ob/ob mice. Compared with ob/ob mice, the double mutant mice had a
decreased incidence and severity of diabetes, and increased fertility and body length.
However, removal of NPY did not completely reverse the symptoms of leptin
deficiency. The residual obesity presented in the double mutant mice suggests that
other downstream factors required for response to increased weight may still exist in
these animals. The one possible downstream factor has been suggested to be POMC.

2.7.6 Regulation of Neuropeptide Y
Numerous factors including leptin, insulin and glucocorticoids have been
known as peripheral signals to signal brain regulation of energy balance (Erickson et
al., 1996; Leroy et al., 1996; Schwartz and Seeley, 1997) (Fig. 2.9). The hypothalamic
NPY pathway is a central neuronal effector that responds to negative feedback
provided in proportion to body adiposity and energy stores.
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2.7.6.1 Interactions Between N P Y , Leptin and Insulin
Both leptin and insulin have a negative feedback influence on hypothalamic
NPY involved in energy balance (Fig 2.9). The effects of leptin on suppressing
food intake and stimulating thermogenesis are mediated in part by inhibiting NPY
neurons in the hypothalamus (Stephens et al., 1995). A central administration of
leptin appears to reduce expression levels of NPY mRNA in the Arc and NPY
protein in the Arc, PVN and DMH, indicating inhibition of NPY synthesis in
hypothalamus (Stephens et al., 1995; Wang et al., 1997a). On the other hand, NPY
has also been shown to regulate ob gene expression (Sainsbury et al., 1996).
Intracerebroventricular injection of NPY increases adipose tissue ob mRNA levels
in the normal rats, either in the absence or in the presence of hyperphagia
(Sainsbury et al., 1996). Therefore, leptin and NPY appear to be involved in a
negative feedback loop. Increased hypothalamic NPY stimulates leptin production
in the adipose tissue, which in turn inhibits hypothalamic NPY synthesis.
The role of insulin in regulating hypothalamic NPY gene expression has

been well investigated (Schwartz et al., 1992; Sipols et al., 1995). Insulin recepto
are co-localized with NPY neurons in the Arc (Schwartz et al., 1992). It has also
been suggested that a negative feedback loop of the hypothalamic NPY is

reciprocally regulated by insulin. Like leptin, insulin might act by modulating the
activity of NPY neurons in the Arc, and then inhibiting energy intake. After

intracerebroventricular insulin infusion on streotozotocin-induced diabetic rats fo
days, hypothalamic NPY mRNA was reduced by 40% and diabetic hyperphagia
was reduced by 58% (Sipols et al., 1995). Furthermore, increased levels of NPY
mRNA in the Arc and PVN during a fasting were prevented by i.e.v.infusion of

insulin into the third cerebral ventricle (Schwartz et al., 1991). The result sugges
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that central neuronal system insulin deficiency during food deprivation can
stimulate Arc NPY synthesis and its release in the PVN, producing increased food
intake.
Administration of insulin into the third cerebral ventricle increases adipose
tissue ob mRNA expression suggesting that insulin might act centrally to modulate

ob gene expression in adipose tissue (Sainsbury et al., 1996). In the periphery, the
correlation between insulin level and levels of ob mRNA and plasma leptin suggest
that insulin might have direct effects on ob gene expression (Frederich et al.,

1995b; Saladin et al., 1995). A negative feedback loop between leptin and insulin is
shown below (Fig 2.9).
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Fig. 2.9 Schematic diagram indicating positive and negative
feedback regulation between hypothalamic neuropeptide Y
(NPY) and peripheral circulating factors

2.7.7

High Fat Diet and N P Y

In the diet induced obese animal model, after 14 weeks of a high fat diet, LongEvans rats increased 30% body weight with 28% and 48% reduction of NPY
concentration in the Arc and PVN, respectively (Beck et al., 1994). Consistent with the

result, Guan et al (1998) also reported that, after a high fat diet for 23 weeks, diet
induced obese mice had a 44% decreased in Arc NPY mRNA expression. These results
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suggest that long-term high fat feeding might alter the Arc N P Y - P V N axis to lead to a
counter-regulatory effect for limiting over-consumption of food and fat deposition. The
decreased NPY level in the Arc-PVN axis might contribute to an attempt to increase
thermogenesis and then to a decreased fat storage (Beck et al., 1994). However, the

reaction was not sufficient to control the increasing accumulated adipose tissues in the
obese animals. In contrast, inconsistent with these results, Wilding et al measured the
hypothalamic NPY mRNA in the rat after feeding a high fat diet for 7 weeks. They
found that hypothalamic NPY mRNA level was unchanged in the obese rat compared
with lean controls (Wilding et al., 1992). In another study, Levin et al reported that
39% increased Arc NPY mRNA was observed in obese rats after 2 weeks of a high fat
diet (Levin and Dunn Meynell, 1997). The reason for such discrepancy is still
unknown. It has been suggested that it might be caused by the variations of species and
/or the age of the animals, and duration of the high fat diet (Guan et al., 1998).
Mice fed a high fat diet for 6 months increased 77% body weight accompanied
by a 40-fold elevated NPY mRNA expression in VMH and DMH compared with lean
controls (Guan et al., 1998). And they also found that the changes in NPY mRNA
expression was reversible after the DIO mice were put on the regular diet for 3 weeks,
showing a gradual decrease in DMH and VMH NPY expression to their respective lean
control levels. These results suggest that different diet compasition might influence
NPY gene expression in DMH and VNH.

2.8 Pro-opiomelanocortin mRNA and cc-Melanocyte-Stimulating
Hormone
2.8.1 Overview of POMC mRNA and a-MSH
The POMC gene expresses primarily in the intermedia lobe of the pituitary
gland, but has also been detected in numerous non-pituitary tissues, including
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hypothalamus, lung, liver, thymus and lymphocytes (Smith andFunder, 1988; Tonon et
al., 1993). P O M C is the precursor of three families of biologically active peptides: the
adrenocorticotropins, melanotropins and (3-endorphins (Weatherhead and Logan, 1981;
Cone et al., 1993; Tonon et al., 1993). The three peptides are derived from three
different regions of P O M C m R N A (Fig.2.10). Adrenocorticotropic hormone ( A C T H )
is produced predominantly by the corticotroph cells of the anterior pituitary. The a, P
and y- melanocyte-stimulating hormone (a, 3 and y- M S H ) peptides are processed from
different regions of P O M C m R N A to yield a variety of forms (Cone et al., 1993;
Tonon et al., 1993). A C T H and a - M S H are overlapping peptides cleaved from the
middle portion of P O M C

gene and consisted of amino acids 1-39 and 1-13,

respectively (Fig. 2.10).
The a - M S H is originally isolated and characterized from the intermediate lobe
of the pituitary, and recognised by its effect on mammalian pigment cells and the
central nervous system (Weatherhead and Logan, 1981; Catania and Lipton, 1993). The
a - M S H has been reported to be involved in several physiological roles, such as
hyperalgesia, cardiovascular and neuroendocrine regulation, sexual behavior, grooming
and feeding behavior.

Y-MSH

a-MSH

0-MSH

P-endorphin

Fig. 2.10 Structure and processing of pro-opiomelanocortin. The major POMC
peptides are indicated by brackets.
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2.8.2

Distribution

of

POMC

and

a-MSH

Neurons

in

Hypothalamus
The distribution of POMC neurons in the hypothalamus of rodents has been
investigated by using immunohischemical and in situ hybridization techniques
(Yoshida and Taniguchi, 1988; Cheung et al., 1997; Schwartz et al., 1997). A major
hypothalamic POMC pathway arise from the Arc neurons, which send afferent fibers to
the LHA and midbrain central gray (Yoshida and Taniguchi, 1988; Flier and Maratos
Flier, 1998; Elias et al., 1999). The POMC projection between Arc and LHA is thought

to play an important role in regulating energy balance (Flier and Maratos Flier, 1998
Elias etal., 1999).
Using immunohistochemistry in combination with retrograde tracing methods
several studies have demonstrated that the hypothalamic alpha-melanocyte stimulating
hormone like immunoreactive (a-MSH-Lir) neurons, are in two distinctive groups, aMSH-Lir and a-2-MSH-Lir group (Saper et al., 1986; Presse et al., 1990). The first
group a-MSH-Lir neurons are very heavily stained and localise at the arcuate nucleus
and adjacented retrochiasmatic area. The size of this type of neurons is about 15-18

in diameter and mostly bipolar in shape (Saper et al., 1986). These neurons project to

the lateral hypothalamic area (Elias et al., 1999), and exert an anti-obesity function
tonic inhibition of feeding behaviour and increased energy expenditure (Fan et al.,
1997).
The second group a-2-MSH-Lir neurons are derived from the melanin
concentrating hormone (MCH) mRAN (Presse et al., 1990). The a-2-MSH-Lir

neurons are primarily located in the lateral hypothalamic area and zona incerta at th
level of the ventromedial nucleus of the hypothalamus. These multipolar neurons,
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which are 20-25 urn in diameter, stained slightly less heavily than those in the Arc, and

project to the hippocampal formation and the spinal cord (Kohler et al., 1984; Saper e
al., 1986).

2.8.3 Role of POMC and a-MSH in Regulation of Energy Balan
The biological effect induced by the hypothalamic POMC and a-MSH is likely
to be modulated by the activation of specific melanocortin receptors in the
hypothalamus (Cone et al., 1996). The MC4 receptor is an important melanocortin
receptor subtypes related to feeding behavior and energy balance (Fan et al., 1997;
Giraudo et al., 1998; Rossi et al., 1998). The MC4 receptor mRNA is found in the
hypothalamus, limbic system, cortex and brainstem (Gantz et al., 1993; Cone et al.,
1996).
The a-MSH plays an important role in the regulation of feeding behavior and

weight homeostasis (Shimizu et al., 1989). Intracerebroventricular administration of aMSH agonists MTII acts on the MC4 receptor to inhibit food intake, while antagonists
to the MC4 receptors, such as agouti-related protein, increases food intake and body
weight (Fan et al., 1997). Furthermore, long-term administration of MC4 receptor

antagonists leads to severe obesity (Kask et al., 1998). The targeted disruption of MC
receptor in mice caused obesity, similar to the phenotype of agouti obesity syndrome,
showing over-expression of agouti protein and severe obesity (Huszar et al., 1997).
Altogether, these findings indicate that a-MSH, the natural ligand of MC4 receptor,

might mediate physiological satiety signals and appear to be important in the regulati
of energy balance, influencing both food intake and energy expenditure. Therefore,
impairment in production, or responsiveness to a-MSH might contribute to one of the
aetiology of obesity.
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2.8.4

P O M C Gene Mutation and Obesity

Accumulated data shows that mutations in the POMC gene may result in early

onset severe obesity in animal models and humans (Jackson et al., 1997; Krude et al.,
1998; Yaswen et al., 1999). Together with the research in the POMC gene defect of the

agouti mouse model, as well as linkage studies (Boston et al., 1997; Fan et al., 1997

Ollmann et al., 1997), it makes this gene a relevant candidate for the inherited basis
obesity.
Yaswen et al (1999) made a mutant mouse strain lacking all POMC-derived
peptide. The POMC mutant mice raised on a high-fat diet gained body weight faster
than those raised on standard lab chow, and had a greater food intake than wild-type
littermates. After 6-7 months of feeding, the POMC-null mice showed obesity,
defective adrenal development and altered pigmentation. When treated with a-MSH
agonist, the mutant mice reduced body weight by 40% after 2 weeks of the treatment.
This study shows that a-MSH influences body weight mainly through food intake.
Similar to POMC mutant mice, two research groups have identified obese
humans related to mutations in the POMC gene (Jackson et al., 1997; Krude et al.,
1998). An early report by Jackson et al showed an association in human obesity with a
defect in the gene, which was known to process POMC peptide. Furthermore, Krude et

al (1998) reported that two subjects had a genetic defect within the POMC that define

a monogenic endocrine disorder resulting in early-onset obesity, adrenal insufficienc
and red hair pigmentation. These findings demonstrate that the products of POMC gene
can influence body weight and energy expenditure in humans.

2.8.5 Leptin-Hypothalamic POMC/ a-MSH Pathway
POMC has also been suggested as a downstream effector of leptin actions on
energy balance (Friedman and Halaas, 1998). The following evidence supports this
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suggestion (1) Leptin is thought to influence energy balance via binding to the leptin

receptor in the hypothalamus (Mercer et al., 1996b). A co-localised leptin receptor and
POMC mRNAs have been found in the Arc neurons of rodents (Cheung et al., 1997;
Thornton et al., 1997). (2) The ob/ob mice, in the absence of circulating leptin, have
decreased POMC mRNA expression in the hypothalamus, indicating that leptin might
interact with the POMC neuronal system. (3) The db/db mice, with leptin receptor
mutation, are associated with a reduced POMC mRNA expression in the Arc. (4)
Central administration of leptin has been shown to reduce the elevated POMC gene
expression in the hypothalamus of ob/ob and db/db mice (Schwartz et al., 1997). (5)
The agouti obese mice, with an antagonist of a-MSH, have an elevated plasma leptin,

suggesting there is an inefficiency of leptin sensitivity in the animal model. Altoget
these findings provide the evidence that the leptin-Arc leptin receptor-POMC/a-MSH
pathway might be involved in a homeostatic loop to regulate body fat mass and energy
balance. When body fat mass increases, in response to high circulating leptin,
hypothalamic POMC peptide increases to act on MC4 receptor, resulting in inhibiting
food intake and increasing energy expenditure. On the other hand, when there is a loss
in body fat mass, in response to decrease circulating leptin, hypothalamic POMC

peptide decrease to stimulate the MC4 receptor, resulting in stimulating of food intak
and decreasing energy expenditure (Friedman, 1997a). It has been proposed that the
hypothalamic leptin-leptin receptor-POMC/a-MSH pathway might be necessary for the
biological response to obesity (Friedman and Halaas, 1998). Impairment of the

pathway might contribute, at least in part, to cause obesity. Fig. 2.11 outlines the r
of the hypothalamic leptin-leptin receptor-POMC/a-MSH pathway in food intake and
energy expenditure by circulating leptin.
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Fig. 2.11 Schematic diagram of suggested response of hypothalamic
P O M C and a-MSH, acting via M C 4 receptor, to changes in body fat
mass and circulating leptin.

2.8.6

Regulation of P O M C m R N A and a-MSH in Energy Balance

The activity of POMC / a-MSH is regulated by multiple factors including
nutritional status, leptin, and N P Y (Tonon et al., 1993; Ollmann et al., 1997; Mizuno et
al., 1998). In order to maintain a constant body weight, P O M C / a-MSH-MC4 pathway
may receive signals from the periphery as to the level of fat stores and respond by
influencing the periphery to adjust food intake and energy balance.

2.8.6.1

Interactions Between P O M C / a-MSH and Leptin

In the Arc, approximately 30% of POMC neurons express the mRNA for
the leptin receptor long form (Thornton et al., 1997). Leptin has a positive influence
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on the hypothalamic Arc P O M C m R N A expression (Schwartz et al., 1997; Mizuno

et al., 1998; Hixson et al., 1999). The effect of leptin on suppressing food intak

mediated in part by stimulating the neurons in the hypothalamus (Schwartz et al.,
1997)
Central administration of leptin appears to increase the levels of POMC
mRNA expression in the Arc, suggesting it might also stimulate POMC peptide

synthesis in the hypothalamus. Intracerebroventricular injection of a stable a-MS
analogue, MTII, inhibits food intake with dose-dependent fashion in four animal
models of hyperphagia (Fan et al., 1997). Therefore, leptin and a-MSH appears to
involve a negative feedback loop. Increased the hypothalamic a-MSH might

increase in sympathetic neuronal system to reduce leptin production in the adipos
tissue, which in turn inhibit hypothalamic POMC mRNA expression and a-MSH
synthesis.
The role of leptin in regulating hypothalamic POMC gene expression in

leptin-deficient ob/ob and leptin-resistant db/db mice or in fasted rodents has b
well investigated (Schwartz et al., 1997; Thornton et al., 1997; McShane et al.,
1999). Food deprivation in the db/db mice and rodents decreases the leptin gene
expression in adipose tissue and plasma leptin accompanied by a low hypothalamic
Arc POMC mRNA (Schwartz et al., 1997; Thornton et al., 1997; McShane et al.,
1999). Fasting also induces hypothalamic POMC mRNA expression in genetic

leptin deficiency ob/ob mice (Schwartz et al., 1997; Thornton et al., 1997). The l
levels of POMC mRNA expression can be reversed by i.e.v.injection of leptin in
fasted ob/ob mice and normal mice, but not in the db/db mice (Schwartz et al.,
1997; McShane et al, 1999). In addition, Bergen et al (1998) also report that a
gold-thioglucose injection into adult mice produce a profound obese phenotype,
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including hyperphagia, increases body weight, and increases leptin m R N A and
peptide, associated with reduced hypothalamic POMC mRNA. Altogether, these
results suggest that leptin plays an important role in the POMC/a-MSH pathway
regulation.

2.8.6.2 Interactions Between a-MSH, and NPY and AgRP
Blasquez et al (1995) have shown that hypothalamic a-MSH release is
inhibited by NPY. In vivo a single dose of NPY does not modify a-MSH levels but
chronic infusion into the lateral ventricle over 7 days induces a significant
reduction in a-MSH content in the hypothalamus (Blasquez et al., 1995). The
results suggest that there is an inhibitory effect of a-MSH by NPY.
AgRP, an endogenous antagonist of a-MSH at MC4 receptor in the
hypothalamus, is synthesised and co-localised with NPY neuron in the arcuate
nucleus (Ollmann et al., 1997). Since a-MSH is a potent inhibitor of food intake,
has been suggested that secretion of AgRP in the hypothalamus might block aMSH effects. Hahn et al's findings support this suggestion by demonstrating that
fasting increases both NPY and AgRP gene expression in the arcuate nucleus,
which can be a combination effect of NPY to increase food intake and that of
AgRP to block the anorexic action of a-MSH (Hahn et al., 1998). Furthermore, a

study by Kesterson et al (1997b) show significantly increased NPY gene expression
in the DMH in both the agouti yellow (Ay) obese mice and MC4 receptor knockout
mice. This result implies that a-MSH, binding to MC4 receptor, might inhibit NPY
gene expression in the DMH. Altered function of the DMH might contribute to
melanocortinergic obesity syndromes.
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2.8.6.3 Other Factors Influencing P O M C m R N A Expression and
a-MSH production in Hypothalamus
Acquired obesity can be produced by chemical lesion of hypothalamus with
gold thioglucose (GTG) in mice (Bergen et al., 1998). The mice show a profound
obese phenotype, including hyperphagia, increased body weight and leptin mRNA
expression and plasma leptin, in association with reduced hypothalamic POMC
mRNA expression. This result suggests that decreased activity of hypothalamic
neurons synthesising POMC might play a role in regulating hypothalamic obesity.
Changes in nutritional status also affect the POMC mRNA expression in the
hypothalamus. Bergendahl et al (1992) reported that starvation for 2 days induced a
24% decline in Arc POMC mRNA expression in rats. Mizuno et al showed that Arc
POMC mRNA was reduced by fasting ob/ob and db/db mice for 48 hours, but was
stimulated by i.p.injection of leptin (Mizuno et al., 1998). It is shown that fasting
can induce low level of leptin mRNA expression in adipose tissues (Saladin et al.,
1995), and an increased leptin receptor mRNA expression in the hypothalamus in
mice (Lin and Huang, 1997). Taken together, these results indicate that reduced
activity of POMC pathway might be caused by low plasma leptin following fasting
status.

2.8.7 High Fat Diet and POMC mRNA/ a-MSH
It is well known that a high fat diet can induce obesity in rodents and humans.
The roles of a-MSH in the central control of feeding and its regulative effects have
been investigated. Although elevated hypothalamic NPY and decreased hypothalamic
POMC are thought to promote the development and maintenance of obesity, the
mechanism mediating diet-induced obesity have still not been completely elucidated.
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Bergen et al (1999) report that a resistance to a high fat diet-induced obesity is
associated with increased POMC mRNA expression in the hypothalamus, suggesting
that a high fat diet is involved in the regulation of POMC system. On the other hand,
several reports have found that a high fat diet does not change POMC mRNA
expression in the hypothalamus (Guan et al., 1998; Harrold et al., 1999). The exact
reason for such a discrepancy is unknown.

2.9 Summary
After reviewing the extensive literature related to obesity it is evident that obesity is
characterized by an increased mass of adipose tissue, arising from complex interactions
between environmental and genetic factors. A high fat diet can induce obesity
accompanied by hyperleptinemia (leptin resistance) in animal models as well as in humans.
Although dysfunction of leptin or its related hypothalamic two downstream pathways are
thought to be critically involved in the development of high fat diet-induced obesity. The
role or involvement of plasma leptin, central leptin receptor, POMC and NPY in the
development of leptin resistance in diet- induced obesity has not been systematically
investigated.
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EXPERIMENTAL SECTION A:

DEVELOPMENT OF HIGH FAT DIET-INDUCED
OBESITY AND LEPTIN RESISTANCE IN C57 B1/6J
MICE
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Chapter 3
The Progressive Development of a High Fat Diet
Induced Obese Mice
3.1 Introduction
Mice unable to produce leptin {ob/ob) or to respond to it {db/db) were characterized

by hyperphagia and decreased energy expenditure, as well as other metabolic abnormalities

such as hyperinsulinemia, insulin resistance, glucose intolerance and diabetes (Campfield

et al., 1995; Pelleymounter et al., 1995). Treatment with leptin inhibited feeding, increa

energy expenditure, and subsequently reduced body fat in a dose-dependent fashion in both
ob/ob and normal mice, but not in db/db mice (Halaas et al., 1995; Ahima et al., 1996).
The efficacy of such murine monogenic models of obesity in determining the
mechanisms underlying human obesity remained to be seen. There was no convincing

evidence to indicate that mutations in the genes encoding either leptin or its receptor w

a part of the aetiology of common human obesity (Considine et al., 1995; Considine et al.

1996a). Indeed, plasma leptin levels were closely correlated to body mass index in humans,
and ob mRNA has been shown to be increased in obese humans relative to non-obese

humans (Caro et al., 1996a; Klein et al., 1996; Niskanen et al., 1997a). As such it has be
suggested that obese humans might be insensitive, or 'resistant' to the leptin signal.
In support of this hypothesis, leptin resistance has been described in a murine
model of obesity that might more closely reflect the human condition, namely, DIO mice
(Van et al., 1997). Although previous studies have examined peripheral and central leptin
resistance in DIO animals (Van et al., 1997; Widdowson et al., 1997), no study showed the
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difference of calorie intake, the gain of body weight, body fat mass and the level of plasma
leptin in different stages of high fat-diet induced obesity in C57 B1/6J mice.
My study was therefore undertaken to investigate, whether or not the high fat dietinduced obesity was associated with a progressive development of leptin resistance. The
aims of this study are: (1) to develop the DIO mouse model by feeding a high-fat diet for
19 weeks in C57 B1/6I mice; (2) to investigate whether or not changes in body weight,
calorie intake, visceral and inguinal fat mass and level of plasma leptin in the early (1
week), middle (8 weeks) and late (19 weeks) stages of development of DIO mice.

3.1.1 Hypothesis
Based on previous study (see Chapter 2), the following hypotheses are tested for the
present study:
(1) A high fat-diet would induce obesity in C57B1/6J mice with a gradually
increase in visceral and inguinal fat mass accompanied by rising of plasma
leptin.
(2) A high fat-diet would gradually breakdown the central energy balance
regulative system to reduce central leptin sensitivity in C57B1/6J mice.
(3) A high fat-diet might not affect growth of body size in the C57 B1/6J mice.

3.2 Materials and Methods
3.2.1 Animals
Seventy-two 3-week-old C57B1/6J mice were used in this study. Mice were
obtained from the Animal Resource Center (Western Australia). On arrival, the mice
weighed approximately 15 grams in average. Only male mice were used to avoid the
gender differences in plasma leptin, which had been well documented previously
(Frederich et al., 1995a; Ostlund et al., 1996; Wing et al., 1996; Saad et al., 1997). Of
seventy-two mice, 24 mice were used to test various aspects of proposed experimental
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design in pilot studies. A further 48 mice were randomly assigned to two groups, which

had an average 15.2 grams of body weight each. One group of mice was fed a high-fat

diet, and the others fed a low-fat diet. All mice were fed standard laboratory cho
the first week to allow them to adjust to a new environment.
The mice were housed in communal housing with environmentally controlled
conditions (Fig 3.1) in an animal house at the University of Wollongong, NSW,

Australia. The room was rnaintained at a temperature of about 22°C, light cycle fr

06:00 to 18:00 and dark cycle from 18:00 to 06:00. Sawdust was placed on the floor
each box for absorbing urine. A layer of woodshavings was placed on the top of the
sawdust to enable the mice to make warm nests for themselves. The boxes were
cleaned weekly.

Figure 3.1 Communal Housing - standard 'long boxes': plastic rectangular
box with a removeable wire lid. At one end, the wire lid holds a water bottle
and chow pellets. Each box holds a m a x i m u m of six mice.
3.2.2

T h e Composition of Diet

The composition of the respective diets is shown in Table 3.1. The energy of

high fat diet included 58.7% calorie from fat (14.7% tallow beef fat + 44.1% saffl
oil), 14% from carbohydrate and 27.3% from protein. The energy of low fat diet
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included 9.7% calorie from fat (safflower oil), 6 3 % from carbohydrate and 27.3% from
protein. The quantity of vitamin mix, mineral mix, cellulose powers and D L methionine were the same as used previously (Ikemoto et al., 1996)

Table 3.1. Composition of the high-fat and low-fat diets
Component

Hieh-Fat

Low-Fat

Gram(%)

Gram {%)

24.0

4.0

Safflower Oil

8.0

Tallow Stearin
Casein

33.5

25.3

Sucrose

10.0

10.0

7.2
1.4

48.4

Cellulose Powder

9.8
5.6

DL-Methionine

0.5

6.9
4.0
0.4

Fat energy kcal/lOOg (%)

288.0 (58.7)

36.0 (9.7)

Carbohydrate kcal/lOOg (%)

68.8 (14.0)

233.6 (63.0)

Protein kcal/lOOg (%)

134.0 (27.3)

101.2(27.3)

Total energy kcal/lOOg

490.8 (100.0)

370.8 (100.0)

Starch
Vitamin Mix
Mineral Mix

3.2.3

1.0

Feeding Procedure and Period

Diets were freshly made every week and stored at 4°C. In order to accurately
measure the amount of daily food consumption, all food was made about 5 c m 3 and
dried out in an oven before being fed to the animals. Mice were fed using small plastic
dishes and free access to food. All left over food from previous day was cleaned and
then fresh food was replaced just before the beginning of the dark cycle. All mice were
given ad libitum access to tap water throughout the study. Feeding periods were
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different from 1 to 19 weeks according to the experimental design shown in flow chat
(see Section 3.4).

3.2.4 Body Weight and Food Consumption Measurement
The body weight of mice was measured weekly. Strictly measure time was
fixed at 16:00 to 17:00 every Monday in order to avoid being affected by different
amount of food intake daily.
Amount of daily food consumption was measured before replacing fresh food.
Food consumption was estimated by subtracting the amount of food left in the plastic
dishes and the amount of food spilled from the initial food weight. Food spillage was
determined as follows: any food that spilled was collected on absorbent paper placed
beneath the cages in which the mice were kept. After removing faces and woodshaving
from the paper, food spillage was collected and weighed.

3.2.5 The Time to Sacrifice Mice
All mice were sacrificed with intraperitoneal injection of an overdose of sodium
pentobarbitone anaesthesia (120mg /kg). The method of euthanasia was adopted, as it
was quick and painless and easy to use in mice. According to experimental design (see

Section 3.4), mice were sacrificed after 1, 8, 15 and 19 weeks of feeding. All mice wer
sacrificed at a fixed time between 04:00 to 05:00 h. A fixed time chosen to sacrifice
mice was to avoid possible fluctuation of mRNA and protein during the day. Further, it
was shown that nocturnal animal appeared to have the highest levels of leptin
production at 04: 00 h (Saladin et al., 1995).

3.2.6 Blood Samples
Using heart puncture procedure blood samples were collected from mice to
measure plasma leptin levels, after 1, 8, 15 and 19 weeks of feeding.
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After deep anesthesia for 15-20 seconds, the euthanased mice were placed in
the supine position on the laboratory bench. Immediately a vertical incision was cut
from the abdominal region, and then extended up through the thorax. After opening the
pleural cavity and diaphragm, the heart was exposed. In order to prevent rupturing the
heart and in order to collect as much blood samples as possible, a 0.50 x 16mm needle
was used. After the needle was inserted into the left ventricle of the mice, the blood
was slowly drawn into a 1ml syringe. Normally, 800 ul blood was collected from each
mouse and then placed into an eppendorf tube containing 1% heparin. Plasma was
separated out after centrifugation (12,000 rpm x 5 min) of the blood samples at room
temperature and collected to a new-labeled eppendorf tube and stored at -20°C until
leptin radioimmunoassay.

3.2.7 Tissues Samples
3.2.7.1 Adipose Tissues
Following the subsequent heart puncture procedure, epidydimal, perirenal
and inguinal fat masses were collected. Specific attention was given to collect
epidydimal adipose tissue excluding epididymal mass. The collected adipose tissues
were immediately weighed on a scale and recorded.

3.2.7.2 Measure of the Length of Tibia
In order to examine body growth in the mice on different diets, tibial length
was measured.

3.2.7.3 Brain Tissue
Because two different techniques were used in my study, brain tissues of mice
were collected by two different procedures. One procedure was that brain tissues
were fixed for immunohischemistry (see Chapters 5, 7 & 8) and another was that
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brain tissues were freshly collected and then frozen for in situ hybridisation (see
Chapters 6-8).

3.3 Pilot Studies
A series of pilot studies were performed to develop and test various aspects of the
proposed experimental design. Twenty-four 3-week-old C57 B1/6J mice were used in the

pilot studies that included fat composition of diet, average daily food intake, and feeding
duration.

3.3.1 Pilot Study of Fat Composition of Diet
A pilot study was carried out to determine the type and amount of fat to be used
in this study. According to the literature, both safflower and beef tallow fat could
induce obesity in rodents. In the pilot study, firstly, 58.7% safflower oil was used to
induce obesity in C57 Bl/6 mice, according to the protocol by Ikemoto et al (1996).
After 6 weeks of feeding, the mice fed a high fat diet (58.7% safflower oil) increased
body weight by 8% compared to the mice a fed low (9.7%) fat diet. It has been
reviewed in the literature section that saturated fat has a much greater influence in
promoting fat deposition in the regulatory system. Therefore, it was expected in this
pilot study that modifying the fat type might ensure the success of the diet-induced
obesity model to be used in this study. In order to increase the difference in body
weight between the mice fed a high and low fat diet, about 15% beef tallow was used
to supplement safflower oil in which the total percentage of dietary fat was still 58.7%
(Table 3.1). After 6 weeks of feeding, the mice fed the modified high fat diet had 21%
increase in body weight compared with the mice fed a low fat diet. This modified high
fat food was then accepted and used throughout this study.
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3.3.2

Pilot Study of Average Daily Food Intake and Feeding Period

The second purpose of the pilot study was to determine the amount of food
intake each mouse ate on average per day and found out how long feeding period
needed to be carried in the development of DIO mice in this study. Twenty-four mice
were divided into two groups to test average daily food intake and feeding period. In
the first week, all mice were fed standard laboratory chow to allow them to adjust to
the new environment. In the second week, a fixed amount of standard laboratory
powdered chow was presented to the animals for one week according to preexperimental design. The food intake was then monitored on a daily basis for the entire
week to determine the animal's average daily intake.
At the end of the second week of the pilot study, the mice ate an average of
5.8g of powdered chow per day, an amount equal to 17.9 kcal/day (The standard
laboratory chow contained 3240.67 kcal/kg). This figure was later used in calculating
how many grams of food to give each mouse per day when they were fed either a highor low-fat diet.
According to the pre-experimental design, the feeding period would be
determined by the gain of body weight by 25% in the mice fed a high-fat diet,
compared with the mice fed a low-fat diet. After 19 weeks feeding, the mice fed a highfat diet had 30.5% greater body weight than that of mice fed a low-fat diet. In the
present study, the feeding period of 19 weeks was later selected for developing DIO
mice.

3.4 Experimental Design
3.4.1 Flow Chat of Experimental Design
According to pilot experimental results, forty-eight mice were divided into two
groups (Fig. 3.2). The mice in the first group were fed with a high-fat diet (HFF) and
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the mice in the second group were fed with a low-fat diet (LFF). Six mice from each

group were sacrificed after being fed either a high- or low-fat diet for 1, 8, 15 and
weeks. The body weight and calorie intake was measured every week for a 19-week

feeding period. After the mice were sacrificed at week 1, 8, 15 and 19, adipose tissu

(epididymal, perirenal and inguinal fat masses) and tibial length were measured. Bloo
samples were obtained by puncturing right ventricle of the heart.

48 C57B1/6J mice,
3 w k old, fed with lab chow for 1 w k

24 mice, low fat diet

24 mice, high fat diet

T
6 mice sacrificed from each group
after lwk feeding

6 mice sacrificed from each group
after 8 w k feeding

6 mice sacrificed from each group
after 15 w k feeding
6 mice sacrificed from each group
after 19 w k feeding

Fig. 3.2 Flow chat of experimental design

3.5

Analysis

3.5.1 Blood Analyses
The plasma samples were taken out from the -20°C freezer and melted at
room temperature. Plasma leptin level of each mouse was assayed using a
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homologous radioimmunoassay kit (Linco Research Immunoassay, St. Charles, M O ,
USA).
3.5.2 Statistical Analyses
All data were shown as mean ± SE for groups based on six mice in each
group. Analyses were performed using the JMP statistical package (SAS institute,
Inc, NC, USA, 1997). Differences in variables between the high-fat diet fed mice and
the low-fat diet fed mice were analyzed using a Student's f-test.

3.6 Results
3.6.1 Measurement of Body Weight
As the .P-values in Table 3.2 showed, that a significant increase in body weight
gain in mice fed the high-fat diet was evident after only 2 weeks of high fat feeding
(Fig. 3.4). After 8 and 19 weeks of feeding, body weight gain of the HFF group was
11.4% and 30.5%, respectively, higher than that of the LFF group (Fig. 3.3).

Development of diet-induced obesity is a progressive
process of deterioration of energy balance regulation

HF
Diet: LF
Time: 1 Week
B W G No difference

LF
HF
8 Weeks

+ 11.4%

LF
HF
19 Weeks
+ 30.5%

Figure 3 J Physical appearance of high fat diet induced obese mice after 1, 8 and
19 weeks of feeding. H F F : High fat diet fed mice; LFF: L o w fat diet fed mice.
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Figure 3.4 Body weight in mice fed either a high- or low-fat diet for 19 weeks
(Mean ± SE, * shows significant differences {P < 0.05).

3.6.2

Measurement of Calorie Intake

As the P-values in Table 3.2 and Figure 3.5 showed, in the HFF group, caloric

intake paralleled that of the LFF controls for 4 weeks. However, at this point, the cal
intake of HFF mice began to decrease, and by the fifth week of feeding, it had fallen
significantly below that of the LFF mice. From 8 weeks, however, the calorie intake of
the HFF group began a gradual increase; then, at approximately 15 weeks, it increased

dramatically, surpassing that of the LFF mice, and after 19 weeks of feeding, was 14.6%
greater than the calorie intake of the LFF controls (Fig. 3.5).

3.6.3 Measurement of Feed Efficiency
Feed efficiency was calculated in the ratio of body weight gain /calorie intake.
Body weight gain and the amount of food consumption were measured at 14:00 on a

daily basis. After 19 weeks of the high-fat diet, HFF mice had a 62% significant higher
feed efficiency than that of low-fat diet fed mice. Results were mean ± SE, *P < 0.05;
comparisons between the mice fed a high and low fat diet, n = 6 per group (Fig. 3.6).
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Figure 3.5 Calorie intake in mice fed either a high- or low-fat diet for 19 weeks
M e a n ± SE, * shows significant differences {P < 0.05), n = 6 per group.
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Figure 3.6 The ratio of body weight gain/calorie intake in mice after
19 weeks of a high- or low-fat diet
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Table 3.2 P-values obtained from Mest comparison of body weight and calorie intake in mice
fed either a high- or low-fat diet for 19 weeks (n = 6 per group)
Feeding
Weeks

Body Weight
P Value

Calorie Intake
P Value

Feeding
Weeks

Body Weight
P Value

Calorie Intake
P Value

0
0
1
2
3
4
5
6
7
8
9

0.7713
0.9480
0.0611
0.0055
0.0009
0.0005
0.0022
0.0001
0.0002
0.0001
0.0001

0.9421
0.9555
0.7630
0.4651
0.7330
0.3056
0.0006
0.0010
0.0020
0.0001
0.0001

10
11
12
13
14
15
16
17
18
19

0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001
0.0001

0.0001
0.0001
0.0116
0.0340
0.0916
0.6457
0.1818
0.0465
0.0027
0.0011

3.6.4

Measurement of Fat Storage and Plasma Leptin

As the P-values in Table 3.3 showed, that in conjunction with the changes in

body weight, the increases in weight of the epididymal and perirenal fat masses of th

HFF group were significantly greater than those of the LFF controls after 8, 15 and 1

weeks of feeding (Fig. 3.7). The final gains in epididymal and perirenal fat masses o
the HFF group were +144% and +130%, respectively. The gain in inguinal fat mass of
the HFF group was not significantly greater than that of the LFF controls at 1 and 8
weeks feeding, and was +33.6% greater in the HFF group at 19 weeks (Fig. 3.7).
As the P-values in Table 3.3 showed, plasma leptin levels were significantly
elevated in the HFF mice compared with LFF mice when measured at 8, 15 and 19
weeks of feeding (Fig. 3.7; Table 3.3). Compared with the LFF mice, plasma leptin
levels were increased 5-fold after 19 weeks in the HFF mice.

75

Table 3 3 P-values obtained from t-test comparison of epididymal, perirenal and inguinal fat
masses and plasma leptin in mice fed either a high-fat or low-fat diet for 1,8, 15 and 19
weeks (n = 6 per group)
Feeding Period

1 week

8 weeks

15 weeks

19 weeks

Epididymal Fat M a s s

0.2426

< 0.0001

<0.0001

<0.0001

Perireanal Fat M a s s

0.1184

< 0.0001

<0.0001

0.0041

Inguinal Fat M a s s

0.3628

0.0969

0.0029

<0.0001

Plasma Leptin

0.0534

0.0298

0.0112

<0.0001
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Figure 3.7 A m o u n t of fat storage in mice fed either a high fat or low fat diet for 1, 8,15 and
19 weeks. A : Epididymanl fat mass; B: Perirenal fat mass; C: Inguinal fat mass; D: Plasma
leptin concentration in mice fed a high-fat or low-fat diet for 1, 8, 15 and 19 weeks. Results
are mean ± SE, * denotes significant differences {P < 0.05), comparisons between the mice
fed a high and low fat diet, n = 6 per group.
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3.6.5

Measurement of the Length of Tibia
A s the P-values in Table 3.4 showed that, although body weight gain of the H F F

group was +11.4%, + 2 3 . 1 % and +30.5%, respectively, higher than that of the L F F group
after 8, 15 and 19 weeks feeding, there was no significant difference in tibia bone length
between the two groups (Fig. 3.8).
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Figure 3.8 The length of tibia in mice fed either a high fat or low fat diet for 1, 8, 15 and
19 weeks. Results are mean ± SE, * P < 0.05, comparisons between the mice fed a high
and low fat diet, n = 6 per group.

Table 3.4 P-values obtained from f-test comparison of the length of tibia in mice fed
either a high-fat or low-fat diet for 1, 8, 15 and 19 weeks
Feeding Period

1 week

8 weeks

15 weeks

19 weeks

The Length of Tibia

0.5155

0.7073

0.7872

0.8613

3.6.6

Measurement of Ratio of Visceral Fat/Body Weight and
Ratio of Calorie Intake /Plasma Leptin

Ratios of Visceral Fat/Body Weight ( R V B )
The amount of visceral fat storage was represented here as total epididymal and
perirenal fat masses from both the left and right sides of the body. The total amount of
fat was divided by body weight and given a percentage of the visceral fat (mg) of body
weight (g). After 1 week feeding, there were no significant differences in the ratio of
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visceral fat / body weight ( R V B ) between the H F F and L F F groups. However, after 8
and 19 weeks feeding, the HFF mice showed a progressive +45% and +84% increase in
RVB compared to LFF mice, respectively (Table 3.5).
Ratio of Calorie Intake/Plasma Leptin Concentration (RCL)
The RCL was used to represent the endogenous leptin sensitivity in the dietinduced obese mice. After 1 week feeding, no significant difference in RCL could be
seen between HFF and LFF mice (Table 3.5). However, after 8 week feeding, the RCL
showed a -74% decrease in HFF mice compared with LFF mice. Further, after 19
weeks feeding, there was -80% decrease in RCL in the HFF mice compared with LFF
mice.

Table 3.5 Plasma leptin, ratio of visceral fat/body weight and ratio of calorie intake
leptin in mice after 1, 8 or 19 weeks of high- or low fat diet

lWeek(n=12) 8 Weeks (n= 12) 19 Weeks (n = 12)
HFF

LFF

HFF

LFF

HFF

LFF

BW(g) 17.8 ±1.2 16.9 ±0.5 26.5 ±1.4* 23.8 ±1.2 33.9 ±1.8* 26.1 ±1.6
Fl (kcal/m/d)

22.1 ±0.5

21.6 ±1.1

25.2 ±1.7*

30.1 ± 1.2

34.6 ±1.9*

30.2 ±1.3

Leptin (ng/ml)

2.42 ±0.08

2.05 ±0.02

11.41 ±2.36*

3.53 ±0.12

29.58 ±3.34*

5.21 ±1.01

RVB

15.2 ±0.8

14.9 ±0.9

29.1 ± 1.3*

20.1 ± 1.2

45.1 ±1.9*

24.5 ±1.3

RCL

9.1 ±0.7

10.5 ±0.9

2.2 ±0.3*

8.6 ±0.7

1.3 ±0.2*

6.2 ±0.5

Results are mean ± SE of individual mean values for groups of 12 mice. High-fat fed (HFF)
versus low-fat fed (LFF) mice by two-sample t-test. *P < 0.05; B W : Body weight (g); Fl: Food
intake (kcal/mouse/daily); R V B : Ratio of visceral fat (mg)/body weight (g); R C L : Ratio of
calorie intake (kcal/daily)/plasma leptin concentration (ng/ml).

3.7 Discussion
The results presented here showed that C57 B1/6J mice exposed to a high-fat diet
for 19 weeks developed obesity. More than that, my results suggested that the

progressively developed obese mice experienced three stages. (1) Early stage: high-fat die
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gradually induced body weight gain; (2) Middle stage: followed by a reduced food intake
stage during which the leptin feedback mechanism reacts against this energy surplus; (3)
Late stage: there was a dramatic increase in food intake, body weight and plasma leptin.
Male C57 B1/6J mice were used in developing high-fat diet induced obesity in this
study. During the progressive development of obesity, C57 B1/6J mice showed a

significant difference in responding to a high fat diet in the three different stages, incl
changes in calorie intake, body weight, and adipose fat mass and plasma leptin.

3.7.1 C57 B1/6J mice
Male C57 B1/6J mice were used in this study for several reasons. Firstly,
C57B1/6J mice had a specific character in their metabolic response to high fat diet
feeding, indicating the mice had a genetic factor and appeared to be easily triggered by
diet to develop obesity. Secondly, C57 B1/6J mice showed a significantly higher feed
efficiency (FE = weight gained/calories consumed) on the high fat diet, compared with
low fat diet fed mice (Parekh et al., 1998). This suggested that high fat diet fed C57
B1/6J mice actually consumed fewer calories per gram of body weight than low fat diet
fed controls during the development of obesity. Thirdly, after 2-8 months high fat diet,
C57 B1/6J mice presented adipocyte hyperplasia accompanied by significantly increase
in plasma glucose, insulin and leptin, compared with low fat diet fed mice (Surwit et
al., 1997; Van et al., 1997). These results resemble humans with diabetes, obesity and
leptin resistance. In addition, it has been well documented that human females and
animal models had a higher plasma leptin concentration than that of males. Using only
male C57 B1/6J mice to develop high fat diet induced obesity could avoid gender
difference in present study. Finally, rapid accumulative data related to the study of
C57B1/6J mouse provided more and more comparative information for the present
study.
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3.7.2

Early Stage of Developing D I O Mice

The first stage of a high-fat diet induced obesity in mice, showed that in the
early high-fat feeding response stage, was characterized by an increase in total food
intake and body weight of HFF mice and was significantly greater than that of LFF
mice after high-fat feeding for 2 weeks. This was consistent with the study of West et
al., which compared the effects of a diet containing 33% fat and the other diet
containing 11% on the mice for 7 weeks. They found that there was a transient
hyperphagia during the early weeks of exposure to a high fat diet in most mice (West et
al., 1992). It was possible that the transient hyperphagia in HFF mice is due to initial
exposure to a high fat diet.
However, at this stage HFF mice had no significant differences in the amount of

visceral fat and plasma leptin. This result suggested that HFF mice still had a relativel
normal metabolic regulative function in early stage.

3.7.3 Middle Stage of Developing DIO Mice
The middle stage was a central regulative stage - that was, the increase in
energy stored in adipose tissue induced an increase in adipose tissue leptin output. The
subsequent elevation in plasma leptin seemed to lead to a decrease in energy intake via
activation of the central regulative system. Consistent with this idea, plasma leptin
levels of HFF mice were greatly elevated after 8 weeks of feeding (Fig. 3.7).
Concomitantly, there was a dramatic decrease in calorie intake after 3 weeks of feeding
in the high-fat fed mice; intake continued to drop for another 3 weeks, falling below
control levels after 1 week where it remained for the next 11 weeks.
Further, in the middle stage, both epididymal and perirenal fat masses of HFF
mice were significantly greater than those of LFF controls after high-fat diet feeding

for 8 weeks, indicating greater fat deposition. In support of this notion, several studies
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suggested that increasing the percentage of fat in the diet led to an increase in adiposity
(Masuzaki et al., 1995). Certainly evidence suggested that fat was stored more
efficiently than carbohydrate (Storlien et al., 1986; Ikemoto et al., 1996). In a direct
comparison between a high carbohydrate and a high fat diet fed equicalorically, a high
fat diet appeared to be handled more efficiently, resulting in a greater increase in
adipose mass in rats (Storlien et al., 1986).
My results showed that during the middle stage HFF mice reduced their daily
calorie intake and gradually fell below control levels accompanied by an increase in
visceral fat mass and plasma leptin, compared with LFF mice. The results suggested
that it might be, as body adiposity increase, regulatory factors led to a negative

feedback to decrease energy intake to limit further increases in adipose lipid stores in
this stage.

3.7.4 Late Stage of Developing DIO Mice
In this stage, the energy intake of the HFF mice increased dramatically after 15
weeks feeding, and by 19 weeks their energy intake was 14.6% greater than that of

LFF controls. In agreement with previous studies (Frederich et al., 1995a; Surwit et al.,
1997; Widdowson et al., 1997), there was a 141% significant increase in visceral fat
mass accompanied by more than 458% greater of plasma leptin than those of LFF
controls after 19 weeks (Fig. 3.7). An interesting fact was that the large increase in
plasma leptin in the HFF mice did not inhibit energy intake the same as it showed in
the middle stage. The result indicated that leptin resistance had occurred in HFF mice
in the late stage of development of obesity.
Furthermore, the present results showed that in the late stage the HFF mice had
84% increase in RVB and 80% decrease in RCL compared with those of LFF mice.
Consistent with a previous study (Parekh et al., 1998), the feeding efficiency of HFF
81

mice was 7 2 % higher than that of L F F mice in the present study. These results
suggested that HFF mice actually consumed fewer calories per gram of body weight
than LFF mice. Therefore, hyperphagia could not be the only reason to explain the
dramatic increase in body weight and adipose fat mass in the late stage of the
development of obesity.

3.8 Conclusion
This study showed that a high-fat diet induced obesity in C57 B1/6J mice was a
progressive course of development and could be divided into three stages over 19 weeks of
feeding. (1) Early stage: high-fat diet gradually induced body weight gain; (2) Middle
stage: followed by a reduced food intake stage during which the leptin feedback

mechanism reacted against this energy surplus; (3) Late stage: developed leptin resistance
showing a dramatic increase in feeding efficiency and plasma leptin.
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Chapter 4
Effects of Exogenous Leptin in DIO Mice
4.1 Introduction
The data have identified leptin as an afferent signal in a negative-feedback loop

regulating the energy intake and energy expenditure (Campfield et al., 1995; Seeley et al.,
1996). Genetically obese animal models and leptin resistance has been intensively
investigated in db/db mice and fa/fa Zucker rats (Campfield et al., 1995; Maffei et al.,
1995a; Seeley et al., 1996). These genetically obese animals had a normal ob gene but a
genetic defect in the leptin receptor in the hypothalamus (Tartaglia et al., 1995; Chen et
1996; Lee et al., 1996). The defect in the leptin receptor resulted in profound obesity in

both animals with a high circulating leptin (Seeley et al., 1996). It has been suggested tha

their obesity might be a direct result of relative central neural system insensitivity to l
resulting in a failure of the normal regulatory feedback that inhibited excessive calorie
intake and body weight gain (Seeley et al., 1996).
High fat diet induced obese animal models accompanied by leptin resistance has
also been successfully produced in several experimental groups (Van et al., 1997;
Widdowson et al., 1997). The general characters of the DIO animals were severe obesity,
hyperglycemia, hyperinsulinemia and hyperleptinemia (Surwit et al., 1991; Surwit et al.,
1997). High fat diet induced C57 B1/6J obese mice were one of the most popular obese
animal models used to study diet-induced obesity (Surwit et al., 1988). C57 B1/6J mouse

had a genetic background that let it easily develop into obesity after high fat diet feedin
The DIO mice showed hyperleptinemia that was similar to human obesity and provided a
good animal model for studying leptin resistance.
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The study of peripheral and central leptin resistance in D I O mice has also been
carried out in several research groups. Van Heek et al. firstly reported peripheral
insensitivity (but centrally sensitivity) to exogenous injection of leptin in the DIO mice
after 56-days high fat-diet feeding (Van et al., 1997). Widdowson et al. showed that after a
high fat diet over 8 weeks, Wistar rats became obese with hyperglycemia and
hyperleptinemia. The diet induced obese rats had a reduced central leptin sensitivity
showed in inhibition of food response to i.c.v injection of leptin (Widdowson et al., 1997).
The results provided direct evidence that a long term high fat diet feeding could produce
obese animal models with reduced leptin sensitivity peripherally and centrally in DIO
animals.
Although previous studies showed that DIO animals had reduced leptin sensitivity,
the course of progressive development of leptin resistance was still unclear. Therefore, the
aims of the present study was undertaken to investigate, whether or not high fat dietinduced obesity was associated with a progressive development of leptin insensitivity

peripherally and centrally, and whether the duration of high fat feeding might be a factor in
the development of such leptin insensitivity.

4.1.1 Hypothesis
Based on the early study (see Section 2.4), the following hypotheses were
adopted for the present study:
1. A high fat diet would induce obesity in C57B1/6J mice (DIO mice) with an
increase in body weight and calorie intake but remaining leptin sensitive in the
early stage of development of obesity.
2. The DIO mice with a gradual reduction in peripheral leptin sensitivity in the
middle stage of development of obesity still remained central leptin sensitive.
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3.

After long-term high fat diet feeding, the D I O mice would reduce central leptin

sensitivity in late stage of development of obesity.

Material and Method
4.2.1 Animals
One hundred and twenty, 3-week-old, male C57B1/6J mice were used in this
study. All mice were fed standard laboratory chow for the first week to allow them to
adjust to a new environment. Sixty mice were then fed a high-fat diet, and the other 60
mice fed a low-fat diet (diet composition was the same as used in Section 3.2.2).

4.2.2 Experimental Design
4.2.2.1 Flow Chart of Experimental Design
In accordance with the observed variability in energy intake of HFF mice in
Section 3.6.2, three time points were selected for the administration of leptin as
representative of the three time periods, namely, weeks 1, 8, and 19 of the feeding
protocol (Fig. 4.1).
After 1 week of high or low fat diet, six mice from each group received an
i.p.injection of 2.0 ug/g (body weight) leptin or saline as controls. Body weight
change and cumulative calorie intake were then measured every 6 hours for 72
hours following the injection.
After 8 weeks of a high or low fat diet, six mice from each group received
an /.^.injection of 2.0 |Xg/g (body weight) leptin or saline as controls, while other

six mice from each group received an z'.c.v.injection of leptin (0.1|i,g) or vehicle (5
ul of 10 uM sodium acetate, pH 7.4) as controls. The injection site for i.c.v.
administration and needle placement was confirmed by a visual examination of the
lateral ventricle in the tissue sections. Body weight change and cumulative calorie
intake were then measured every 6 hours for 72 hours following the injection.
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After 19 weeks of a high or low fat diet, two dosages of i.e.v.leptin were

used for this part of the study. Six mice from each group received an i.e.v.injection
of 0.1 |ig leptin or vehicle, while an other six mice from each group received a
higher dosage (2 pig) of j.c.v.leptin or vehicle as controls. Body weight change and
cumulative calorie intake were then measured every 6 hours for 72 hours following
the injection.

120 C57B1/6J mice,
3 w k old, fed with lab c h o w for 1 w k

60 mice, high fat diet

60 mice, low fat diet

After 1-wk feeding

6 mice from each group, i.p. injection of leptin
6 mice from each group, i.p. injection of saline

After 8-wk feeding

J.
6 mice from each group,
i.p. injection of leptin;
6 mice from each group,
i.p. injection of saline

6 mice from each group,
i.c.v injection of 0.1 \ig leptin;
6 mice from each group,
i.c.v injection of saline

After 19-wk feeding

6 mice from each group,
i.c.v injection of 0.1 p,g leptin;
6 mice from each group,
i.c.v injection of saline

6 mice from each group,
i.c.v injection of 2.0 u,g leptin;
6 mice from each group,
i.c.v injection saline

Fig. 4.1 Flow Chart of Experimental Design
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4.2.3

Site for Lev. administration in the Mouse Skull

The injected site for i.c.v. administration is localized at stereotaxic
coordinates -0.70 mm relative to bregma, 1.25 mm lateral of midline according to the
Altas of Mouse Brain in Stereotaxic Coordinates (Franklin and Paxinos, 1997).

4.2.4 The Time for the Lev. Injection of Leptin
The time point for the i.e.v.injection of leptin was at 16:00. The reasons for
the selection of this time for the injection were:
1. The rhythmicity of adipose tissue ob gene expression was reported to be
linked to changes in food intake. In the rat, adipose tissue ob mRNA levels were the
lowest at 16:00, increasing soon after the rats started eating and reaching a maximum
around 04:00 (Saladin et al., 1995). In the present study, the selected time for
injecting leptin at 16:00 would set up examination for the responding effects of
exogenous leptin on a basic level, because the mouse plasma leptin would be at the
lowest level at this time.
2. In the pilot study, the best effects of exogenous leptin in the mice were also
found at 16:00, showing the strongest inhibition of food intake compared with the
administration at 04:00 and 08:00.

4.2.5 Change in Body Weight and Cumulative Calorie Intake
Body weight was measured every 6 hours for 72 hours following the injection.
The amount of body weight change was estimated by comparing the previous body
weights with these after injection for every six hours.
The amount of calorie intake was estimated by subtracting the amount of food
left in the plastic dishes and the amount of food spilled from the initial food weight.
Change in cumulative calorie intake was measured by summing up total amount of
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calorie intake after injection every six hours. The spillage of food was determined
according to the method provided in Chapter 3 (3.2.4).

4.2.6 Statistical Analysis
All data were shown as mean ± SE for groups based on six mice in each group.
The effect of the leptin dose and differences in body weights and cumulative calorie
intake over time between HFF and LFF mice were analysed using a two-way analysis
of variance (ANOVA). Analyses were performed using the IMP statistical package
(SAS institute, Inc, NC, USA, 1997). Differences in variables between HFF mice and
LFF mice were analysed using a Student's r-test.

4.3 Results
4.3.1 Peripheral Effects of Exogenous Leptin in Mice After
Feeding a High-Fat Diet for 1 Week
2 ftg/g body weight i.p. leptin. After an i.p. injection of leptin, HFF mice had a
significant 9.3%, 9.1%, and 7.8% reduction in body weight at 24, 48 and 72 h,
compared with saline treated controls. Similarly, after an i.p. injection of leptin, LFF
mice had a significant 10.2%, 10.4%, and 9.7% reduction in body weight at 24, 48 and

72 h, compared with saline treatment controls (Fig. 4.2). Cumulative calorie intake after
72 h leptin treatment was reduced by 14.7% (P < 0.0001) in HFF mice and 18.4% (P <
0.0001) in LFF mice, compared with saline treatment controls (Fig. 4.3). However,
comparing the mice fed a high fat diet with the mice fed a low fat diet, no significant
differences in body weight change at 24 h (F(i,20) = 0.146, P = 0.706), 48 h (F(i,20) =
0.29, P = 0.596) and 72 h (F(i,20) = 0.796, P = 0.383), and no significant differences in
cumulative calorie intake at 72 h (F(i,20) = 4.157, P = 0.055), were found after
i.p.injection of leptin, that is, there was no significant interaction between diet and
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injected treatment for body weight change at 24, 48 and 72 h, nor for cumulative calorie
intake at 72 h.

4.3.2 Peripheral and Central Effects of Exogenous Leptin in Mice
After Feeding a High-Fat Diet for 8 Weeks
(A) 2 jug/g body weight i.p. leptin. After an i.p.injection of leptin until 72 h,
HFF mice did not show leptin effects on body weight (P = 0.9772) and cumulative

calorie intake (P = 0.7842; Figs. 4.4 and 4.5), compared with saline treatment controls

However, after an i.p. injection of leptin, compared with saline treatment controls, LF
mice showed significant 4.5% (P < 0.0001), 3.5% (P = 0.012) and 0.6% (P = 0.045)

reduction of body weight at 24, 48 and 72h, respectively (Fig. 4.5). Cumulative calori
intake after 72 h leptin treatment was also reduced by 7.0% (P < 0.0001) (Fig. 4.5).

(B) 0.1 jug i.c.v. leptin. After an i.c.v. injection of 0.1 ]xg leptin, HFF mice had
a significant 3.1%, 0.9% and 1.1% reduction in body weight at 24, 48 and 72 h,

compared with saline treatment controls (Fig. 4.6). Similarly, after an i.c.v. inject
0.1 ug leptin, LFF mice had 4.1%, 1.3% and 0.9% reduction in body weight at 24, 48

and 72 h, compared with saline treatment controls (Fig. 4.6). Cumulative calorie intak
after 72 h leptin treatment was reduced by 17.7% (P = 0.0003) in HFF mice and 18.3%
(P < 0.0001) in LFF mice, compared with saline treatment controls (Fig. 4.7). However,
comparing the mice fed a high-fat with the mice fed a low fat diet, no significant
differences in body weight change at 24 h (F(i,20) = 1.264, P = 0.2743), 48 h (F(i,20)

0.014, P = 0.905) and 72 h (F(i,2Q) = 0.922, P = 0.348), and no significant differences

cumulative calorie intake at 72 h (F(i,20) = 0.848, P = 0.368), were found after i.c.v.
injection of leptin (Fig. 4.7).
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4.3.3

Central Effects of Exogenous Leptin in Mice After Feeding a

High-Fat Diet for 19 Weeks
(A) 0.1 jug i.c.v. leptin. This study showed that 0.1 ug i.c.v. leptin had no
significant effects on body weight and cumulative calorie intake in the HFF mice at
24, 48 and 72 h, compared with saline treatment controls (Figs. 4.8 and 4.9). However,
LFF mice, after i.c.v. injection of 0.1 ug leptin, showed a significant reduction in
weight for 2.2% (P < 0.0001) and 1.0% (P = 0.005) at 24 and 48 h, respectively,

compared with saline treatment controls (Fig. 4.8). Cumulative calorie intake after 7
h leptin treatment was reduced by 7.0% (P = 0.0013) compared with saline treatment
controls (Fig. 4.9).
(B) 2 fig i.c.v. leptin. HFF mice, after an i.e.v.injection of 2 ng leptin, had a

significant reduction in body weight for 2.5% (P < 0.0001) and 0.7% (P = 0.007) at 2
and 48 h, respectively, compared with saline treatment controls (Fig. 4.10). LFF mice,

after an i.e.v.injection of 2 ug leptin, had 5.4% (P < 0.0001), 2.7% (P < 0.0001) and
1.1% (P < 0.0001) reduction in body weight at 24, 48 and 72 h, compared with saline
treatment controls (Fig. 4.10). Compared with saline treatment controls, cumulative
calorie intake after 72 h leptin treatment was reduced by 6.7% (P = 0.0019) in HFF
mice and 16.6% (P < 0.0001) in LFF mice (Fig. 4.11). Compared with the LFF mice,

the HFF mice, after an i.c.v. injection of 2 ug leptin, had a significant 2.9% (F(i,2
32.47, P < 0.0001), 2.0% (F(i,20) = 55.35, P < 0.0001) and 1.0% (F(i,20) = 52.99, P <
0.0001) less reduction in body weight at 24, 48 and 72 h, respectively. After an
i.c.v.injection of 2.0 ug leptin, HFF mice had a significantly 9.9% (F(i,20) = 15.11,
0.0009) less cumulative calorie intake than that of LFF mice at 72 h.
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Time (h)
Figure 4.2 Peripheral effects of exogenous leptin on the body weight change
of mice fed either a high fat or a low fat diet for 1 week. Although body
weight changes were measured every 6 hours, the data was presented at 3
time points (24,48 and 72 h).
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Figure 4.3 Peripheral effects of exogenous leptin on the change of
cumulative calorie intake of mice fed either a high fat or low fat diet for 1
week. Although body weight changes were measured every 6 hours, the
data was presented at 3 time points (24,48 and 72 h).
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Figure 4.4 Peripheral effects of exogenous leptin on the body weight
change of mice fed either a high fat or a low fat diet for 8 weeks. Although
body weight changes were measured every 6 hours, the data was presented
at 3 time points (24, 48 and 72 h).
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Figure 4.5 Peripheral effects of exogenous leptin on the change of
cumulative calorie intake of mice fed either a high fat or low fat diet for 8
weeks. Although body weight changes were measured every 6 hours, the
data was presented at 3 time points (24,48 and 72 h).
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Figure 4.6 Central effects of 0.1 ug exogenous leptin on the body weight
change of mice fed either a high fat or low fat diet for 8 weeks. Although
body weight changes were measured every 6 hours, the data was presented
at 3timepoints (24, 48 and 72 h).
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Figure 4.7 Central effects of O.lug exogenous leptin on the change of
cumulative calorie intake of mice fed either a high fat or low fat diet for 8
weeks. Although body weight changes were measured every 6 hours, the
data was presented at 3 time points (24,48 and 72 h).
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Figure 4.8 Central effects of 0.1 ug exogenous leptin on the body weight
change of mice fed either a high fat or low fat diet for 19 weeks.
Although body weight changes were measured every 6 hours, the data
was presented at 3 time points (24, 48 and 72 h).
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Figure 4.9 Central effects of 0.1 |ig exogenous leptin on the change of
cumulative calorie intake of mice fed either a high fat or low fat diet for
19 weeks. Although body weight changes were measured every 6 hours,
the data was presented at 3 time points (24,48 and 72 h).
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Figure 4.10 Central effects of 2.0 ng exogenous leptin on the body weight
change of mice fed either a high fat or low fat diet for 19 weeks. Although
body weight changes were measured every 6 hours, the data was presented
at 3 time points (24, 48 and 72 h).
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Figure 4.11 Central effects of 2.0 ug exogenous leptin on the change of
cumulative calorie intake of mice fed either a high fat or low fat diet for
19 weeks. Although body weight changes were measured every 6 hours,
the data was presented at 3 time points (24, 48 and 72 h).

95

4.4 Discussion
The results presented here showed that mice exposed to a high fat diet for 19 weeks
developed obesity and, progressively, peripheral and then central leptin insensitivity. The
obese mice progressively developed through early, middle and late stages.
Early stage
During the early stage of the first week, HFF mice were shown to be normal in
body weight, fat gain and there were no significant changes in plasma leptin concentration,
compared with LFF mice. The results were consistent with previous human study
examining the effect of diet composition on leptin concentration in 12 lean subjects
(Schrauwen et al., 1997). They reported that no significant changes in plasma leptin
concentration were observed after 7 days on the high-fat diet. This result suggested that a
similar response to short-term high fat diet stimulation in both humans and C57 B1/6J
mice. The present results also supported previous study of Surwit et al (1988), showing
that after acute exposure C57 B1/6J of mice to a high fat diet for 1 week, there was no
significant alteration in body weight, blood glucose and insulin were observed. Taken
together, these results suggest that a short-term change in diet composition may not either
have an effect on plasma leptin concentration or play a role in early development obesity.
However, after 1 week feeding, the early stage of high fat diet induced obesity in
mice was characterised by relatively normal food intake but gradually elevated body
weight and fat gain. As shown previously, in a direct comparison between a high

carbohydrate and a high fat diet fed equicalorically, a high fat diet appeared to be handled
more efficiently, resulting in a greater increase in adipose mass in rats (Storlien et al.,
1986). Present study showed, however, that the mice fed a high fat diet for 1 week had
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similar response in body weight change and cumulative calorie intake following i.p. leptin
injection, indicating that no peripheral leptin resistance had occurred.
Middle stage
The middle phase was perhaps the most fascinating in the present study. Here there
seemed to be an active attempt, possibly driven by increasing leptin level, to control the
rate of excess fat gain by significantly reducing food intake. The hypophagia might be
driven via activation of hypothalamic leptin receptors. However, despite the hypophagia,
excess fat still accumulated with apparent gains in energetic efficiency at least partially
thwarting this regulatory endeavour. Peripheral leptin insensitivity was evident by 8 weeks
of HFF. This was in agreement with other work showing peripheral leptin resistance after 8
weeks on HFF (Van et al., 1997).
However, in the present study, direct evidence showed that central leptin sensitivity

was still intact at the middle stage of 8 weeks time point. The result was consistent with the
findings by Van Heek et al (1997). They reported that the mice fed a high fat diet for 8
weeks still retained sensitivity to centrally administered leptin. Taken together, these

results suggest that there may be a central regulative period in response to a high fat diet t
modulate energy balance in the middle stage. Because another finding in this study
suggests that there may be a gradual development of central leptin resistance at this stage,
and it is manifested as a slow though steady increase in energy intake from 9 to 15 weeks
of feeding. Furthermore, Schwarte et al (1996b) suggested that the central transport system
might be saturated or defective in human obesity, because obese humans did not have
elevated cerebrospinal fluid levels of leptin, although their plasma leptin was higher than
that of non-obese humans. In the middle stage, the present results: that mice exhibited
resistance to peripherally injected leptin, while being sensitive to centrally administered
leptin, would support this hypothesis.
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hate stage
By some 4 months of high fat feeding, the energy intake of the HFF mice increased
dramatically after 15 weeks, and by 19 weeks their energy intake was 14.6% greater than

that of LFF controls. Furthermore, the inhibitory effects of central leptin administration o
calorie intake and body weight were attenuated in HFF mice but not in LFF mice; a 0.1 ug
injection of leptin had virtually no effects on the calorie intake and body weight change,
and there was significantly less of an effect of a 2 ug injection. Consistent with this,
Widdowson et al (1997) detected a reduction in central leptin sensitivity in rats after 8
weeks of high-fat feeding. Here, the energy intake of the HFF mice increased dramatically
after 15 weeks feeding compared with LFF controls. It suggested that this was indicative of

the onset of central leptin resistance. This notion was supported by the fact that, consiste
with other reported examples of central leptin resistance, plasma leptin levels remained
greatly elevated during this period (Frederich et al., 1995a; Widdowson et al., 1997).
Several hypotheses had been proposed to account for the apparent leptin
insensitivity. Although the mechanism causing central leptin insensitivity was not fully
understood, some suggested that the presence of high levels of leptin might induce
desensitisation of the hypothalamic leptin receptor (Zimmet and Alberti, 1996; Widdowson

et al., 1997). Alternatively, it has been suggested that the reduction in leptin action may b
due to the down-regulation of leptin receptor density or even saturation of the receptors
with endogenous leptin as a result of the elevated leptin output (Widdowson et al., 1997;
Chang et al., 1999). In addition, another explanation might be that a high fat diet affects
hypothalamic neural networks downstream from the leptin receptor, such as the leptinPOMC-a/MSH or leptin-NPY pathways. Evidence was accumulating to suggest that these
pathways might be involved in mediating leptin effects on energy intake and body weight.
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4.5

Conclusions

This Chapter study showed that a high fat diet-induced obesity (19 weeks) in C57
B1/6J mice was a progressive course of development and could be divided into three

stages: 1) In the early stage, in response to a high fat diet mice were sensitive to exogeno

leptin; 2) In the reduced food intake stage, when mice had an increase in leptin production,
they still remained central leptin sensitive; and 3) an increased food intake stage,
accompanied by a reduction of central leptin sensitivity.
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EXPERIMENTAL SECTION B:
CENTRAL NEURAL NETWORKS INVOLVED
IN DIET INDUCED-OBESITY IN C57BL/6J MICE
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Chapter 5
Altered hypothalamic c-Fos-like immunoreactivity in
Development of Diet Induced-obese Mice
5.1 Introduction
Obesity was believed to be both genetic and environmental, such as excess caloric
intake and decreased physical activity (Ikemoto et al., 1996; Lee et al., 1996; Scheen,
1996; Perusse et al., 1997). It was known that an oversupply of fat was associated with the
development of obesity in the C57B1/6J mice (Surwit et al, 1988). Previous investigation
by Rebuffe-Scrive et al (1993) showed that C57B1/6J mice fed a diet containing 35.8% fat
for 5 months had greater body weight and visceral fat mass compared with mice fed a diet
containing 9.8% fat and 56% carbohydrate controls. It implied that not only fat increased
the palatability of food but it was also converted into body fat far more efficiently than
carbohydrates in the mice (Rebuffe Scrive et al., 1993). The mechanism of a high-fat diet
induced obesity was still unclear. After acute exposure (1 week) to the high-fat diet
(35.8%), mice did not significantly alter body weight, blood glucose and insulin levels
(Surwit et al., 1988). However, long-term exposure to a high fat diet could induce obesity
with hyperphagia, hypergluconemia, hyperleptinemia and insulin resistance (Surwit et al.,
1988; Widdowson et al., 1997). It has been suggested that the high-fat diet induced obesity
may be attributed to an increase in white and brown fat growth (Storlien et al., 1986).
Another characteristic of the high-fat diet induced obese mouse was that it had a
low sympathetic activity, in turn, resulted in decreased energy expenditure (Levin et al.,
1983a). However, it was not known whether the reduced sympathetic activity was due to a
primary defect in the central nervous system during the development of obesity.
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Hypothalamus was well recognized for its important role in regulation of food
intake and energy homeostasis (Stephens et al., 1995; Woods et al., 1998; Elmquist et al.,
1999). The purpose of this Chapter is to investigate whether there were neurones within the
hypothalamus that were responsible for a long-term high-fat diet induced obesity in mice.

In order to compare the neuronal activity in response to a high fat diet, during the differe
stages in the development of obesity, mice were exposed to a high-fat diet for 1, 8 and 19
weeks, respectively. Then c-Fos-like immunoreactivity was used as a marker of neuronal
activity to map the effects of high-fat diet feeding in the individual mouse brain compared
with the lean controls (low-fat diet group).
C-Fos was an immediate-early gene, which was rapidly expressed in many neurons
in response to either acute physiological or chemical stimulation (Dragunow and Faull,
1989; Chan et al., 1993; Li et al., 1994). Although the significance of c-Fos expression in
neurons remained to be determined, an elevated c-Fos expression provided a potential
insight for the location of functional activation in the neural system (Dragunow and Faull,

1989; Chan et al., 1993). No data is currently available in relation to dietary fat feeding a
hypothalamic c-Fos activity. The result of this Chapter would provide a basic
understanding of the neuronal activity in response to a high fat diet, during the different
stages in the development of obesity in the mice.

5.2 Hypotheses
Based on results arising from Chapter 3 and 4, the following hypotheses were tested:
(1) A high fat diet would induce obesity with altered neural activity of the
hypothalamic nuclei related to central regulation of energy balance.
(2) Differences of hypothalamic neuronal activity in response to a high fat diet would
exist at different stages of development of obesity.
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5.3

Materials and Methods

5.3.1 Animals
Thirty-six, 3 weeks old, C57B1/6J male mice, were obtained from the Animal
Resources Centre (Murdoch, WA) and fed a standard laboratory chow for 1 week to
accommodate to the new environment. The mice were housed individually in
environmentally controlled conditions (temperature 22 C, light cycle from 0600 to
1800 and dark cycle from 1800 to 0600), and allowed access to tap water ad libitum
throughout the study.

5.3.2 Experimental Design
Mice were subsequently randomly assigned to one of the groups shown in Fig
5.1. The first group was given a high-fat diet and the other group was given a low fat
diet (the composition of diet See Chap. 3.2.2). Six mice for each group were sacrificed
after fed either a high or low fat diet for 1, 8, and 19 weeks, respectively.

5.3.3 Histology
All mice were sacrificed within 1 minute with an overdose injection of sodium
pentobarbitone anaesthesia (120 mg/kg i.p.). To attain the least variation in c-Fos-like
immunoreactivity, mice were sacrificed at a fixed time between 0400 and 0500 h.
The brains were fixed by perfusion through the left ventricle of the heart with
25 ml 0.9% saline in phosphate buffer, followed by cold 4% paraformaldehyde made in
0.1 M phosphate buffer (pH 7.4). The brains were immediately removed and placed in
30% sucrose solution in phosphate buffer overnight. The following day, the brains
were frozen in liquid nitrogen and the entire brain was cryostat sectioned into 25 jLtm
thickness coronal sections at -17°C. Sets of three consecutive sections were taken. The
first set was used for the detection of c-Fos, NPY and a-MSH immunoreactivity, the

second set was used for Nissl staining for accurate identification of the neural structure
103

according to the Atlas of M o u s e Brain in Stereotaxic Coordinates (Franklin and

Paxions, 1997) and the third set was used for controls. The specificity of the antisera
had been tested previously (Huang and Wang, 1998) and the immunohistochemical
reactions were tested by omission of the primary antisera. No peroxidase reaction
occurred in these experiments.

36 C57B1/6J mice,
3 w k old, fed with lab chow for 1 w k

18 mice, low fat diet

18 mice, high fat diet

6 mice sacrificed from each group
after lwk feeding
6 mice sacrificed from each group
after 8 w k feeding

i

6 mice sacrificed from each group
after 19 w k feeding

All mouse brains were collected for
the detection of c-Fos immunoreactivity

Figure 5.1 Experimental design and assignment of mice

5.3.4 Detection of c-Fos-like Immunoreactivity
The detailed descriptions of technical procedures for immunohistochemistry
were described previously (Huang and Wang, 1998). Briefly, the brain sections were
firstly washed in 0.8% HC1 in 50% alcohol for 30 min for the abolition of endogenous
peroxidase activity. The primary antibody, rabbit anti-c-fos (Arnel-Lab, US), was
diluted at 1:8000 in PBS containing 0.1% Triton X-100 (PBS-Triton), and then applied
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at room temperature overnight. After three washings in PBS-Triton for 10-min each,
sections were incubated in the biotinylated secondary antibody (Boehringer Mannheim,
Germany), diluted at 1:250 in Tris-HCl for 1 h and then incubated in the avidin-biotinperoxidase complex (Sigma, US) diluted at 1:100 in PBS-Triton, for 2 h. Sections were
washed in Tris-HCl for 30 min before reacting them with 0.05% diaminobenzidine
tetrahydrochloride (Sigma), in Tris-HCl (pH 7.4) and 0.007% hydrogen peroxide in the
presence for 0.04% nickel ammonium sulphate.

5.3.5 Counting the FLI Neurons
A microscope driven by an IBM compatible computer with the application of
the Magellan Computer Program was used to obtain data concerning cell counting
(Huang and Wang, 1998). Sections were screened for visualization of c-Fos using an
Olympus BX40 microscope. In regions where differences in c-Fos were readily
apparent, Fos-positive nuclei were counted following the area outlined. Every third
section was counted for each nucleus for quantitation of FLI neurons, according to the
Atlas of the Mouse Brain in Stereotaxic Coordinates (Franklin and Paxinos, 1997).
FLI-positive cells were based on relative size and dark stained nuclei. Comparisons
were made between two groups stained at the same time. Comparisons between
experimental groups were performed by an analysis of six animals per group and the
average cell counts in each nucleus was determined from both the left and right sides.
All groups were then pooled for the final analysis.

5.3.6 Statistical Analysis
All data were shown as mean ± SD for three groups of mice. Analyses were
performed using the JMP statistical package (SAS Institute Inc., NC, USA, 1997).
Differences in variables between the mice fed high fat and low fat diets were analysed
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using Student's t-test. The difference was considered statistically significant if p <
0.05.

5.4 Results
5.4.1 General Observations
Obesity was induced in C57 B1/6J mice by exposure to a diet in which 58.7% of
calories were derived from fat. Compared with mice fed a low-fat diet (lean mice),
mice fed a high-fat diet (obese mice) increased body weight by 4.1% after 1 week of
feeding and eventually being 30.5% heavier after 19 weeks of feeding. Parallel to the
body weight change, the weights of regional fat mass (epdidymal, perirenal) were
significantly higher in obese mice than in lean controls after 19 weeks feeding. The
final gain of epdidymal fat mass (DIO/lean = 140%) and perirenal fat mass (DIO/lean =
130%) in obese mice displayed a significant increase in visceral fat mass compared
with lean controls. After feeding on a high-fat diet for 19 weeks, obese mice showed a
significant 5-fold increase in plasma leptin level compared with low fat diet fed
controls.

5.4.2 Distribution of c-Fos-like Immunoreactivity
Overall, the LFF mice displayed the least number of FLI neurons in the
hypothalamus among all mice examined after 8 and 19-week feeding (Tables 5.2, 5.3).
The number of FLI neurones was gradually increased in the hypothalamus of the highfat diet induced obese mice, including in the Arc, LHA, DMH and PeF (Fig. 5.2). After
19-week feeding, compared with the mice fed for 1 week, the HFF mice significantly
increased in +140%, +229%, +240% and +300% FLI neurons in the LHA, Arc, DMH
and PeF, respectively.
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5.4.3

Hypothalamic c-Fos-like Immunoreactive Neurons in the

Mice Fed High Fat Diet for 1 Week
In the hypothalamus, there were no significant differences in FLI neurons in the
Arc, L H A , D M H , V M H , P V N and PeF after 1 week of high-fat diet, compared with
that of mice fed low-fat diet controls (Fig 5.2 and Table 5.1).

5.4.4

Hypothalamic c-Fos-like Immunoreactive Neurons in the

Mice Fed High Fat Diet for 8 Weeks
In the hypothalamus, the numbers of FLI neurons in the L H A (+100%), D M H
(+140%), Arc (+100%) and PeF (+100%) were increased in the mice fed a high fat diet
for 8 weeks, compared with the low-fat diet controls (Fig 5.3 and Table 5.2). However,
no significant change in the number of FLI neurons was seen in the P V N or V M H
(Table 5.2).

Table 5.1 Distribution of the number of c-Fos-like immunoreactive
neurons in the hypothalamus of mice fed a high- or low-fat diet for
1 week

HFF
(n = 6)

LFF
(n = 6)

P Value

Arc

5±1

4±2

0.1028

LHA

7±2

6±1

0.6643

DMH

5±2

6±2

0.2604

VMH

5±1

5±2

0.7342

PeF

2±1

2±1

0.3421

PVN

2±1

3±1

0.0843

Regions
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Table 5.2 Distribution of the number of c-Fos-like immunoreactive
neurons in the hypothalamus of mice fed a high- or low-fat diet for
8 weeks

HFF
(n = 6)

LFF
(n = 6)

Arc

10±2

4±1

0.0001

LHA

12±3

6±3

0.0001

DMH

12±3

5±2

0.0001

VMH

4±2

5±1

0.2212

PeF

4±1

2±1

0.0001

PVN

3±1

3±1

0.8684

Regions

5.4.5

P Value

Hypothalamic c-Fos-like Immunoreactive Neurons in the

Mice Fed High Fat Diet for 19 Weeks
Compared with L F F mice, H F F mice had a significant increase in the number
of FLI neurons in the L H A (+156%), D M H (+113%), Arc (+100%) and PeF (+100%).
(Fig. 5.4 and Table 5.3). There were no significant differences in the number of FLI
neurons in the P V N or V M H after 19 weeks on the high fat diet, compared with the
low fat diet controls (Table 5.3).
Table 5.3 Distribution of the number of c-Fos-like immunoreactive
neurons in the hypothalamus of mice fed a high- or low-fat diet for
19 weeks

HFF
Regions

LFF
(n = 6)

(n = 6)

P Value

Arc

14 ±4

6±2

0.0015

LHA

23 ±4

9+3

<0.0001

DMH

17 ±4

8±2

0.0013

VMH

5±2

6±2

0.1114

PeF

8±3

4±1

<0.0001

PVN

3±1

4±2

0.3304
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Figure 5.2 Photomicrographs showing c-Fos-like immunoreactive neurons in the
hypothalamic nuclei of mice fed high- (HFF) or low-fat diet (LFF) for 1 week. Arc:
arcuate hypothalamic nucleus (A and A'); D M H : dorsomedial hypothalamic nucleus (B
and B'); L H A : lateral hypothalamic area (C and C ) ; P V N : paraventricular hypothalamic
nucleus (D and D'); third ventricle (3V)

109

Figure 5 3 Photomicrographs showing c-Fos-like immunoreactive neurons in the
hypothalamic nuclei of mice fed high- (HFF) or low-fat diet (LFF) for 8 weeks. Arc:
arcuate hypothalamic nucleus (A and A'); D M H : dorsomedial hypothalamic nucleus (B
and B'); L H A : lateral hypothalamic area (C and C ) ; P V N : paraventricular hypothalamic
nucleus (D and D'); third ventricle (3V)
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Figure 5.4 Photomicrographs showing c-Fos-like immunoreactive neurons in the
hypothalamic nuclei of mice fed high- (HFF) or low-fat diet (LFF) for 19 weeks. Arc:
arcuate hypothalamic nucleus (A and A'); D M H : dorsomedial hypothalamic nucleus (B
and B'); L H A : lateral hypothalamic area (C and C ) ; P V N : paraventricular hypothalamic
nucleus (D and D'); third ventricle (3 V )
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5.5

Discussion

Previous studies indicated that microinjection of leptin into the Arc or VMH could
induce significant and dose-dependent reduction in food intake and body weight gain in the
rats (Satoh et al., 1997a). It was reported that genetically obese {ob/ob) mice showed a

significant increase in FLI activity after food deprivation for 24 hours, especially in the
Arc, DMH and PVN (Huang and Wang, 1998). These findings implied that the neurons of
the hypothalamus might play a role in regulating central energy homeostasis and could be
directly activated by nutritional status change or injection of exogenous leptin.
In the present study, it was observed that DIO mice had a significant increase in the
number of FLI neurones in the Arc, LHA, DMH and PeF after 8 and 19-week feeding.
This result indicated that upper-regulated activities existed in these areas and directly
implicated that these regions of hypothalamus might be involved in the development of
high-fat diet induced obesity.
Obesity was induced in C57B1/6J mice, by exposure to a high-fat diet for 19 weeks.
Compared with LFF mice, HFF mice increased in body weight by 5.3% and 11.4% after 1
and 8 week-feeding, respectively, and increased in body weight by 30.5% with 5-folds

increased plasma leptin after 19-weeks feeding. According to the criteria of energy intake,
body weight gain, fat storage, and peripheral and central leptin sensitivity, the DIO mice
followed a course of development, which could be divided into early, middle and late
stages (see Chapter 4). The present study found that, during the three stages of the
development of diet-induced obesity, the increased body weight and plasma leptin were
accompanied by a gradually elevated different neural c-Fos expression in the Arc, LHA,
DMHL and PeF of the obese mice. The results suggested that the constantly activated
status of these neurones in the hypothalamus might be responsible for causation of
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differences in the body weight and plasma leptin levels in the different stages of
development of obesity.
In the early stage, there were no significant changes in FLI neurones in the
examined hypothalamic areas between high-fat and low-fat diet fed mice. The result
implied that a short-period stimulation by high fat diet did not alter the c-Fos neural
activity in the hypothalamus. After high-fat diet feeding for 1 week, HFF mice slightly
increased body weight but not the plasma leptin level. It has been suggested that plasma
leptin may be the primary afferent signal by which adipose tissue communicated with
hypothalamic leptin receptor for the purpose of regulating energy balance (Campfield et

al., 1996; Caro et al., 1996b). In the present study, no change in plasma leptin in the early
stage of development of high fat diet induced obese mice might contribute, at least
partially, to no significant difference in hypothalamic FLI neurones between the high-fat
and low-fat diet fed mice.
In the middle stage, the HFF mice showed a significant increase in FLI in the Arc,
LHA, DMH and PeF, indicating an elevated neuronal activity existing in these regions

after high fat diet exposure for 8 weeks. Interestingly, at this stage, the HFF mice showed a
223% elevated plasma leptin and relative hypophagia with peripheral, but not central leptin
resistance. The results indicated that hyperleptinemia might contribute to increase
hypothalamic FLI activity and inhibit energy intake in the HFF mice. However, central
leptin sensitivity still remained in the stage, it suggested that homeostatic regulation of
food intake and energy expenditure was still intact. So an increase in FLI in the
hypothalamic regions might be responsible only for a physiological response to an
increased plasma leptin.
Late stage was the most important stage in the development of DIO mice in this
study. The results showed that, after long term high-fat diet feeding for 19 weeks, dietary
fat might be the main stimulating factor to cause the changes of FLI activity in the Arc,
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L H A , D M H and PeF. It was k n o w n that arcuate hypothalamic nucleus in normal mice
contained leptin receptor (Huang et al., 1996; Baskin et al., 1998). Leptin, by binding to

the leptin receptor, could activate its central neuronal pathways inhibiting energy intake
and body weight gain (Campfield et al., 1996; Mercer et al., 1996a). However, the present
study found that the reduced function of leptin might exist as an inhibitor to the Arc
neurones of the HFF mice. It was shown that the HFF mice had a higher FLI activity in the

Arc than lean controls (Table 5.3). The results were consistent with the previous study th
there was an increase in the leptin receptor mRNA expression in the Arc of genetically

obese ob/ob mice, whose obesity resulted from a lack of leptin (Zhang et al., 1994). It was
known that long-term hyperleptinemia could result in leptin insensitivity in the brain of
DIO mice (Chang et al., 1999). It has also been reported that leptin can increase
thermogenic sympathetic nerve activity and reduce body weight in the normal mice, but

this was not the case in obese Zucker rats with a higher plasma leptin levle (Seeley et al.

1996; Haynes et al., 1997). So the present results might suggest that high-fat diet induced
obesity with high plasma leptin might reduce the sensitivity of leptin as an inhibitor to
suppress energy intake and body weight gain in the DIO mice. As the result, it might
produce attenuated leptin sensitivity in the Arc of the obese mice, in turn, contribute to
abnormalities of eating behaviour and body weight regulation.
This study showed that LHA dramatically increased its FLI neurones in DIO mice
after 19 weeks feeding. The LHA was known as a feeding centre (Bray et al., 1981; Levin
et al., 1983a). Stimulation of the LHA increased food intake and body adiposity. On the
other hand, lesion of the LHA, decreased food intake accompanied by increased energy
expenditure (Dumont et al., 1992; Rohner-Jeanrenaud, 1995). Importantly, it was reported

that DIO (3 months) rats had a significant decrease in norepinephrine turnover rate (Levin
et al., 1983a), which was also an indication of low sympathetic activity. Therefore, the
activated FLI neurons in the LHA might contribute to the development of diet-induced
114

obesity. Another possibility was related to recently discovered orexin-containing neurons.

Sakurai et al (1998) reported that orexin-containing neurons were localised in the latera
hypothalamus. Central injection of orexins induced dose-dependent stimulation of food
intake in the rat (Sakurai et al., 1998). Although it was not known about the relation
between orexin-containing neurons and activity of FLI neurons in lateral hypothalamus of
the obese mice, two neuronal systems in this region suggested the possibility that the
changed central orexin perhaps played an important role in the development of obesity in
the diet induced obese mice.
In the present study, another finding was that the DIO mice had a significant
increase in the numbers of FLI neurons in the DMH and PeF. It had been reported that the
DMH also received a dense projection of NPY from Arc, and that PeF contained the high
concentration of feeding-related NPY receptor (Dumont et al., 1992). These studies
demonstrated that DMH and PeF were also involved in the hypothalamic NPY regulative
system. Kesterson et al (1997a) reported that aberrant NPY mRNA expression in the DMH
was associated with MC4-R knockout obesity syndrome. It was suggested that the DMH
might play a special role in the central a-MSH/MC4-R pathway of energy balance
regulation (Kesterson et al., 1997b). In agreement with the results, my study also found
that there were a reduced number of immuno-stained a-MSH boutons in DMH and PeF of
the DIO mice. It implied that the reduced a-MSH activity of DMH and PeF might also
contribute to a high activity of FLI in the DMH and PeF, in turn, to induce low
sympathetic activity found in the DIO mice.
Finally, this study found that there were no significant changes of FLI activity in
the PVN and VMH of the DIO mice through the three stages of development of DIO mice.
The results suggested that both hypothalamic regions might play a less important role in
the development of high-fat diet induced obesity in this animal model.
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5.6

Conclusion

The present study showed that there were significant differences in the neuronal
activity of hypothalamus between obese and lean mice in their respective response to longterm high-fat or high-carbohydrate feeding. Increased FLI activity in the LHA, DMH, Arc
and PeF of obese mouse might be involved in the central mechanisms of the high-fat diet
induced obesity. The observations might lead to the better understanding of the relation
between the neural activity and dietary effects in the development of obesity.
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Chapter 6
Hypothalamic and Choroid Plexus Leptin Receptor
mRNA Expression During the Development of High Fat DietInduced Obesity
6.1 Introduction
Chapters 3 & 4 showed that high fat diet-induced obese mice followed a course of
development which could be divided into early (1 week), middle (8 weeks) and late (19
weeks) stages according to the criteria of energy intake, body weight gain, fat storage, and
peripheral and central leptin sensitivity. In the early stage, the D I O mice were sensitive to
exogenous leptin both peripherally and centrally. In the middle stage, D I O mice were
resistant to exogenous leptin peripherally, but sensitive centrally with evidence of
homeostatic mechanisms controlling food intake, if not entirely capable of preventing
excess adiposity. In the late stage, D I O mice became insensitive to central leptin as well,
with a more dramatic breakdown of both energy intake and body fat regulation.
Leptin, a hormone secreted by adipocytes, was transported through the blood
stream, and acted on the hypothalamus to regulate energy intake and expenditure (Zhang et
al, 1994; Halaas et al., 1995). Leptin concentration in C S F was strongly correlated to the
plasma leptin level (Schwartz et al, 1996b). However, a decreased ratio of CSF/plasma
leptin was found in obese subjects, suggesting that the reduced efficiency of brain leptin
delivery might be a possible mechanism for leptin resistance (Caro et al., 1996a; Schwartz
et al., 1996b). The leptin receptor on the choroid plexus played an important role in
transporting plasma leptin into the brain (Lee et al., 1996; Boado et al., 1998). Upregulation of the blood-brain barrier short-form leptin receptor gene products has been
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reported in rats fed a high fat diet for 12 weeks (Boado et al., 1998). Obese humans
appeared to have higher levels of leptin in plasma compared with normal subjects,

suggesting that the absence of the satiety effect in this condition might be either related
reduction or desensitization of the leptin receptor on the choroid plexus. The leptin
receptor was also highly expressed in the Arc, where the leptin receptor co-localised with
POMC (Thornton et al., 1997) and NPY neurons (Baskin et al, 1999b). Direct
microinjection of leptin into the Arc reduced food intake and body weight gain in rats
(Satoh et al., 1997a). However, i.c.v. injection of leptin to DIO animals caused the
inhibition of food response to leptin was attenuated compared with that of lean controls

(Widdowson et al., 1997). It had been speculated that the insensitivity to the administration
of exogenous leptin in DIO animals might be due to down-regulation of leptin receptor
gene expression in the Arc (Widdowson et al., 1997; Baskin et al., 1998).
Although several studies suggested that expression levels of the leptin receptor
mRNA in the brain might play an important role in regulating food intake and energy
expenditure (Zirnmet and Alberti, 1996; Baskin et al., 1998). However, little was known
about the leptin receptor mRNA expression level in the mouse brain during the
development of diet-induced obesity. The present study was designed to investigate the
mRNA levels of leptin receptor during the courses of progressive development of
peripheral and central leptin resistance at 3 defined stages (1,8 and 19 weeks) of high fat
diet-induced obesity in mice. Using a radioactive in situ hybridization detection method
and a computer-assisted image analysis system, the present study showed that three
different levels of leptin receptor mRNA expression, during the courses of progressive
development at 3 stages of high-fat diet induced obesity, in the choroid plexus and
hypothalamic arcuate nucleus of mice.

118

6.2

Hypotheses

Based on results arising from Chapters 3, 4 & 5, the following hypotheses were tested:
(1) A high fat diet might induce obesity with altered leptin receptor mRNA expression in
the choroid plexus of DIO mice during the courses of progressive development of
high fat diet induced obesity at 3 stages.
(2) Hypothalamic Arc leptin receptor mRNA expression levels might be changed in
response to a high fat diet during 3 different stages in the development of obesity in
mice.

6.3 Materials and Methods
6.3.1 Animals and Experimental Design
Thirty-six, 3 weeks old, C57B1/6J male mice were housed individually in
environmentally controlled conditions (temperature 22°C, light cycle from 0600 to
1800 and dark cycle from 1800 to 0600), and allowed access to tap water ad libitum
throughout the study. The mice were fed standard laboratory chow for the first week to
allow them to adjust to the new environment.
After one week, mice were randomly divided into two groups. The first group
was given a high-fat diet and the other group was given a low fat diet (the composition
of diet See Chap. 3.2.2). Six mice from each group were sacrificed after 1, 8 or 19
weeks of feeding (Fig. 6.1). Both peripheral and central data were measured (see
Chaps. 3 and 4). The peripheral data were the amount of energy intake, body weight,
visceral (epididymal and perirenal) fat mass and plasma leptin concentration. The
central data were the mRNA levels of leptin receptor, POMC and NPY (also see
Chaps. 7 and 8). All mice were sacrificed within 1 minute with an injection of overdose
sodium pentobarbitone anaesthesia (120 mg/kg i.p.). In order to minimise possible
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circadian m R N A expression variation, all mice were sacrificed at a fixed time between
0400 - 0500h.

6.3.2 Histology
The brains were immediately removed after death. The brains were frozen in

liquid nitrogen and cryostat sectioned into 14/nm thickness coronal sections at

The sections were divided into four sets. The first three sets were used for th

of leptin receptor, POMC and NPY mRNAs (also see Chaps.7 and 8). The fourth set

was used for determining the probe specificity. Brain sections were immediately
in an ice-cold 4% phosphate-buffered paraformaldehyde. Acetylation was carried

0.25% acetic anhydride in 0.1 M triethanolamine buffer (pH 8) for 10 min. Secti

were then dehydrated in ethanol and stored in -70°C until use. Identification o

structures was according to the Atlas of Mouse Brain in Stereotaxic Coordinates
(Franklin and Paxions, 1997).

6.3.3 Probe Design and Labeling
Two antisense oligonucleotide probes complementary to the conserved region

of leptin receptor mRNA were synthesized (Life-Tech, USA). The probes for lepti
receptor are 5-GCTAACTCGGTCACTCACAATGCTGTACTGTATCTCAGGGA-3'
(Nucleotide number 1121-1161 of GenBank sequence MMU 49110) and 5'AATTCAGCATAGCGGTGATGGCACGCCTGCTCATTGCAGCAGT-3'
(MMU42467, 1286-1328). No known homology to the designed probes was found in

the Gene Bank. All oligonucleotide probes were terminally labeled using a 10-fo
molar excess of [35S] dATP (specific activity: 1000 Ci/mmol, Amersham, UK) and
terminal transferase (Promega, USA), and purified over a MicroSpin G-50 column

(Amersham, UK). The probe concentration is 107 pcm of [35S] labelled probes in 7
hybridization solution.
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6.3.4

In Situ Hybridization

The hybridizations were carried out by incubating the sections in the
hybridization solution containing 4 x SSC, 1 x Denhardt's solution, 50% deionised
formamide, 200ug/ml sperm DNA, lOOug/lml polyA, 120ug/ml heparin, 20mM
sodium phosphate, pH 7.0) at 37°C for 18 h. After hybridization, the sections were
washed in lx SSC at 55°C for 3 times of 30 min each, and then washed in room
temperature for 1 hour. The sections were rinsed in distilled water, air dried and
exposed to Beta-Max Hyperfilm (Amersham, UK). After 4 weeks exposure, the films
were developed using standard procedures. After the completion of exposure to the

Hyperfilm, the sections containing positive signals were dipped in Emulsion soluti
(Amersham, UK) and then exposed for 9 weeks. This then allowed a further

examination of positive signals at cellular level and for a confirmation of the re
from the film.

6.3.5 Quantification and Data Analysis
All films were analysed by using a computer-assisted image analysis system,
Multi-Analyst, connected to a GS-690 Imaging Densitometer (Bio-Rad, USA).

Quantification of mRNA expression levels in various brain regions were obtained by

measuring the average density of each region in five adjacent brain sections, and t
the values were compared against a 14C-labeled autoradiographic standard (Amersham,
USA).

6.3.6 Statistical Analysis
All data are shown as mean ± S.E. for groups based on six mice in each group.

Analyses were performed using the IMP statistical package (SAS Institute, Gary, NC,
USA).
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36 C57B1/6J mice,
3 w k old, fed with lab chow for 1 w k

18 mice, high fat diet

18 mice, low fat diet

6 mice sacrificed from each group
after lwk feeding

6 mice sacrificed from each group
after 8 w k feeding
6 mice sacrificed from each group
after 19 w k feeding

All mouse brains were collected for
the detection of leptin receptor m R N A

Fig. 6.1 Experimental design and assignment of mice

6.4 Results
6.4.1 Leptin Receptor mRNA Expression in the Early Stage
After 1 week feeding, HFF mice showed no significant difference in the level of
leptin receptor mRNA expression in either the ChP (P = 0.7288) or Arc (P = 0.6730),
compared with LFF group (Figs. 6.2, 6.3, 6.4 and 6.5).

6.4.2 Leptin Receptor mRNA Expression in the Middle Stage
After 8-week feeding, HFF mice had significantly increased levels of leptin
receptor mRNA in both the ChP (+98%) (P < 0.0001) and Arc (+66%) (P = 0.0160),
compared with the LFF group (Figs. 6.2, 6.3, 6.4 and 6.5).
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Figure. 6.2 Histograms show that the leptin receptor m R N A expression in
choroid plexus of mice fed a high- or low-fat diet for 1, 8 and 19 weeks. All
values are expressed as mean ± S.E.; *P < 0.05; n = 6 per group.
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Figure 6.3 Histograms show that the leptin receptor m R N A expression in
hypothalamic arcuate nucleus (Arc) of mice fed a high- or low-fat diet for 1,
8 and 19 weeks. All values are expressed as mean ± S.E.; *P < 0.05; n = 6
per group.
123

6.4.3

Leptin Receptor m R N A Expression in the Late Stage

After 19-week feeding, HFF mice showed a dramatic reduction in the level of

leptin receptor mRNA in the ChP (-26%) (P = 0.0015) and Arc (-33%) (P = 0.0
compared with LFF group (Figs. 6.2, 6.3 6.4 and 6.5).
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Figure 6.4 Emulsion autoradiographs of the leptin receptor m R N A expression in the
hypothalamic arcuate nucleus. In the left column, the mice were fed a high fat diet for 1
week (A), 8 weeks (B) and 19 weeks (C). In the right column, the mice were fed a low
fat diet for 1 week (A»), 8 weeks (B') and 19 weeks (C»).
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Figure 6.5 Emulsion autoradiographs of the leptin receptor m R N A expression in the
choroid plexus. In the left column, the mice were fed a high fat diet for 1 week (A), 8
weeks (B) and 19 weeks (C). In the right column, the mice were fed a low fat diet for 1
week (A'), 8 weeks (B') and 19 weeks ( C ) .
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6.5

Discussion and Conclusion

Previous studies have shown that the leptin-Arc leptin receptor and its downstream
signaling pathways played an important role in the regulation of energy balance (Friedman
and Halaas, 1998; York, 1999). My early study (Lin et al., 2000) showed that the
development of diet-induced obesity in C57 mice featured sequential peripheral then
central leptin resistance and progressive breakdown of energy balance homeostasis. This
study was designed to characterize the leptin receptor mRNA expression in the early,
middle and late stages of mice during the course of the development of diet-induced
obesity. The main findings of the study were: a triphasic leptin receptor response with no
change early, an increase and then decrease in both Arc and ChP mRNA at the middle and
later stages respectively. The current results were suggestive of a progressive downregulation of leptin receptor mRNA to cause dysfunction of energy balance with long-term
high fat feeding.
Early stage
This study showed that, after 1-week diet, HFF mice had no significant differences
in the amount of visceral fat, plasma leptin and the levels of the leptin receptor mRNA
compared with the LFF group. The results indicated that short-term exposure to high fat
diet did not alter the gene expression of the Arc or ChP leptin receptor mRNA. These

results supported my finding that the mice fed a high fat diet for 1 week had not developed

leptin insensitivity (Lin et al., 2000). Van Heek et al fed mice with high fat (45%) diet fo
4 days and also showed no differences in exogenous leptin sensitivity (Van et al., 1997).
Fatty acids were clearly known to be potent gene regulators (Clarke et al., 1997).
However, the lack of effect of the 1 week of high fat feeding on mRNA levels suggested
no direct gene regulation effect at least in relation to leptin receptor.
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Middle stage
My previous study showed that, in the middle stage, the HFF mice were relatively
hypophagic with peripheral, but not central, leptin insensitivity (Lin et al., 2000). This
study showed that there was a significant increase in the level of leptin receptor mRNA in
both the ChP and Arc. Increased Arc leptin receptor mRNA was reported in the ob/ob

mice (Baskin et al., 1998), which were also sensitive to i.e.v.injection of leptin (Campfiel
et al., 1995; Wang et al., 1997a). Consistent with these studies, Boado et al (1998) showed
an up-regulation of leptin receptor mRNA as well as protein in the choroid plexus, which

might contribute to an increased transport of plasma leptin into the brain. It was reported
that i.c.v.injection of leptin decreased Arc NPY mRNA expression and inhibited food
intake (Schwartz et al., 1996a; Wang et al., 1997a), which was in agreement with my
finding that HFF mice had a higher level of plasma leptin concentration and decreased

calorie intake after 8 weeks of diet. Therefore, it was likely that a decreased energy inta
in HFF mice at the middle stage might be due to increased plasma leptin into the brain. I

had shown central leptin sensitivity to be normal at this stage also (Lin et al., 2000). The
increase in leptin receptor mRNA during the middle stage, along with my previously
reported decrease in food intake, suggested that homeostatic regulation of food intake was

still intact at this time. In contrast, body adiposity was significantly elevated and leptin

resistance was evident peripherally (Lin et al., 2000). This dissociation of control systems
of food intake and body adiposity needs further investigation.
Late stage
It has previously been shown that there are both peripheral and central leptin
resistance after prolonged HFF (Lin et al., 2000). The present study found that this was
accompanied by a significant decrease in LR mRNA in the ChP and Arc, similar to the
findings by Chang et al (1999). It had been hypothesised that the leptin receptor was an
autoreceptor (Huang et al., 1997) and a high plasma level of leptin might cause a down127

regulation of the leptin receptor, leading to the development of a vicious cycle with a
further increase in leptin production (Zimmet and Alberti, 1996). The down-regulation of
the leptin receptor mRNA after long-term high fat feeding, might contribute to increased
food intake and lead to increased adiposity in DIO mice. The mechanism causing downregulation of the leptin receptor mRNA was not known. However, this study showed that
there was a progressive increase of plasma leptin and a decrease in leptin sensitivity,

which implied a progressive desensitisation of the function of the leptin receptor by longterm stimulation.
In summary, long-term high fat feeding resulted in a progressive dysregulation of
energy balance homeostasis. This was characterized by sequential peripheral, then

peripheral plus central, leptin insensitivity accompanied by a rise, then fall, of brain lep
receptor mRNA. After longer-term exposure to high fat feeding, a more profound
breakdown occurred with overt hyperphagia and major obesity associated with the reduced
leptin receptor expression.
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Chapter 7
Detection of Expression Levels POMC mRNA and
a-MSH-LI Neurons in Hypothalamus of DIO Mice
7.1 Introduction
POMC was a precursor of three families of biologically active peptides, including
the adrenocorticotropins, melanotropins and P-endorphins (Weatherhead and Logan, 1981;
Cone et al., 1993; Tonon et al., 1993).
POMC mRNA was expressed in the Arc. The hypothalamic POMC pathway arises
from Arc neurons, which projected afferent fibers to the LHA and midbrain central gray

(Yoshida and Taniguchi, 1988; Schwartz et al., 1997; Flier and Maratos Flier, 1998; Elias
et al., 1999). The POMC projection between Arc and LHA was thought to play an

important role in regulating energy balance (Flier and Maratos Flier, 1998; Elias et al.,
1999). Hypothalamic alpha-melanocortin stimulating hormone like immunoreactive
neurons were found in two distinct groups, a-MSH-LI and a-2-MSH-LI group. (Saper et
al., 1986; Presse et al., 1990). The first group a-MSH-LI neurons were very heavily

stained and localized at the arcuate nucleus and adjacent retrochiasmatic area. The Arc a
MSH-LI neurons were derived from the precursor molecule POMC and projected to the
lateral hypothalamic area (Elias et al., 1999), and exerted an anti-obesity function via
inhibition of feeding behaviour and increased energy expenditure (Fan et al., 1997). The
second group a-2-MSH-LI neurons were derived from the melanocortin concentrating
hormone (MCH) precursor (Presse et al., 1990). Cross-reactivities detected with rat aMSH and neuropeptide E-I (NET) antisera were found in the MCH containing neurons in
the dorsolateral hypothalamic area (Presse et al., 1990; Cardot et al., 1994). The a-2-
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M S H - L I neurons were primarily located in the L H A and ZI at the level of the ventromedial
nucleus of the hypothalamus and projected to the hippocampal formation and the spinal

cord (Kohler et al., 1984; Saper et al., 1986). Arc was well recognized for its importan

role in regulation of food intake and homeostasis (Brady et al., 1990; Satoh et al., 199
Wang et al., 1997a). LHA was considered to be a 'hunger center', which was involved in
the regulation of food intake and decreased in parasympathetic and increased in
sympathetic activities (Yoshida et al., 1983; Bray, 1985).
It was found that Arc POMC neurons were co-localized with Arc leptin receptor
mRNA in the rodents (Cheung et al., 1997; Thornton et al., 1997). Leptin was thought to

influence energy balance via binding to the leptin receptor in the hypothalamus (Mercer
al., 1996b). Ob/ob and db/db mice had a decreased POMC mRNA expression in the
hypothalamus. The reduced POMC mRNA could be elevated by central administration of

leptin (Schwartz et al., 1997). These results indicated that leptin might somehow intera
with the POMC neuronal system. Fasting induced low leptin mRNA and its peptide
(Boden et al, 1996; Saladin et al., 1995) with a 24% decline in cellular POMC mRNA

expression in the hypothalamic arcuate nucleus in the rats (Bergendahl et al., 1992). Ta
together, these studies suggested that POMC was one of the leptin downstream pathways
in the hypothalamus (Friedman and Halaas, 1998), in which POMC might be involved in a
homeostatic loop by regulating feeding behavior, body fat mass and energy balance.
Several recent studies showed that mutations in the POMC gene might result in

early onset severe obesity in animal model and humans (Jackson et al., 1997; Krude et a
1998; Yaswen et al., 1999). Yaswen et al (1999) reported that a mutant mouse lack of
POMC-derived peptides had a greater food intake than wild-type littermates. After 6-7
months of feeding, the POMC-null mice showed obesity, defective adrenal development
and altered pigmentation. When treated with a-MSH agonist, the mutant mice reduced
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more than 4 0 % of body weigh after 2 weeks, showing a - M S H influenced body weight
mainly through food intake, or in combination with a direct effect of melanocortins on
adipocytes (Yaswen et al., 1999). Similar to POMC mutant mice, two research groups have
identified obese humans that related to mutations in the POMC gene (Jackson et al., 1997;
Krude et al., 1998). These findings demonstrated that the products of POMC gene had
influenced on body weight control and energy expenditure in the human.
Furthermore, the biological effects induced by hypothalamic POMC and a-MSH
was likely to be modulated by the activation of specific melanocortin receptors in the
hypothalamus (Adan and Gispen, 1997; Cone et al., 1996). MC4 receptor was an important

melanocortin receptor subtypes related to feeding behaviour and energy balance (Fan et al

1997; Giraudo et al, 1998; Rossi et al., 1998). Obesity in the lethal yellow (Ay/a) mice wa

caused by ectopic expression of the endogenous antagonist, agouti protein for melanocorti

receptor (Fan et al., 1997). In a transgenic mouse, over-expression of agouti-related prote
led to obesity (Ollmann et al., 1997). The Ay/a mice had a defect in the POMC signalling

in the brain and were resistant to the anorexigenic effect of leptin (Boston et al., 1997)

these results suggested that a defect in the POMC gene might play a role, at least partia
in genetic development of obesity.
It was well known that a high-fat diet could induce obesity in rodents and humans.
Although elevated hypothalamic NPY and decreased hypothalamic POMC were thought to
promote the development and maintenance of obesity, the mechanism mediating genetic

susceptibility to diet-induced obesity has still not been clearly elucidated. Bergen et a
(1999) reported that resistance to high-fat diet-induced obesity was associated with
increased POMC mRNA expression in the hypothalamus, suggesting that a high-fat diet
was involved in regulating the POMC gene. However, several reports found that a high-fat
diet did not change POMC mRNA expression in the hypothalamus (Guan et al., 1998;
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Harrold et al., 1999). The reason for such a discrepancy was unknown. It could be due to

the variations of the duration of high-fat diet of feeding, different dietary composition
different species and/or age of animals. This study was designed to investigate the
expression levels of POMC mRNA and a-MSH in the hypothalamus of DIO mice during
the three stages of development of high fat-diet induce obesity.

7.2 Detection of Expression Levels of POMC mRNA
7.2.1 Hypotheses.
Based on results arising from Chapters 4 - 7, the following hypotheses were
tested in this study:
The hypothalamic POMC system might be affected by high-fat diet feeding
during the 3 stages of progressive development of obesity.

7.2.2 Materials and Methods
7.2.2.1 Animals and Experimental Design
The same 36 mice were used for this part of study as in Chapter 6. The mice
were divided into two groups given a high and low fat diet, respectively (Fig. 7.1).
Six mice from each group were sacrificed after the feeding for 1, 8 and 19 weeks.
The level of POMC mRNA was measured for the evaluation of the role of POMC
in relation to the development of high fat diet induced obesity.

7.2.2.2 Histology
The procedures for tissue collection, brain section and pretreatment for in
situ hybridization detection of POMC mRNA expression were the same as those
described in the Histological Section of Chapter 6.
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36 C57B1/6J mice,
3 w k old, fed with lab chow for 1 w k

£

18 mice, high fat diet

18 mice, low fat diet

6 mice sacrificed from each group
after lwk feeding
6 mice sacrificed from each group
after 8 w k feeding

1

6 mice sacrificed from each group
after 19 w k feeding

All mouse brains were collected for the
detection of Arc P O M C m R N A

Fig. 7.1 Experimental design and assignment of mice

7.2.2.3

Probe Design and Labeling

One antisense oligonucleotide probe for POMC mRNA detection was
synthesized. The probe was 5'-CGTTCTTGATGATGGCGTTCTTGAAGAGCGTCACCAGGGGCGTCT-3' (J00612, 547-591). No known homology to
the designed probe was found in the Gene Bank. The oligonucleotide probe was

terminally labeled using a 10-fold molar excess of [ S] dATP (specific activity:
1000 Ci/mmol, Amersham, UK) and terminal transferase (Promega, USA), and
purified over a MicroSpin G-50 column (Amersham, UK). The probe concentration
is 107pcm of [35S] labeled probes in 750 ul hybridization solution.
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7.2.2.4

In Situ Hybridization

The hybridizations were carried out by incubating the sections in the
hybridization solution (detailed in Chap. 6.3.4). After the completion of exposure to
the Hyperfilm, the sections containing positive signals were dipped in Emulsion
solution (Amersham, UK) and then exposed NPY mRNA for 5 weeks. This
allowed a further examination of positive signals at a cellular level and for a
confirmation of the results from the film.

7.2.2.5 Quantification and Data Analysis
All films were analyzed by using a computer-assisted image analysis system,
Multi-Analyst, connected to a GS-690 Imaging Densitometer (Bio-Rad, USA).
(detailed in Chap. 6.3.5)

7.2.2.6 Statistical Analysis
All data are shown as mean ± S.E. for groups based on six mice in each
group. Analyses were performed using the JMP statistical package (SAS Institute,
Cary, NC, USA).

7.3 Results
7.3.1 Arc POMC mRNA Expression in the Early Stage
After 1 week of feeding, HFF mice showed no significant difference in the level
of POMC mRNA expression in the Arc (P = 0.9102), compared with LFF group (Fig.
7.2).

7.3.2 Expression Levels of Arc POMC mRNA in the Middle Stage
After 8-week feeding, there was still no significant difference in the level of
POMC mRNA expression in the Arc of HFF mice (P = 0.7301), compared with LFF
group (Fig. 7.2).
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7.3.3

Expression Levels of Arc P O M C m R N A in the Late Stage

After 19-week feeding, HFF mice showed a significant reduction (-55%) in the
level of POMC mRNA in the Arc (P = 0.004), compared with LFF group (Fig. 7.2).
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Figure 7.2 Histograms show that the P O M C m R N A expression in hypothalamic
arcuate nucleus of mice fed a high- or low-fat diet for 1, 8 and 19 weeks. All
values are expressed as mean ± S.E.; *P < 0.05; n = 6 per group.

7.4

Detection of Expression Levels of Hypothalamic a-MSH-LI

Neurons
7.4.1 Hypotheses
Based on results arising from Chapters 4-6, the following hypotheses were
tested in the present study:
Hypothalamic a-MSH-LI neurons may be changed in response to a high-fat
diet during 3 different stages in the development of obesity in the mice.
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7.4.2

Materials and Methods

7.4.2.1 Animal and Experimental Design
Same mice (36 mice) were used for this part of the study as in Chapter 5. The
mice were divided into two groups given a high and low fat diet, respectively (Fig
7.3). Six mice from each group were sacrificed after the feeding for 1, 8 and 19
weeks. The level of hypothalamic a-MSH-LI neurons was counted for the
evaluation of the role of a-MSH in relation to the development of high fat diet
induced obesity.

7.4.2.2 Histology
The procedures for tissue collection, brain section and pretreatment for aMSH-like immunoreactivity were the same as described in the Histological Section
of Chapter 5.

7.4.2.3 Detection of Hypothalamic a-MSH-LI Neurons
The detailed descriptions of technical procedures for immunohistochemistry
were described previously (see Chap. 5.3.4).

7.4.2.4 Counting the Hypothalamic a-MSH-LI Neurons
Sections were screened for visualisation of a-MSH-LI neurons using an
Olympus Bx50 microscope. In regions where differences in a-MSH-LI neurons
were readily apparent, a-MSH-LI neurons were counted following the area
outlined. Every third section was counted for each nucleus for quantitation of aMSH-LI neurons, according to the Atlas of the Mouse Brain in Stereotaxic
Coordinates (Franklin and Paxinos, 1997). a-MSH-LI neurons were based on the
relative size of the dark stained neurons in the hypothalamus. Comparisons were
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made between two groups stained at the same time. Comparisons between
experimental groups were performed by analysis of six animals per group and the
average of a-MSH neurons was determined from the both left and right sides, and
then all groups were pooled for final analysis.

7.4.2.5 Statistical Analysis
A microscope driven by an IBM compatible computer with the application
of Magellan Computer Program was used to obtain data concerning counting
positively stained a-MSH-LI neurons (Huang and Wang, 1998). All data were
shown as mean ± SE for two groups of mice and differences were analysed with

analysis of variance (ANOVA). The difference is considered statistically significa
ifP<0.05.
36 C57B1/6J mice,
3 w k old, fed with lab chow for 1 w k

v

v
18 mice, low fat diet

18 mice, high fat diet

6 mice sacrificed from each group
after 1-wk feeding

+
6 mice sacrificed from each group
after 8-wk feeding

6 mice sacrificed from each group
after 19-wk feeding

1
All mouse brains were collected for the
detection of hypothalamic a - M S H -LI neurons
Fig. 7.3. Experimental design and assignment of mice
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7.5

Results

This study counted hypothalamic a-MSH-LI neurons in mice fed either high fat or
low fat diets for 1, 8 and 19 weeks. The mouse hypothalamic a-MSH-LI neurons could be
divided into two types. Type 1 a-MSH-LI neurons were small sized and localized at Arc
only. Type 2 a-MSH-LI neurons were medium-sized found in LH and ZI. Both HFF and
LFF mice displayed no significant differences in the number of a-MSH-LI neurons in the
hypothalamus after 1 and 8-week feeding. However, after 19 week feeding, the number of
a-MSH-LI neurons was decreased in the hypothalamus of the HFF mice, including in the

Arc, LHA and ZI. The following sections showed the differences between the groups in th
number of a-MSH-LI neurons in the hypothalamus after 1, 8 and 19 weeks feeding.

7.5.1 Alpha-MSH-like Immunoreactive Neurons in the
Hypothalamic Arcuate Nucleus After 1, 8 and 19 Weeks of
Feeding
Compared with the LFF controls, there were no significant differences in aMSH-LI neurons after 1 and 8 weeks in the Arc of HFF mice (Fig 7.4). While after 19
weeks of feeding, compared with LFF mice, the HFF mice had a significant reduction
in the number of a-MSH-LI neurons in the Arc (-50%). (Figs.7.4 and 7.5).

7.5.2 Alpha-MSH-like Immunoreactive Neurons in the
Hypothalamus After 1-Week Feeding
In the hypothalamus, there were no significant differences in a-MSH-LI
neurons in the LHA and ZI after 1 week on the high-fat diet, compared with the low-fat
diet controls (Fig 7.6 and Table 7.1).
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Table 7.1 Distribution of the number of a-MSH-like immunoreactive neurons
in the hypothalamus of mice fed a high- or low fat diet for 1 week

HFF

LFF

(n = 6)

(n = 6)

P Value

LHA

10+2

8±2

0.2862

ZI

4+1

3±2

0.0820

Regions
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Figure 7.4 Histograms show that the a-MSH-like immunoreactive neurons in the
arcuate hypothalarnic nucleus of mice fed high- or low-fat diet for 1, 8 and 19 weeks.
All values are expressed as mean ± S.E.; *P < 0.05; n = 6 per group.

Figure 7.5 Photomicrographs showing a-MSH-like immunoreactive neurons in the
arcuate hypothalamic nucleus of mice fed high- (HFF) or low-fat diet (LFF) for 19
weeks. Arc: arcuate hypothalamic nucleus (A and A')
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Figure 7.6 Photomicrographs showing a-MSH-like immunoreactive neurones in the
hypothalamus of mice fed high- (HFF) or low-fat diet (LFF) for 1 week. L H A : lateral
hypothalamic area (A and A'); ZI: zona incerta (B and B')

7.53

Alpha-MSH-like

Immunoreactive

Neurons

in

the

Hypothalamus After 8-Week Feeding
In the hypothalamus, there were no significant differences in a-MSH-LI neurons

in the LHA and ZI after 8 week on the high-fat diet, compared with the low-fat die
controls (Fig 7.7 and Table 7.2).
Table 7.2 Distribution of the number of a-MSH-like immunoreactive neurons
in the hypothalamus of mice fed high- or low fat diet for 8 weeks
HFF

LFF

(n = 6)

(n = 6)

P Value

LHA

8± 2

10±3

0.1633

ZI

4±1

4+2

0.5517

Regions
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Figure 7.7 Photomicrographs showing a-MSH-like immunoreactive neurons in the
hypothalamus of mice fed high- (HFF) or low-fat diet (LFF) for 8 week. L H A : lateral
hypothalamic area (A and A'); ZI: zona incerta (B and B')

7.5.4

Alpha-MSH-like

Immunoreactive

Neurons

in

the

Hypothalamus After 19-Week Feeding
Compared with L F F mice, H F F mice had a significant reduction in the
number of a-MSH-like immunoreactive neurons in the L H A (-50%) after 19 weeks
of feeding [Fig. 7.8 and Table 7.3]. There were no significant differences in the
number of a-MSH-like neurons in the ZI after 19 weeks, on the high fat diet,
compared with the low fat diet controls [Fig. 7.8 and Table 7.3],
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Table 7.3 Distribution of the number of a-MSH-like immunoreactive neurons
in the hypothalamus of mice fed a high- or low fat diet for 19 weeks
HFF

LFF

(n = 6)

(n = 6)

.P Value

LHA

6±2

12 ±2

0.0012

ZI

4±1

3±2

0.5117

Regions

Figure 7.8 Photomicrographs showing a-MSH-like immunoreactive neurons in the
hypothalamus of mice fed high- (HFF) or low-fat diet (LFF) for 19 weeks. L H A :
lateral hypothalamic area (A and A'); ZI: zona incerta (B and B')

7.6

Discussion a n d Conclusion
Previous studies have demonstrated that P O M C was a part of down-stream

regulations of the leptin-leptin receptor and played an important role in the regulation of
energy balance (Schwartz et al., 1997; Friedman and Halaas, 1998). Recently m y study
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(Lin et al., 2000) showed that a high fat diet led to progressive development of obesity and

leptin resistance in C57 Bl/6 mice with a middle stage of peripheral, but not central, lep
resistance. This stage was characterized by increased fat accumulation despite relative

hypophagia. At a later stage central leptin resistance ensued along with hyperphagia, rapi

weight and fat gain (Lin et al., 2000). Using the animal model, this study was designed to
characterise POMC gene and its peptide a-MSH expression in the early, middle and late

stages of the mice during the course of the development of diet-induced obesity. The major
findings of the study were: (1) no significant changes in Arc POMC mRNA and a-MSHLI neurons in the early and middle stages; (2) only at the late stage, but major, declined
Arc POMC mRNA expression and a-MSH-LI neurons in the Arc and LHA, respectively.
The results suggested that there was a down-regulation of POMC mRNA and its peptide in
the late stage of diet-induced obesity.
Early stage
This study showed that, after 1-week diet, HFF mice had no significant changes in
body weight, calorie intake, plasma leptin and the levels of the POMC mRNA and aMSH-LI neurons compared with the LFF group. Consistent with the results showing that
the mice fed a high fat diet for 1-week had not developed leptin resistance and

hyperphagia, suggesting that short-term exposure to a high fat diet did not alter the POMC
gene expression and its product a-MSH.
Middle stage
Consistent with a previous study (Harrold et al., 1999), this study showed that no
significant changes in Arc POMC mRNA and hypothalamic a-MSH-LI neurons were
detected between HFF and LFF after a high-fat diet feeding for 8 weeks. Furthermore, this
study found that, at the middle stage, the HFF mice were relatively hypophagic with a
+223% increase in plasma leptin, and showed no significant reduction in food intake and
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body weight after an i.p. leptin injection, which indicated the existence of peripheral leptin

insensitivity. It has been reported that i.c.v. injection of leptin inhibited food intake
increase in POMC mRNA and decrease in Arc NPY mRNA expression (Schwartz et al,
1997; Wang et al., 1997a), which were similar to my findings that the HFF mice had a
higher level of plasma leptin concentration and hypophagia after 8 weeks of diet.
However, at this stage, no changes in POMC mRNA expression were found in HFF mice,
suggesting that there might be an abnormal POMC gene regulation after 8 weeks of high-

fat diet. In addition, this study found that, although there was an increased plasma leptin

and peripheral leptin insensitivity, the HFF mice showed that central leptin sensitivity s
remained normal. In Chapter 8, it was found that, in response to the high plasma leptin
there were down-regulations of Arc NPY mRNA and NPY protein in the hypothalamus of
the HFF mice. These results suggested that the middle stage mainly represented a

physiological regulative stage in response to high-fat diet stimulation in the animal mode
The no alteration of POMC gene expression and its peptide a-MSH in the hypothalamus
suggested that breakdown of POMC pathway occurred earlier than that of NPY pathway in
the animal model since Arc NPY mRNA could still be down-regulated at this stage (see
Chapter 8).
Late stage
My previous study found that both peripheral and central leptin resistance after
prolonged HFF, showing significant less food intake and body weight reductions after an

i.c.v. leptin injection, compared with the mice fed a low-fat diet (Lin et al., 2000). Thi
study showed that POMC mRNA was significantly low at the later stage. As it was known
that leptin stimulated POMC mRNA expression (Schwartz et al., 1997). Obviously it was
not the case here. It was possible that the downstream of POMC pathway was blocked in
this stage. Another possible mechanism could be due to reduced efficiency in transporting
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leptin into the brain, as a down-regulated choroid plexus leptin receptor m R N A expression
was seen in this study (see chapter 6). Taken together, the results of Arc POMC mRNA
suggested that the breakdown in regulation of the POMC pathway was an important
element in the major dys-regulation after chronic, long-term high fat feeding.
Another finding in this study was that, consistent with down-regulation of Arc
POMC mRNA, HFF mice had a decrease in POMC gene product a-MSH in Arc and LHA.
The lateral hypothalamus was known as a feeding center involved in regulating
sympathetic activity and adiposity (Bray et al., 1981; Bray, 1984). Destruction of the LHA
produced graded hypophagia and weight loss with an increase in peripheral
nonepinephrine turnover and metabolic rate (Yoshida et al., 1983). Previous studies
showed that a high fat diet induced obese mice had high parasympathetic activity and a
low metabolic rate (Matsuo et al., 1995; Matsuo and Suzuki, 1997). Elias et al (1999)
reported that leptin induced Fos expression in Arc POMC neurons of rats and the neurons
were also innervated to the LHA. They suggested that leptin directly engaged POMC
neurons that projected to the LHA linking circulating leptin and neurons that regulated
feeding behaviour and body weight homeostasis (Elias et al., 1999). The present study
showed that HFF mice had a reduction of central leptin sensitivity with a low level of aMSH in the LHA, suggesting that such a reduction might result in a reduction of

sympathetic outflow to contribute to dramatically increased body fat mass after a long-ter
high fat diet feeding.
In summary, high fat feeding resulted in a progressive dys-regulation of energy
balance homeostasis. After a longer-term exposure to a high-fat diet, a more profound
breakdown occurred with overt hyperphagia and major obesity associated with failure of
leptin stimulation of the POMC system.
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Chapter 8
NPY mRNA expression and NPY-like Immunoreactive
Neurons in the Hypothalamus of DIO Mice
8.1 Introduction
NPY stimulated food intake and decreased energy expenditure, as it was

administered into the third ventricle or various regions of hypothalamus (Clark et al., 198

Matsuda et al., 1993; Zarjevski et al., 1994). Billington et al (1991) reported that i.c.v.
injection of NPY decreased brown adipose tissue thermogenesis and increased fat storage
in white adipose tissue of the rat. Also administration of NPY into hypothalamic PVN had

a significant effect on food intake and sympathetic activity. Microinjection of NPY into th
hypothalamic PVN showed a significantly suppressed the sympathetic nerve activity to
brown adipose tissue (BAT) (Egawa et al., 1991). Injection of NPY into hypothalamic
PVN also induced hyperphagia, obesity, and increased secretion of insulin, glucagon and

corticosterone in the rats (Billington et al., 1994; Frankish et al., 1995; Shibasaki et al
1995). These results suggested that increased NPY-ergic activity in the hypothalamus
might be responsible for change of feeding behavior and neuroendocrine abnormalities and
produced central effects on modulating positive energy balance.
A co-localization of leptin receptor and NPY mRNAs had been found in the Arc of
rodents (Hakansson et al., 1996; Mercer et al., 1996a; Baskin et al., 1999b). NPY had been
suggested as a downstream effector of leptin actions on feeding and energy balance
(Friedman and Halaas, 1998). Hypothalamic NPY mRNA and protein levels had been
measured in a number of animal models of obesity. Most genetically obese rodents, such as
ob/ob, db/db and fatty (fa/fa) Zucker rats, showed significant increases in NPY

concentration in the hypothalamus (Sanacora et al., 1990; Schwartz et al., 1996a). The fatty
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Zucker rats were characterized by hyperphagia, hyperinsulinemia and low brown adipose

tissue thermogenesis (Frankish et al., 1995). The streptozocin-induced diabetic rats had a
increased in NPY concentrations in the PVN of hypothalamus (Williams et al., 1988; Sahu
et al., 1992), suggesting the increased NPY secretion in the PVN might be responsible for
hyperphagia in the diabetic rats.
Central administration of leptin appeared to reduce expression levels of NPY
mRNA in the Arc and NPY protein in the Arc, PVN and DMH, indicating inhibition of
NPY synthesis in the hypothalamus (Stephens et al., 1995; Wang et al., 1997a). After 6

days i.c.v.insulin infusion on streotozotocin-induced diabetic rats, the hypothalamic NPY
mRNA was reduced by 40% and diabetic hyperphagia was reduced by 58% (Sipols et al.,
1995). Adrenalectomy reduced NPY mRNA expression levels in the Arc due to a low
plasma corticosterone stimulation (White et al., 1990), while central corticosterone
replacement restored NPY elicit feeding and weight gain (King, 1988). Altogether, these
results suggested that the hypothalamic NPY pathway was one of the central neuronal

regulators that responds to negative feedback in proportion to peripheral signal fat mass
and body energy stores.
In the diet induced obese animal model, after 14 weeks on the high fat diet, LongEvans rats increased in 30% body weight with 28% and 48% reduction of NPY
concentration in Arc and PVN (Beck et al., 1994). Consistent with the result, Guan et al

(1998) also reported that, after high-fat diet feeding for 23 weeks, diet induced obese m
had a 44% decreased in Arc NPY mRNA expression. However, inconsistent with these
results, Wilding et al (1992) measured the hypothalamic NPY mRNA by Northern blotting
in the rat after feeding a high-fat diet for 7 weeks. They found that hypothalamic NPY
mRNA was unchanged in the obese rat compared with lean controls (Wilding et al., 1992).
In another study, Levin et al (1997) reported that 39% increased Arc NPY mRNA was

observed in obese rats after 2 weeks high fat diet feeding. Altogether, these results imp
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that high-fat diet induced obesity might or might not influence the N P Y m R N A expression
in the hypothalamus of rodents.
Using a radioactive in situ hybridisation detection method and a computer-assisted
image analysis system, the present study was designed to re-examine the expression levels
of NPY mRNA in the hypothalamus of high-fat diet induced obese mice. Furthermore, this
study also investigated the NPY protein in the hypothalamus during the courses of
progressive development of high fat diet induced obesity at 3 stages.

8.2 Hypothalamic Neuropeptide Y mRNA Expression in DIO Mice
8.2.1 Hypotheses
Based on results arising from Chapters 4-7, the following hypotheses were
tested in the present study:
The hypothalamic NPY system might be affected by high-fat diet feeding
during the 3 stages of progressive development of obesity.

8.2.2 Materials and Methods
8.2.2.1 Animals Experimental Design
The same 36 mice were used for this part of the study as in Chapter 6. The
mice were divided into two groups and given high and low fat diets, respectively
(Fig 8.1). Six mice from each group were sacrificed after the feeding for 1, 8 and 19
weeks. The level of NPY mRNA was measured for the evaluation of the role of
NPY in relation to the development of high fat diet induced obesity.

8.2.2.2 Histology
The procedures for tissue collection, brain section and pretreatment for in
situ hybridization detection of NPY mRNA expression were the same as those
described in the Histological Section of Chapter 6.
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36 C57B1/6J mice,
3 wk old, fed with lab chow for 1 wk

18 mice, high fat diet

18 mice, low fat diet

6 mice sacrificed from each group
after lwk feeding

6 mice sacrificed from each group
after 8 wk feeding

A

6 mice sacrificed from each group
after 19 wk feeding

All mouse brains were collected for the
detection of hypothalamic N P Y m R N A

Figure 8.1. Experimental design and assignment of mice

8.2.2.3 Probe Design and Labeling
One antisense oligonucleotide probe complementary to the specific NPY
mRNA was synthesized. The probe is 5'-GAGTGTATCTGGCCATGTCCTCTGCTGGCGCGTCCTCGCCCGG-3' (M15792, 1650-1693). No known

homology to the designed probe was fund in the Gene Bank. The oligonucl

probes were terminally labeled using a 10-fold molar excess of [35S] dAT

(specific activity: 1000 Ci/mmol, Amersham, UK) and terminal transferas

(Promega, USA), and purified over a MicroSpin G-50 column (Amersham, UK

The probe concentration is 107 pern of [35S] labeled probes in 750 (xl h
solution.
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8.2.2.4

In Situ Hybridization

The hybridizations were carried out by incubating the sections in the
hybridization solution (detailed in Chap. 6.3.4). After the completion of exposure to
the Hyperfilm, the sections containing positive signals were dipped in Emulsion
solution (Amersham, UK) and then exposed NPY mRNA for 5 weeks. This
allowed a further examination of positive signals at cellular level and for a
confirmation of the results from the film.

8.2.2.5 Quantification and Data Analysis
All films were analysed by using a computer-assisted image analysis
system, Multi-Analyst, connected to a GS-690 Imaging Densitometer (Bio-Rad,
USA) (detailed in Chap. 6.3.5).

8.2.2.6 Statistical Analysis
All data are shown as mean ± S.E. for groups based on six mice in each
group. Analyses were performed using the IMP statistical package.

8.3 Results
8.3.1 Arc NPY mRNA Expression in the Early Stage
After 1-week feeding, HFF mice showed no significant difference in the level
of NPY mRNA expression in the Arc {P = 0.9044), compared with LFF group (Fig.
8.2).

8.3.2 Arc NPY mRNA Expression in the Middle Stage
After 8-week feeding, there were -45% significant decrease in the level of NPY
mRNA expression in the Arc of HFF mice {P = 0.0062), compared with LFF group
(Fig. 8.2).
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8.3.3

Arc N P Y m R N A Expression in the Late Stage

After 19-week feeding, HFF mice showed a significant reduction (-32%) in the
level of NPY mRNA in the Arc (P = 0.0099), compared with LFF group (Fig. 8.2).

NPY m R N A Expression in Arc
1600
1400

• High Fat Diet
• Low Fat Diet

E -1200
a. 31000
zw
H-

f

tL 800 -

O O)
OJ O 600 -

> c
» w 400 .
£ 200-

•
19
Feeding Period (Weeks)

Figure 8.2 Histograms show that the N P Y m R N A expression in hypothalamic
arcuate nucleus of mice fed a high- or low-fat diet for 1, 8 and 19 weeks. All
values are expressed as mean ± S.E.; *P < 0.05; n = 6 per group.

8.4

Detection of Expression Levels of Hypothalamic NPY-like

Immunoreactive Neurons and Varicosities
8.4.1 Hypotheses
Based on results arising from Chapters 4 - 7, the following hypotheses were
tested in the present study:
Hypothalamic NPY-LI neurones and varicosities might be changed in response
to a high-fat diet during 3 stages of high fat diet induced obesity in mice.
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8.4.2

Materials and Methods

8.4.2.1 Animal and Experimental Design
The same 36 mice were used for this part of the study as in Chapter 5. The
mice were divided into two groups given high and low fat diet, respectively (Fig
8.3). Six mice from each group were sacrificed after the feeding for 1, 8 and 19
weeks. The level of hypothalamic NPY-LI neurons was counted for the evaluation
of the role of NPY in relation to the development of high fat diet induced obesity.

8.4.2.2 Histology
The procedures for tissue collection, brain section and pretreatment for
NPY-like immunoreactivity were the same as those described in the Histological
Section of Chapter 5.

8.4.2.3 Detection of Hypothalamic NPY-LI Neurons and
Varicosities
The detailed descriptions of technical procedures for immunohistochemistry
were described previously (see Chap. 5.3.3).

8.4.2.4 Counting the Hypothalamic NPY-LI Neurons and
Varicosities
Sections were screened for visualisation of NPY neurons and NPY
varicosities using an Olympus Bx50 microscope. In regions where differences in
NPY neurons and NPY varicosities were readily apparent, NPY neurons and NPY
varicosities were counted following the area outlined. Every third section was
counted for each nucleus for quantitation of NPY neurons or varicosities, according
to the Atlas of the Mouse Brain in Stereotaxic Coordinates by Franklin and Paxinos
(1997). NPY neurons or varicosities were based on the relative size of the dark
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stained neurons or varicosities in the hypothalamus. Comparisons were made
between two groups stained at same time. Comparisons between experimental
groups were performed by analysis of six animals per group and the average of
NPY neurons or varicosities was determined from both left and right sides, and
then all groups were pooled for final analysis.

36 C57B1/6J mice,
3 w k old, fed with lab chow for 1 w k

18 mice, low fat diet

18 mice, high fat diet

6 mice sacrificed from each group
after 1-wk feeding

6 mice sacrificed from each group
after 8-wk feeding

i
6 mice sacrificed from each group
after 19-wk feeding

All mouse brains were collected for the
detection of hypothalamic N P Y - L I
neurons and varicosities

Figure 8.3 Experimental design and assignment of mice used in this study

8.4.2.5

Statistical Analysis

A microscope driven by an IBM compatible computer with the application of
Magellan Computer Program (Huang and Wang, 1998) was used to obtain data
concerning counting positively stained NPY-LI neurons and varicosities. All data
were shown as mean ± SE for two groups of mice and differences were analyzed
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with analyses of variance ( A N O V A ) . The difference is considered statistically
significant ifP< 0.05.

8.5 Results
The present study examined hypothalamic NPY-LI neurons and varicosities in mice

fed either a high- or low fat diet for 1, 8 and 19 weeks. Overall, the hypothalamic NPY-L
neurons were localized at Arc. No significant differences of the numbers of Arc NPY-LI
neurons and hypothalamic varicosities were found in both HFF and LFF after 1-week
feeding. However, the number of NPY-LI neurons in the Arc and varicosities in the DMH
and PVN decreased in the HFF mice after 8 weeks feeding, while they increased in the

HFF mice after 19 weeks feeding. In addition, no significant differences of the number o
NPY-LI varicosities in the LHA were found in both HFF and LFF mice after 8 and 19
weeks feeding. The following sections showed the differences between the groups in the
numbers of NPY-LI neurons and varicosities in the hypothalamus after 1, 8 and 19 weeks
feeding.

8.5.1 NPY-like Immunoreactive Neurons in the Hypothalamic Arc
After 1,8 and 19 Weeks of Feeding
In the hypothalamus, compared with the low-fat diet controls, there were no
significant differences in NPY-LI neurons in the Arc after 1 week on the high-fat diet
(Fig. 8.4). Compared with LFF mice, the HFF mice had a significant decrease in the
number of NPY-LI neurons in the Arc (-80%) after 8 weeks of feeding (Fig 8.4). While
after 19 weeks of feeding, the HFF mice showed a significant increase in the number of
NPY-LI neurons in the Arc (+70%), compared with LFF mice (Figs. 8.4 and 8.5)
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8.5.2

NPY-like Immunoreactive Varicosities in the Hypothalamus

After 1-Week Feeding
In the hypothalamus, there were no significant differences in NPY-LI
varicosities in the DMH, PVN and LHA after 1 week on the high-fat diet, compared
with the low-fat diet controls (Fig 8.6 and Table 8.1).

8.5.3 NPY-like Immunoreactive Varicosities in the Hypothalamus
After 8 -Week Feeding
Compared with LFF mice, HFF mice had a significant decrease in the number of
NPY-like immunoreactive varicosities in PVN (-43%) after 8 weeks of feeding (Fig

8.7 and Table 8.2). There were no significant differences in NPY-LI varicosities in t
DMH and LHA after 8 week on the high-fat diet, compared with the low-fat diet
controls (Fig 8.7 and Table 8.2).

8.5.4 NPY-like Immunoreactive Varicosities in the Hypothalamus
After 19-Week Feeding
Compared with the LFF mice, HFF mice had a significant increase in the
number of NPY-like immunoreactive varicosities in DMH (+72%) and PVN (+35%).

(Fig. 8.8 and Table 8.3). There were no significant differences in the number of NPY-

LI varicosities in the LHA after 19 weeks on the high fat diet, compared with the low
fat diet controls (Fig. 8.8 and Table 8.3).
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Table 8.1 Distribution of the number of NPY-like immunoreactive
varicosities in the hypothalamus of mice fed a high or low fat diet
for 1 week

HFF

LFF

(n = 6)

(n = 6)

P Value

DMH

584 ± 52

504 ±44

0.0771

PVN

1536 ±239

1434 ±79

0.3438

LHA

802 ±146

762 ± 89

0.5785

Regions

Table 8.2 Distribution of the number of NPY-like immunoreactive
varicosities in the hypothalamus of mice fed a high or low fat diet
for 8 weeks

HFF

LFF

(n = 6)

(n = 6)

P Value

DMH

675 ±146

751 ± 86

0.2938

PVN

1168 ±183

1667 ±134

< 0.0001

LHA

469 ± 80

494 ± 47

0.5044

Regions

Table 8.3 Distribution of the number of NPY-like immunoreactive
varicosities in the hypothalamus of mice fed a high fat or low fat diet
for 19 weeks

HFF

LFF

(n = 6)

(n = 6)

P Value

DMH

1157 ±170

672 ± 70

< 0.0001

PVN

2172 ±171

1606 ± 97

< 0.0001

LHA

487 ± 60

518 ± 8 0

0.4728

Regions
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Figure 8.4 Histograms show that the NPY-like immunoreactive neurons in the
arcuate hypothalamic nucleus (Arc) of mice fed a high or low fat diet f
19 weeks. All values are expressed as mean + S.E.; *P < 0.05; n = 6 per

Figure 8.5 Photomicrographs showing NPY-like immunoreactive neurons in the arcuate
hypothalamic nucleus of mice fed a high (HFF) (A) or low fat diet (LFF) (A
weeks. Arc: arcuate hypothalamic nucleus
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Figure 8.6 Photomicrographs showing NPY-like immunoreactivity in the hypothalamus of
mice fed a high (HFF) or low fat diet (LFF) for 1 week. P V N : paraventricular
hypothalamic nucleus (A and A'); D M H : dorsomedial hypothalamic nucleus (B and B');
L H A : lateral hypothalamic area (C and C ) ; third ventricle (3V)
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Figure 8.7 Photomicrographs showing NPY-like immunoreactivity in the hypothalamus of
mice fed a high (HFF) or low fat diet (LFF) for 8 weeks. P V N : paraventricular
hypothalamic nucleus (A and A'); D M H : dorsomedial hypothalamic nucleus (B and B');
L H A : lateral hypothalamic area (C and C*); third ventricle (3V)
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Figure 8.8 Photomicrographs showing NPY-like immunoreactivity in the hypothalamus of
mice fed a high (HFF) or low fat diet (LFF) for 19 weeks. P V N : paraventricular
hypothalamic nucleus (A and A'); D M H : dorsomedial hypothalamic nucleus (B and B');
L H A : lateral hypothalamic area (C and C ) ; third ventricle (3V)

160

8.6

Discussion and Conclusion

Obesity was the most common nutritional disorder associated with an increased
risk of cardiovascular diseases and type II diabetes. In the genetically C57B1/6J ob/ob
mice, lack of functional leptin, resulted in profound obesity syndrome characterized by
hyperphagia, hyperglycaemia, and hypometabolism. Lean C57 B1/6J mice carried the
genetic predisposition. If the mice fed a high-fat diet for a long period, obesity could
developed and hyperleptinemia and hyperinsulinemia might occur, which closely
resembled common forms of human obesity and type II diabetes. It was reported that diet
induced obese animals had a changed levels of NPY mRNA or NPY protein in the
hypothalamus (Beck et al., 1994; Levin and Dunn Meynell, 1997; Guan et al., 1998).
Previous studies had shown that NPY was down-stream of leptin-leptin receptor
and played an important role in the regulation of energy balance (Friedman and Halaas,
1998). My study (Lin et al., 2000) showed that the development of diet-induced obesity in
C57 mice featured sequential peripheral then central leptin resistance and progressive
breakdown of energy balance homeostasis. This study was designed to investigate the
mRNA and protein levels of NPY during the courses of progressive development of

peripheral and central leptin resistance at 3 defined stages of high fat diet-induced obe
in mice. The main findings of this study were: no change in both mRNA and protein at an
early stage, a decrease in both Arc NPY mRNA and protein at the middle stage and a
decrease in Arc NPY mRNA but an increase in protein at the later stage. The current

results suggested that altered NPY mRNA in the Arc might be partially responsible for the
cause of dysfunction of energy balance with long-term high fat feeding.
DIO mice were induced by exposure to a high-fat diet for 19 weeks. Compared
with the mice fed a low-fat diet, HFF mice increased in body weight by 4.1% after 1-week
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feeding, and increased in body weight by 30.5% and 5-folds plasma leptin after 19 weeks
of feeding. The present study found that, at the middle stage of development of dietinduced obesity, the increased body weight and plasma leptin were accompanied by a
reduction of NPY mRNA and protein expression in the Arc of the HFF mice. The results
suggested that increased plasma leptin might be responsible for inhibiting the Arc NPY
mRNA expression in the HFF mice. However, at the late stage of development of diet
induced obesity, the increased body weight, calorie intake, plasma leptin and reduced
central leptin sensitivity were accompanied by a reduction of NPY mRNA but increased in
protein expression in the Arc of the HFF mice. The results suggested that the mechanism
of reduction of Arc NPY mRNA level, rather than from high plasma leptin, might be
caused by inhibition of the high levels of NPY production at this stage.
Early stage
This study showed that, after 1-week diet, HFF mice showed no significant
differences in the amount of visceral fat, plasma leptin and the levels of the NPY mRNA
compared with the LFF group. The results indicated that a 1-week exposure to a high fat

diet did not alter the gene expression of NPY and its product. This was consistent with m

previous results presented in this thesis, which showed that the mice fed a high fat diet

1-week had not developed leptin insensitivity and hyperphagia (Lin et al., 2000). The lack
of effect of 1-week of high fat feeding on NPY mRNA and protein levels suggested no
direct gene regulation and production effect in relation to NPY system in this stage.
However, Levin et al (1997) reported that 29% increased Arc NPY mRNA was observed

in DIO-prone rats after 2 weeks of a high-fat diet. The inconsistent results between Levi
et al and present study suggested that the regulation of Arc NPY mRNA expression in the
HFF mice was not defective, at least in this stage, after 1-week feeding.
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Middle stage
In the middle stage of the development of obesity, the HFF mice were relatively
hypophagic with peripheral, but not central, leptin insensitivity (Lin et al., 2000). This
study showed that there was a significant -45% decrease in the levels of NPY mRNA in
the Arc, and -80% and -43% reduction in NPY protein in the Arc and PVN. Decreased
NPY mRNA expression levels in the Arc were also reported in the long-Evans rats fed a
high fat diet for 14 weeks compared with the rats fed a low fat diet (Beck et al., 1994).
These results suggested that a high-fat diet feeding might alter the Arc-PVN axis to lead
a counter-regulatory effect for limiting consumption of food and fat deposition. The
decreased NPYergic activity in the Arc-PVN axis might contribute to an attempt to

increase thermogenesis and then to a decreased fat storage (Beck et al., 1994). In addition
peripheral but not central leptin resistance and 3-fold increase in plasma leptin in HFF

mice might induce an increased central leptin sensitivity, in turn, to up-regulate leptinleptin receptor-NPY pathway and inhibit NPY mRNA expression and then result in a

decreased NPY production (Van et al., 1997). Consistent with these results, this study (see
Chapter 6) showed an up-regulation of the leptin receptor mRNA in choroid plexus and
Arc of HFF mice, which might contribute to increased transport of plasma leptin into the
brain and increase in hypothalamic leptin sensitivity. It has been reported that
i.c.v.injection of leptin decreased Arc NPY mRNA expression (Schwartz et al., 1996a;
Wang et al., 1997a), which corresponded to my findings that HFF mice had a higher level
of plasma leptin concentration after 8 weeks of diet. Finally, decreased energy intake in
HFF mice at the middle stage might be due to decreased Arc NPY mRNA expression in
these mice. The increase in the leptin receptor and a decrease in NPY during the middle
stage, along with low energy intake shown in Chapter 3, suggested that homeostatic
regulation of food intake was still intact at this stage.
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Late stage
This study (see Chapter 6) showed that both peripheral and central leptin resistance
after prolonged HFF accompanied by a low expression levels of NPY mRNA in the Arc.
Interestingly, at this stage, NPY protein levels were increased in several hypothalamic
regions including Arc, PVN and DMH. The mechanism causing inconsistent expression
levels between the NPY mRNA and NPY protein production was not known. A possible
explanation was that after long-term high fat feeding HFF mice might increase in NPY
protein levels in the hypothalamus, and then negative feedback to inhibit NPY mRNA
expression levels in the Arc. The up-regulation of NPY protein after long-term high fat

feeding, might contribute to increased food intake and lead to increased adiposity in the
DIO mice. In addition, Kesterson et al (1997b) reported that both obese AY/a and MC-4
receptor knockout mice significantly increased NPY mRNA expression in the DMH. The
present study also found that there was a high NPY protein expression in the DMH of DIO
mice. These results suggested that the highly elevated NPY protein in the DMH of DIO

mice might partially contribute to the progressive development of leptin resistance in th

animal model. Finally, at the late stage, the present study found that the NPY protein st
showed no significant change in the LHA, suggesting that LHA NPY might not play a
main role in development of the DIO mice. In addition, the present study showed that the

levels of NPY contents vary within the same group at different ages of their lives (Wks 5
12, and 23). These phenomena are also seen in the levels of mRNA expressions for leptin
receptor, NPY and POMC (Chapters 6, 7 and 8). However, the comparisons were made at
particular time points between high and low fat feedings. Therefore, the differences in

mice between high and low fat feedings are an indication of mice response to the diets at

that particular time point. These data cannot conclude that mice will respond to high fat
diet in the same way if they start a high fat diet in the late age of their lives.
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In summary, long-term high fat feeding resulted in a progressive dysregulation of
energy balance homeostasis. The decline in NPY mRNA levels was associated with at

least partially successful food intake, if not adiposity, homeostasis. However, after long
term exposure to high fat feeding, a more profound breakdown occurred with overt
hyperphagia and major obesity associated with the low NPY mRNA but high NPY protein
expression in the hypothalamus, which implied a progressive dysfunction of NPY pathway
by the long-term high-fat diet stimulation.
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Chapter 9
Conclusions and Recommendations
9.1 Overall Conclusions
The present study showed that a high-fat diet induced obesity in C57 B1/6J mice
was a progressive course of development and could be divided into three stages over 19
weeks of feeding. (1) Early stage: High-fat diet gradually induced body weight gain with
sensitive to exogenous leptin; (2) Middle stage: The reduced food intake stage when mice

had an increase in leptin production and still remained central leptin sensitivity; and (3)
Late stage: The increased food intake stage, showing a dramatic increase in feeding
efficiency and plasma leptin, accompanied by a reduction of central leptin sensitivity.
The present study concluded that increased FLI activity in the LHA, DMH, Arc and
PeF of obese mouse might be involved in the central mechanisms of the high-fat diet
induced obesity. A long-term high fat feeding resulted in a progressive dysregulation of
energy balance homeostasis and characterized by sequential peripheral, then peripheral

plus central, leptin insensitivity accompanied by a rise, then fall, of brain leptin recepto
mRNA. This rise, and associated decline in NPY mRNA levels, was associated with at

least partially successful food intake, and if not adiposity, homeostasis. After a longer-te
exposure to high fat feeding, a more profound breakdown occurred with overt hyperphagia
and major obesity, associated with the reduced leptin receptor expression and failure of
leptin stimulation of the POMC system.
These observations might lead to a better understanding of the relationship between
the neuropeptide signalling pathway and dietary effects in the development of obesity.
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9.2

Recommendations for Further Research

Based on findings of the present thesis, recommendations for further research are
listed below.
(1) Further research is recommended to extend the high fat-diet feeding period in the
DIO mice to produce diabetic mouse model, and then investigate changes in central
leptin receptor, NPY and POMC systems compared with the results of the present
study.
(2) It is recommended to use the DIO mice model to examine the effects of possible
anti-obesity drugs.
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